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ABSTRACT 
The calcium signal has emerged as an imponant component of intracellular regulation. Pineal 
function was thought to be slowed by the prominent calcification seen with increasing age, but 
recently it has been shown that calcium plays a crucial role in the adrenergic regulation of the gland. 
Beta-adrenoceptor stimulation increases melatonin (aMT) synthesis by increasing the activity of 
cyclic 3 '-5' adenosine mono phosphate (cAMP). Cyclic-AMP regulates the production of the pineal 
hormone, melatonin, from serotonin via the rate-limiting enzyme N-acetyltransferase (NAT). 
Increased intracellular cAMP is essential to the adrenergic induction of NAT. Noradrenaline(NA) 
also elevates pinealocyte cyclic guanosine monophosphate (cGMP). Adrenergic regulation of these 
cyclic nucleotides involves both al - and {3-adrenoceptors. Beta-adrenoceptor stimulation is an 
absolute requirement. Alphal-adrenoceptor activation, which is ineffective alone, serves to amplify 
the {3-stimulated cAMP and cGMP responses via a positive effect on a Ca2+-/ phospholipid-
depep.dent protein kinase (Protein kinase-C) and a net influx ofCa2+ into the pinealocyte. 
Previous studies suggest the use of organic calcium channel blockers (CCBs) as probes of 
calcium-mediated processes. Applying this concept, the study set out to investigate the influence of a 
representative of each of the structurally diverse groups of calcium channel blockers viz. verapamil, 
diltiazem and nifedipine, and to examine their effect on {3-adrenoceptor stimulation. It used the {3-
agonist isoprenaline (ISO) and the mixed [a/{3} agonist noradrenaline (NA), for its combined 
[a/{3}-adrenoceptor stimulation, on agonist-induced increases in the production of radio-labelled 
aMT and N-acetylserotonin(aHT) -measured as the sum of N-acetylated product- from [14C}_ 
serotonin. This was done using organ cultures of rat pineal glands. It was speciously assumed that 
this drug paradigm would allow the determination ofCa2+ influx and/or the blocking thereof in the 
reponed potentiation by using ISO as a non Ca2+ -entry stimulating agonist, compared with NA and 
its Ca2+ -entry stimulating propenies. Surprisingly, all 3 CCB's potentiated the effect of NA. Only 
diltiazem was found not to potentiate the effect of ISO. 
In an attempt to uncover the reason for these results, the study moved toward a mechanistic 
approach,focusing in an antecedent manner on the various steps in the indole metabolic pathway to 
identify the point at which the change occurred, and hence possibly elucidate the mechanism 
responsible for the paradoxical increase. 
Experiments which assayed the levels of NAT, under the same drug conditions, showed the 
paradoxical increase to be already evident at this stage. Secondary experiments confirmed that NA 
stimulation of the pineal is dependent on Ca2+, both in organ culture and with NAT.· the Ca2+ 
chelator EGTA abolished adrenergically-induced stimulation, while Ca2+ added after EGTA, 
restored the enzyme activity. The ionophore A23187 (which is able to transpon Ca2+ directly into the 
pinealocyte via a mechanism which differs from the at - mechanism) when used in conjunction 
with ISO or NA, was able to potentiate the responses of these two agonists relative to control values 
(agonist-alone), but by itself had no effect. 
With the enzyme NAT critically dependent upon cAMP for its induction, it was decided to determine 
the levels of cAMP and then those of its regulator, cAMP-phosphodiesterase (cAMP-PDE). This 
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reasoning was prompted by reports of anti-calmodulin activity shown by the CCBs, in addition to 
their channel blocking effects. By binding to calmodulin (CaM), the CCBs are reportedly able to 
inhibit the CaM-dependent activation of cAMP-PDE. Following NA stimulation, verapamil caused 
a significant decrease in cAMP-PDE levels and an increase in cAMP. The other CCBs showed a 
similar trend. Glands stimulated with ISO in the presence of verapamil and nifedipine showed no 
significant differences in cAMP or cAMP-PDE levels. Diltiazem, however, was found to decrease 
the effect of ISO on cAMP while causing a concomitant increase in cAMP-PDE. This i) supported 
a possible hypothesis that the observed enhancement is a result of cAMP levels remaining elevated 
due to an inhibition of cAMP-PDE by the CCEs and ii) pointed to the possible presence of a CaM-
sensitive PDE within the rat pineal gland. 
To test this hypothesis, two drugs which are more specific in their actions on CaM effects were 
chosen to see if the earlier results could be mimicked and thereby confirmed. Glands stimulated 
. with NA in the presence of the specific CaM inhibitor R 24571 showed increased NAT activity and 
[14C]-aMT production. cAMP-PDE levels were clearly down, thus corroborating the possibility of 
cAMP-PDE inhibition. Glands incubated in the presence of M&B 22948, a CaM-sensitive PDE 
inhibitor, showed similar increases in NAT activity and [14Cl-aMT. These findings therefore support 
the initial results and although indirect, confirm the hypothesis that the paradoxical increase 
following predominantly NA stimulation could be a result of cAMP levels remaining elevated, due 
to inhibition by the CCEs of the CaM-dependent activation of its regulator cAMP-PDE. 
In summary, data presented herein concur with proposals that: 
i) the CCEs are not specific enough to be used as tools to research Ca2+ -mediated events, as they 
appear to have sites of action other than the voltage operated channel (VOC); ego binding to 
calmodulin, 
ii) there are functional differences between the CCEs as shown by diltiazem in this series of 
experiments, 
iii) there is a CaM-sensitive-PDE present in the pineal. 
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CHAPTER 1 
LITERATURE REVIEW 
1 INTRODUCTION 
1.1 History: The pineal and calciwn 
The discovery of the human pineal has generally been ascribed to Herophilos (325 to 280 B.C.), 
the "father of anatomy". During the medieval period circa 400 B.C., when Galen and 
Hippocrates were the "medical authorities", Galen coined the term "konareion" ("conarium" in 
~tin) for the pineal gland, because of its 'pinecone'-like shape in man (c.f. Ariens Kappers, 
1981). He also made the first reference to the calcareous concretions often found in this gland 
(Galen c.f. Simon, 1906). This formed the first tentative link between calcium and the pineal, a 
link that would stimulate much research in the succeeding years. The function of the acervuli, and 
for that matter the function of the pineal, remained enigmatic for the next twenty centuries. 
Interest in the pineal was again revived in the latter nineteenth century, after the discovery of 
endocrine glands by Claude Bernard (1813 to 1878) and Brown-Sequard (1817 to 1894). The 
medical profession continued to believe that the pineal was of no functional significance, and that 
its only medical value was to the neuro-radiologists who made use of the radio-opaqueness of the 
acervuli as a welcome reference point (c.f. Ariens Kappers). In this same period Sydney Ringer 
made the serendipitous discovery that calcium was needed to maintain cardiac contraction, after 
mistakenly making up saline with tap water rather than distilled water (Ringer, 1883). 
In 1963, the year when the first congress on the pineal gland was held in Amsterdam, Albert 
Fleckenstein was able to demonstrate that a newly-synthesized compound, viz. verapamil, could 
mimic the effects of calcium withdrawal from the medium, and thus effectively inhibit the cardiac 
contractility of his isolated frog heart (Fleckenstein, 1964). Verapamil was the first of a new 
group of compounds, the organic calcium channel blockers, which could be used as probes for 
calcium mediated effects. A host of research was to follow. 
Since the initial link of calcium to hormone secretion by Douglas and his co-workers (Douglas and 
Rubin, 1963; Douglas and Poisner, 1964), the crucial role of Ca2+ ions in the organ, and 
particularly in excitable cells, has become well-known (Campbell, 1983). The original term 
"stimulus-secretion coupling" was used to describe an event in which the inward flux of calcium 
was an inevitable and concomitant result of the stimulus and a necessary determinant of the 
hormone response. This was changed by Rasmussen to "stimulus-response coupling". a term 
denoting any specific cellular response to a physiological stimulus which is wholly or partly 
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determined by calcium. A specific mechanism is not implied thereby (Millar and Struthers, 
1984). The pinealocyte, considered to be a paraneuron or excitable cell (Fujita, 1981; Ueck and 
Wake, 1977), is responsible for the transformation of nerve stimuli into a chemical response i.e. 
(by Wurtman and Axelrod's definition, 1965) a neuroendocrine transducer. 
The presence of acervuli in the pineal makes it one of the rare tissues in the body actually 
containing calcifications under normal conditions (Krstic, 1985). It is the presence of these 
acervuli, and the growing evidence that Ca2+ is involved in the physiological regulation of pineal 
function by noradrenaline (NA), that has sparked the renewed interest in Ca2+ metabolism within 
the pineal gland (Zatz and Romero, 1978; O'Dea and Zatz, 1976; Vanecek et aI., 1986; Sugden 
et al., 1986; Sugden et al., 1987). The pineal gland has in fact a higher Ca2+ concentration than 
any other soft tissue in the body; this is indicative of its intense metabolic activity, since Ca2+ is 
involved whenever and wherever hormones are produced and secreted (Krstic, 1985; Meyer and 
Theron, 1988). 
1.2 Anatomy and Physiology 
1.2.1 Location and characteristics 
The pineal body of the rat is rounded and visible in a dorsal view of the brain, lying rostral to the 
cerebellum, and between the occiput poles of the cerebral hemispheres (Figure lola). It is 
connected to the commisural region of the brain via the pineal stalk (Figure LIb). It is generally 
agreed that pineal glands form as evaginations (diverticuli) from the dorsal wall of the 
diencephalon, but that their histology varies among the mature forms of the various vertebrate 
groups (Allen et al., 1981). 
The central projections of the pineal complex of the silver lamprey have been studied. They show 
that the tract courses caudally along the left side of the habencular commissure, and while a few 
fibres penetrate the brain through the caudalmost portion of this commissure, most continue 
caudally to enter the brain through the posterior commissure, in a similar fashion to those reported 
for other anamiote vertebrates (Puzdrowski and Northcutt, 1989). 
The pineal gland is considered to lie outside the blood-brain barrier, with its own arterial blood 
supply of up to four branches of the posterior cerebral artery, and venous drainage consisting of 
some sixteen veins into the great cerebral vein which leads to the systemic circulation via the 
confluens sinuum. The pineal is thus sensitive to stimuli from the periphery, including hormones 
and those drugs not entering the brain (Axelrod, 1974; Tamarkin et ai., 1985). 
-\----_;&ru,,.., lobe -3-
c:nbnl hemIsphere 
"t-----'l--f-plnnJ body 
1.1b 
an~1 
Figures 1.1 a and 1.1 b: Dorsal view (1.1a) and vertical section (l.lb) of the rat 
1.2.2 Histology 
brain showing the position of the pineal gland and its stalk (adapted 
from Rowett, 1962) 
The cell types within the pineal gland are generally divided into parenchymal and interstitial cells. 
The parenchymal cell is the pinealocyte, showing the characteristics of both a paraneuron (Ueck 
and Wake, 1971) and a cell belonging to the amino-acid precursor uptake and decarboxylation -
APUD- series (Ralph, 1983). The classification of the interstitial cells is uncertain but are 
thought to be of glial origin (Erlich and Apuzzo, 1985). 
By definition, paraneurons are derived from neuroectoderm, produce substances identical- or 
related to real neurotransmitters, and are capable of receptor-modulated responses. Paraneurons 
also contain synaptic vesicle-like or neurosecretory granules from which they release products in 
response to stimuli. Parenchymal cells of the pineal gland fit all aspects of this definition (Walker 
and Aloyo, 1987). Pinealocytes metabolise and secrete serotonin (Saavedra, 1977), receive 
adrenergic innervation (Klein et al., 1971) and resemble serotonergic neurons. 
The pineal contains various types of ultrastructural features involved in intercellular 
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communication, such as synapses, gap junctions and tight junctions. Further features indicative of 
active secretory processes include dense-core, clear, granular and agranular vesicles, in addition to 
the normal organelles found in other cells (Samarasinghe et aI., 1983). Pineal cells also have 
synaptic ribbons (considered by some to be the stimuli-transmitting organs facilitating pineal 
secretory function), synaptic ribbon fields and myeloid bodies which make them distinctive 
(Samarasinghe et aI., 1983). It is interesting to note that these processes also show a circadian 
rhythm, coupled to the secretion and metabolic phases of the pineal (Booth, 1987). 
Nuclear and cytoplasmic areas of pinealocytes and the area of condensed chromatin have been 
sh9WD to exhibit inversely-related circadian rhythms; the former two increased, while the latter 
decreased during the light period. Peri capillary and wide intercellular spaces increase during the 
light period, and decrease during the dark period. The number of fenestrae also increase during 
the light period, and decrease at night. It is thought these changes reflect the increased secretory 
functions at night (Matsushima et ai., 1989). 
1.2.3 
1.2.3.1 
Innervation 
Neuroanatomical and neuropbysical connections 
The first detailed studies of the innervation of the rat pineal gland were carried out by Kappers 
(1960, 1965). The gland is innervated by pinealopetal orthosympathetic and pinealopetal 
parasympathetic fibres. The parasympathetic fibres come to the pineal by way of the facial and 
greater superficial petrosal nerves but their function is unclear (Booth, 1987). While there is 
convincing evidence for the existence of central pinealopetal fibres, which enter the gland via its 
stalk (Korf and Moller, 1984), their function also remains an enigma (Reiter, 1989). What is 
certain though, is that if the sympathetic innervation is destroyed, the pineal is rendered non-
functional by all currently measured parameters (Reiter, 1989). A dense innervation by 
vasoactive intestinal peptide (VIP) immunoreactive fibres has also been found in the peripheral 
superficial part of the organ, with the fibres penetrating into its central portion. There they 
mainly terminate in the vicinity of the capillaries. This suggests a possible role for VIP- influence 
in this gland as well (Mikkelsen, 1989). 
The effects of light on the pineal are mediated by a monosynaptic pathway, leaving at the level of 
the optic chiasma and terminating at the suprachiasmatic nuclei (SCN). Using radio-labelled amino 
acids, Moore (1973) was able to prove unequivocally the existence of this retinohypothalmic 
pathway. The SCN contain the circadian timing system which controls the pineal. They can 
continue to oscillate on an ca 24 h cycle, even in animals kept in the dark; the "clock" is 
autonomous, although environmental lighting has the effect of resetting and keeping the clock 
entrained to the light cycle (Reiter, 1991b). 
From the SCN the fibres continue as follows: 
SCN ~ paraventricular nuclei ~ intermediolateral cell collumn 
ganglia (SCG) ~ nervii conarii ~ pineal gland. 
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~ superior cervical 
The postsynaptic fibres from the SCG follow the internal carotid, to arrive caudally in the form of 
the paired nervii conarii (Booth, 1987). There is general agreement that the fibres do not form 
distinct synapses with the pinealocytes (Kappers, 1976), but end in the perivascular spaces and 
~t the neurotransmitter simply diffuses to the surface of the pineal cells. A few of the processes 
may terminate between the perikarya of the pinealocytes (Matsushima et ai., 1981). Apart from 
the delivery of NA, the sympathetic nerves can also act as a sponge, taking up and concentrating 
catecholamines from the perivascular space (Kvetnansky et al., 1979). This protective effect has 
been demonstrated when stressful treatments, known to elevate catecholamine levels have had 
little effect on the pineal / plasma melatonin levels (Vaughan, 1982). This is true, provided that 
the uptake process is not blocked (Parfitt and Klein, 1976). 
1.2.3.2 The third eye 
Considered the vestigial remains of the third eye, the pinealocytes of mammals are derived from 
the same progenitor cells. Occasionally they contain rudimentary structures reminiscent of the 
photoreceptor elements still found in lower mammals (Pevet, 1981). Although the mammalian 
pineal gland no longer responds directly to light, it has evolved a neural pathway to the eye, and 
is thus still influenced by light cycles. 
Innervated by the peripheral autonomic system, the postganglionic sympathetic nerve fibres show 
dramatic biphasic activity, which in turn is reflected in the biphasic pattern of melatonin 
production and secretion (Kappers, 1960; 1965). Influenced by light received on the retina, the 
neural input is converted to an endocrine output, resUlting in the pineal gland being termed a 
neuroendocrine transducer (Booth, 1987). 
This gland therefore functions as a biological clock converting information about environmental 
lighting into a specific hormonal output (Brown et ai., 1981). This specific hormonal output in 
the form of melatonin, is able to provide information about absolute day / nightlength to 
responsive organs. Thus, internal organs are provided with photoperiodic information by the 
circulating melatonin, enabling them to be aware of increasing daylength, e.g. the seasonal change 
from spring into summer, and allowing them to begin physiological adjustments in advance of the 
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time that a change in function will be required (Kennaway, 1984; Reiter, 1991b). 
The opposite is true for pinealectomised mammals. They become either totally aseasonal, or their 
natural annual cycle free-runs; in either case, their physiology becomes inappropriate to the 
current season (Reiter, 1991b). 
1.2.3.3 Light 
Light is the Zeitgeber (entraining agent) regulating melatonin production (Erlich and Apuzzo, 
19.85). It has two apparent effects on the melatonin rhythm: acute reduction of amplitude 
(synthesis and output), and entrainment of the underlying pacemaker as revealed by changes in 
period or phase. 
The acute exposure of animals or humans to light at night leads to a precipitous decline in pineal 
melatonin synthesis and release. The reduction to daytime levels requires only 20 to 30 min. 
Light exposure at night suppresses pineal melatonin production in all animals tested, but the 
brightness (irradiance) of light required to achieve this result varies greatly among mammals 
(Reiter, 1985). To illustrate how these species may differ: the albino rat pineal gland can respond 
to as little as 0.0005 /LW/cm2 of white light at night, whereas the Richardson's ground squirrel 
requires a light irradiance of about 1850 /L W / cm2 . The human pineal is intermediate between 
these two extremes, responding to about 150 /LW/cm2 of white light at night. Normal room light 
averages 50 to 100 /L W /cm2, while on a clear day the sunlight at noon can be as bright as 25 000 
to 50 000 /LW/cm2 (Reiter, 1988a). 
Besides its brightness, the wavelength of the light also determines its ability to suppress melatonin 
synthesis. Light in the blue range, 500 to 510 ~, seems to be most suppressive of pineal 
melatonin production (Brainard, 1985). This includes light in the yellow-green range reported by 
Wurtman and Moskowitz (1977). 
Of interest with regard to light and the pineal gland, is information from autoradiographic studies 
which indicates that vitamin D3 (soHriol) is a somatotrophic activator and modulator. It is 
regulated by the amount of sunshine and the endocrine status of the individual, and its purpose is 
the promotion of development, reproduction, and the maintenance of life. Regulation of Ca2+ 
homeostasis is only one of its many functions. A close link to the pineal hormone system is 
apparent. Evidence supports the concept that the skin-derived hormone of sunlight and the pineal 
hormone{s) of darkness are messengers with comprehensive actions on endocrine-, autonomic-, 
sensory-, skeletal-, and motor funtions. Thus both hormone systems complement each other, and 
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appear to correlate biological activities with the daily and seasonal changes of our solar 
environment (Stumpf, 1988). 
1.2.3.4 Circadian Rhythms 
Conceptually, circadian systems consist of a clock-like pacemaker (Pittendrigh, 1981), from which 
there is at least one pathway driving an overt rhythmic function, and to which there is at least one 
pathway from a photoreceptor that can entrain (Aschoff, 1981) the pacemaker. The overt 
hormonal and biochemical rhythm which has been studied most intensively is that of melatonin 
pr9duction (Binkley, 1981; Klein, 1985). In the rat (and other mammals), the components of this 
circadian system are anatomically distinct; the photoreceptors are in the retina, the pacemaker is in 
the suprachiasmatic nucleus of the hypothalamus (Moore, 1983), and melatonin is synthesized in 
the pineal gland. Multisynaptic pathways connect these components. Figure 1.2 shows the 
neural connections from the eyes to the pineal and the associated rhythms. In vitro, the rat pineal 
is neither rhythmic nor photosensitive, but can be stimulated to make melatonin (Zatz, 1982; 
Klein, 1985). 
In contrast to the rat pineal, the chick pineal in vitro is both rhythmic and photosensitive. 
Circadian pacemakers (Deguchi, 1979), photoreceptors (Deguchi, 1981), and the mechanisms that 
regulate melatonin production (Binkley, 1981) and release, continue to cycle up at night and down 
in the day • spontaneously , in culture, a rhythm which persists for several cycles even in constant 
darkness (Robertson and Takahashi, 1988). 
Calcium influx appears to play an important role in the induction of melatonin synthesis (Zatz and 
Romero, 1978; Sugden et ai., 1986). The results of Zatz and Mullen (1988), however, fail to 
support a role for Ca2+ influx in the regulation of the pacemaker. They suggest rather a role 
distal to the pacemaker, probably at the level of the melatonin-synthesizing apparatus. 
Calcium may even playa role in the secretion of melatonin (Morton et ai., 1989), but this is not 
certain. As melatonin is produced in the pineal gland, blood levels rapidly increase in parallel 
(Wilkinson et ai., 1977; Reiter, 1990). Besides the circadian release of melatonin from the pineal, 
an ultradian release has also been reported by Chen and co-workers (1990). The pulsatile release 
of melatonin is especially apparent when levels are measured in pineal venous effluent (Reiter and 
Vaughan, 1990). Because of its high lipophilicity and the ease with which melatonin passed 
through cell membranes. it was always thought that it diffused out of the pinealocytes and into the 
circulation. However, now that episodic release has been demonstrated. the existence of at least 
short-term storage and an active release mechanism for melatonin must be assumed (Reiter, 
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1991a). 
Whatever the function of the episodic melatonin release, changes in the circadian production and 
release remain important for the execution of its role as a chemical expression of darkness (Stetson 
and Tay, 1983; Reiter, 1991b). Melatonin's high lipophilicity presumably still permits its rapid 
transfer into other fluids. All body fluids tested to date have proven positive for melatonin. These 
include cerebrospinal fluid (Hedlund et ai., 1976), milk (Reppert et ai., 1979), saliva (Vakkuri, 
1985), ovarian follicular fluid (Brzezinski et al., 1987), male seminal fluid (Bornman et al., 
1989), amniotic fluid (Kivela et ai., 1989) and the fluid of the anterior chamber of the eye (Yu 
et gl., 1990). In each of these fluids a circadian melatonin rhythm was found which paralleled that 
found in blood. Thus essentially all cells are exposed to the melatonin rhythm. Because of the 
lipophilicity of melatonin, the cell's organelles too, are exposed to melatonin and thus a signal of 
the photoperiodic state of the organism, provided of course that the signal can be received e.g. via 
receptors (Reiter, 1991b). 
1.3 Melatonin biosynthesis 
1.3.1 Tryptophan 
The production of melatonin within the pinealocyte requires the uptake of the amino acid 
tryptophan from the plasma, by the pineal. Tryptophan within the blood is derived from two 
sources: ingested protein, and free tryptophan pools. Some of the tryptophan is used in protein 
synthesis, while the rest goes into the indole pathways shown in Figure 1.3. Once taken up into 
the pinealocyte, tryptophan is oxidised at the 5-position to form the amino acid 5-
hydroxy tryptophan. This conversion depends on the activity of the enzyme, tryptophan 
hydroxylase and a reduced pteridine co-factor (Lovenberg et ai., 1968). The high substrate Km 
for tryptophan hydroxylase relative to the low levels of free tryptophan, suggest that the enzyme is 
normally unsaturated, and thus the rate of hydroxylation would depend on the availability of the 
amino acid. 
1.3.2 Serotonin 
Once formed, 5-hydroxytryptophan is converted to 5-hydroxytryptamine (serotonin) m the 
presence of the pyridoxine-dependent enzyme aromatic L-amino acid decarboxylase (dopa-
decarboxylase) (Lovenberg et ai., 1982). Serotonin concentrations and turnover are very high in 
the pineal, exceeding those of any other organ in the body (Quay, 1974). 
Walker and Aloyo (1987) have shown that the secretion of serotonin from rat pineal glands 
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appears to be a NA-mediated event acting via CYl-adrenoceptors. The intracellular second 
messenger involved in the serotonin-release process, is a Ca2+ -/phospholipid-dependent protein 
kinase (the effects of the phorbol ester, PMA, simulated those of NA). 
1.3.2.1 Monoamine oxidase 
Three routes exist for the metabolism of serotonin (HT) in the pineal. 
The major enzyme for the metabolism of HT in other organs, monoamine oxidase (MAO), is also 
pr~ent in the pineal. Some pineal serotonin is metabolised by MAO to 5-hydroxyindole 
acetaldehyde, an unstable intermediate that is either oxidised to 5-hydroxyindoleacetic acid 
(HA)or reduced to 5-hydroxytryptophol (HL). 
Two different isozymes of MAO have been identified in pineal tissue: one is confmed to the 
pinealocyte (MAO-B), and one to the sympathetic nerve terminals (MAO-A) within the gland 
(Goridis and Neff, 1972). As serotonin (HT) is only deaminated by MAO-A, the association of 
one isozyme with each cell type implies that two cellular compartments are required in the pineal 
gland for the synthesis of 5-methoxytryptophol (ML) and 5-methoxyindoleacetic acid (MA), while 
melatonin (aMT) and 5-methoxytryptamine (MT) require only one, the pinealocyte (Masson-
P'evet and P'evet, 1989). The indoleamines are abbreviated according to the system of 
nomenclature introduced by Smith (1981). A full listing is presented in Figure 1.3 . 
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1.3.3 Hydroxyindole-O-methyltransferase 
5-Hydroxyindoleacetic acid and 5-hydroxytryptophol are substrates for hydroxyindole-O-
methyl transferase (HIOMT), and are metabolised to 5-methoxyindoleacetic acid or reduced to 5-
methoxytryptophol respectively. 5-Methoxytryptophol may be released into the blood in a 
circadian manner (Wilson et aI., 1978). It reportedly possesses some endocrine effects, although 
these have been sparingly investigated (Reiter, 1980). HIOMT may act directly on serotonin, 
leading to the formation of 5-methoxytryptamine (Prozialeck et ai., 1978). Although this 
compound has been promoted as a pineal hormone (Pevet, 1983), its activity is only one tenth that 
of melatonin, measured relative to effects on the reproductive system (Rollag, 1982). The 
secretion of 5-methoxytryptamine has not yet been proven, although it may be converted 
peripherally to melatonin. 
Several forms ofHIOMT exist in pineal tissue (Jackson and Lovenberg, 1971). Unlike the enzyme 
N-acetyltransferase (NAT), it is restricted to only a few other organs. It is found in the retina 
(Cardinali and Rosner, 1971), the. harderian gland (Vlahakes and Wurtman, 1972) and in 
erythrocytes (Rosengarten et aI., 1972). Monoclonal antibodies to bovine HIOMT, which shows 
a high degree of structural similarity with HIOMT from other species, have allowed the 
immunocytochemical cytosolic localization of this enzyme (Deguchi et ai., 1987). 
1.3.4 N-acetyItransrerase 
Certainly the major pathway for the metabolism of serotonin in the pineal gland is its conversion 
to melatonin via N-acetylation by the enzyme N-acetyltransferase (NAT) to yield N-
acetylserotonin. Next, a methyl group is transferred from S-adenosylmethionine to the 5-hydroxy 
position of N-acetylserotonin, yielding melatonin (Weissback et ai., 1960; Axelrod and 
Weissback, 1961). This conversion is catalysed by HIOMT. 
NAT activity is generally considered to be rate limiting in the production of melatonin (Klein, 
1985). Thus the pineal melatonin content typically rises in parallel to NAT. There are however 
notable exceptions, where a large melatonin peak is present, without a commensurate large 
increase in NAT activity (Menendez-Pelaez et al., 1990). The nightly increase in NAT activity 
varies between species (Rudeen et ai., 1975), from as little as two-fold to the 100-fold increase 
found in the rat (Klein, 1985; Reiter, 1991b). 
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Figure 1.3: Schematic representation showing the chemical and metabolic pathways derived from tryptophan, and the accompanying 
nomenclature published by Smith in 1981. 
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1.3.5 Melatonin 
Melatonin is also synthesized in the other organs where HIOMT is found e.g. the retina 
(Cardinali and Rosner, 1971), the harderian gland (Vlahakes and Wurtman, 1972) and in 
erythrocytes (Rosengarten et al., 1972). Their contribution to the circulating levels IS 
questionable (Reiter, 1989), although Ralph, (1981) has suggested that the retina in some 
mammals may in fact be the major producer. 
Once synthesized, melatonin is released into the circulation I§ 1.2.3.4]. Plasma levels can thus 
give an accurate reflection of melatonin production (Wilkinson et al., 1977). From the 
circulation, melatonin can be taken up by all organs (Erlich and Apuzzo, 1985) to be used if 
required. Once in the liver it is metabolised to 6-hydroxymelatonin. 
1.4 Possible roles for melatonin 
Since its discovery some 30 years ago, melatonin has been the subject of much investigation with 
regard to its synthesis, the distinct rhythms which it has and its possible endocrine consequences. 
In spite of this, no singular true role can be ascribed to the hormone. In fact, it is not even certain 
if all the attention has been rightly focussed ~n melatonin, and not rather on one of the other 
indoles synthesized in the pineal. With the widespread distribution of melatonin, the question of 
which organ system is influenced, has become rather, which system is not? The 24 h cycle is 
found in most mammals, with the night-time peak common to all mammals, indeed all vertebrates, 
regardless of their locomotor activity pattern (Gem and Nervina, 1986), even when th~re are 
variations in photoperiod. The magnitude of the rise varies fairly dramatically between species, 
but the level of change (peak:trough ratio) needed for differences in interpretation by the target 
receptor, is not known. 
The major use of the transducing of light/photic signals into a hormonal response seems to be 
seasonal physiological adjustments, which would control breeding (Arendt, 1986; Reiter, 1988b). 
There are three main hypotheses regarding the interpretation of the hormonal rhythm; the 
duration hypothesis, the coincidence hypothesis and the amplitude hypothesis (Reiter, 1987). 
The duration hypothesis takes into account the length of the night-time high in melatonin, which 
would give seasonal information, e.g. longer nights in winter and shorter nights in summer. This 
hypothesis has now been extended to take into account the direction of change of elevated 
nocturnal melatonin i.e. whether the period of elevated levels is becoming longer as the season 
changes to winter, or shorter, as summer approaches (Hoffamn et ai., 1986; Reiter, 199Ib). 
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The coincidence hypothesis takes into account the increase in melatonin at night, but also has a 
so-called "window of sensitivity": although the level of melatonin is raised, it will mean nothing 
to the particular organ unless that organ is sensitive to a signal at that point in time (Carter and 
Goldman, 1983; Stetson and Watson-Whitmyre, 1986). 
The third hypothesis looks at the amplitude of the nocturnal rise in melatonin, and although this 
is seldom used in animal studies, as most species have comparable nighttime blood concentrations 
(Reiter, 1991a), it is often used in human studies (Berga et al .• 1988). The latter group often 
sh?w altered melatonin levels in the presence of certain disease states. 
While melatonin has an obvious role in controlling hibernation and reproduction in seasonal 
breeders. its role in humans is more debatable . 
In terms of reproductive influences. it has been reported to have a role in sperm motility and 
hence fertility (Oosthuizen et al., 1986) and in oligospermia or aspermia (Karasek et al .• 1990). 
It is however more famous in medical history for the association of pineal tumours and 
precocious puberty, first described by Heubner in 1898. The tumours resulted in reduced pineal 
function, leading Marburg (1909) to suggest that the pineal has an inhibitory role on sexual 
function. Age-related reductions in nighttime melatonin levels associated with puberty have been 
reported by Waldhauser and Dietzel, 1985. Unusual melatonin rhythms have also been found in 
females with hypothalmic amenorrhoea (Berga et al., 1988). 
As for hibernation, the role of light could well playa determining role in another disease linked to 
the pineal. namely seasonal affective disorder syndrome (SADS). Described by Ebadi and 
Govitrapong (1986), SADS is characterised by patients exhibiting a depressive period from 
December through to February (in the northern hemisphere). Increased levels of light (to 
supposedly reduce plasma melatonin levels) are of benefit to these patients. 
Among the more diverse range of reported effects/involvements are: 
1) hormonally dependent tumours: patients dying of breast cancer often have enlarged pineals 
(Tapp, 1982; Blask, 1984), while those dying of disseminated forms of cancer invariably have 
high HIOMT levels, and less Ca2+ deposits in their pineals (Kerenyi et ai., 1977). In rats 
pinealectomy generally promotes the growth of cancer tissue, while melatonin administration does 
the opposite (Reiter, 1989); 
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2) immunocompetence (Pierpaoli and Maestroni, 1987); 
3) stress (Lynch and Deng, 1986), and the effects of stress e.g. stress related ulcers (Khan et ai., 
1990); 
4) Sudden infant death syndrome or "cot deaths" (Sparks, 1988); 
5) phase shifts or "jet-lag", resulting from changes in the environmental light input into the 
"clock", and which reportedly can be readjusted by the administration of triazolam (Turek, 1987). 
(T?is effect may be blocked with the specific benzodiazopine antagonist flumazenil, which is 
useful since it could shorten the time of re-entrainment to the circadian rhythm, and thus readjust 
the sleep-wake cycle shift.); and 
6) part of the "diseases of the aged" syndrome. Ageing has been related to a relative melatonin 
deficiency, a result of the gradual failure of the pineal gland. The hypothesis proposes that the 
persistence of serotonin in the midst of the melatonin decline results in the chain of neuro-
endocrine and peripheral events which promote ageing (Rozencwaig et aI., 1987). Of interest here 
is a study by Hasegawa et ai., (1987). Pineal decline and the presence of calcifications in the 
pineal have often been described. This study, however, found that although there existed a 
correlation between pineal weight and the degree of calcification, some pineals in patients over 90 
years old showed no calcification and were indistinguishable from the ones of younger subjects. 
This suggested that the pineals in humans do not necessarily degenerate after involution. 
The finding of a specific melatonin receptor antagonist, luzindole (N-0774), and the advances with 
radio-labelling of melatonin analogues, may well be the long-needed tools with which to clarify 
and elucidate the mechanisms through which melatonin operates (Dubocovich, 1988). 
Despite initial reports documenting the location and function of melatonin receptors a decade ago, 
reliable characterizations have only come more recently (Stankov, 1990). The major breakthrough 
came in 1984 with the introduction of 2-iodomelatonin, a potent melatonin analogue (Vakkuri 
et al., 1984). 
Not surprisingly most studies have centered on the central nervous system. Within the medial 
basal hypothalamus, melatonin binding sites have been found in the SeN (Reppert et aI., 1988), 
where it is usually tacitly implied that such receptors, may in part mediate the effects of melatonin 
on the neuroendocrine-reproductive axis (Reiter. 1991a). Autoradiographic studies using 
radioactive melatonin have also shown sites in the pars tuberalis of the pituitary gland {Morgan 
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and Williams, 1989). Sites have also been described in nonhypothalmic neurons such as the 
hipocampus, the septum and reticular formation (Zisapel, 1988, Stankov and Reiter, 1990). Two 
interesting peculiarities are noted: 1) wide differences in melatonin receptor distribution have been 
reported, even between closely related species, and 2) many of the binding sites show changes in 
receptor density over a 24 h period, (Zisapel, 1988). 
In the final analysis, there may well be not a single organ system that escapes the influence of this 
hormone (Klein, 1988); certainly the wide range of data being collected from both animal and 
human sources indicates much interest in the pineal gland and its possible roles, very different 
from the previous lack of enthusiasm for this gland. 
1.4.1 Influence of age on the pineal and melatonin biosynthesis 
There are reports of reduced serum melatonin levels with old age in several species. In rodents, 
the pineal melatonin rhythm is not present at birth, but appears before the pups are weaned 
(Vanecek and lllnerova, 1979; Rollag and Stetson, 1981). A pre-pubertal decline in melatonin 
secretion is noted however, and thought to play a possible role in the development of their 
reproductive systems (Tang and Pang, 1988). 
In humans, although the rhythm is not fully developed at birth, it is fully functional by the end of 
the first year (Arendt, 1985). The rhythm continues through adulthood, but then the nocturnal 
rise declines in advanced age (Reiter et ai., 1980). It is felt that the decline is not as a result of 
the deposition of Ca2+ in certain individuals (Kitay and Altschule, 1954), as a similar reduction is 
found in certain species which do not exhibit acervuli (Reiter, 1989). Despite these changes in the 
melatonin rhythm through life, their significance to either endocrine or physiological events 
remains unproven (Reiter, 1989). 
One peptide does hold some interest with regard to ageing: Arginine vasotocin (A VT) release by 
melatonin appears to playa role in sleep patterns (Arendt et al., 1982). Administration causes the 
rapid onset of slow-wave sleep, the period during which most of the body's restorative and 
reparative events take place. Slow-wave sleep has been shown to decline with age, which has 
been linked to the pineals decreasing metabolic activity (Rozencwaig et aI., 1987). 
In the Wistar rat, the capacity of the ,a-adrenoceptors to develop supersensitivity during the light 
period is lost during maturation (ca 6 months), rather than in old age. However, neither ,a-nor Ctj-
receptor density declines with age. HIOMT activity does drop in rats over 18 months, but NAT 
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activity is not altered. This suggests that the reported lowered serum levels of aMT result from a 
reduced capacity of the pineal to synthesize aMT, rather than from an altered responsiveness of 
the gland to neural stimulation (Dax and Sugden, 1988). 
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Figure 1.4: 
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Summary of some of the relationships of the visual system to the pineal 
and possible sites of action for the pineal hormones. 
Some. potential sites that have been proposed include the pineal itself 
(1), the superior cervical ganglia (2), the brain, especially the 
hypothalamus and brain stem (3), the anterior pituitary gland (4), 
and the gonads (5), and other organ systems which are not 
necessarily on the neuro-reproductive axis (adapted from Reiter, 
1989). 
KEY: ILC = 1ntermediolateral cell column, PVN = para ventricular 
nuclei, RHT = retinohyporhaimic tract, SCN = suprachiasmatic 
nuclei. 
1.4.2 Pathways possibly modulating melatonin biosynthesis 
As stated earlier, there are three neural inputs into the pineal gland, and while the sympathetic 
fibres and their transmitter are fairly lucid, the remaining circuits are not. Some of the following 
putative transmitters I peptides have been localized in central pinealopetal connections (for 
references see Korf and Moller, 1984; Shiotani et ai., 1986; Cardinali and Vacas, 1988), 
although their exact significance is not clear (Morgan et ai., 1987). These include vasoactive 
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intestinal peptide (VIP) (Shiotani el aI., 1986), arginine vasopresin (A VP), oxytocin (OT) 
(Nurnberger and Kolf, 1981) and lutenizing hormone-releasing hormone (Matsuura et aJ., 1983). 
The distribution and origins of neuropeptide Y (NPY) calcitonin gene-related peptide, VIP and 
substance P (SP) containing nerve fibres innervating the pineal gland of the gerbil have also been 
described (Shiotani el al., 1986). Gauquelin et a1. (1988), have demonstrated the presence of 
A VP and OT in the harderian gland as well. 
Physiological roles for both VIP and NPY are likely, as VIP has been shown to affect both cAMP 
levels and NAT activity in rats (Kaneko et aZ., 1980), and more recently NPY has also been 
shown to affect NAT activity (Reuss and Schroder, 1987). 
1.4.2.1 Vasoactive intestinal peptide 
The presence of VIP-immunoreactive fibres in the pineal has been mentioned. It exhibits a potent 
stimulating activity on rat pineal cAMP and melatonin synthesis (Kaku et aZ., 1985, 1986), and an 
effect on cAMP accumulation in the ovine pineal has also been shown (Morgan et al., 1988) . 
. 
These effects are mediated via interaction with specific receptor sites in pinealocyte membranes 
(Korf and Moller, 1984, Kaku et aZ., 1985). This is suggested by the fact that combined 
stimulation with isoprenaline and VIP is additive, and not synergistic (Morgan et aZ., 1988). The 
probable mechanism involved will be discussed presently I§ 1.11.12], once the relevant 
background has been covered. There is a daily rhythm in pineal VIP (Kaku et al., 1986), and the 
density of VIP binding sites found in the pineal, is amongst the highest in the central nervous 
system (Besson et aI., 1986). This suggests some role in pineal function. 
1.4.2.2 Neuropeptide Y 
In the pineal gland NPY is detectable by immunohistochemical techniques (Schon et al., 1985; 
Schroder, 1986). NPY apppears to exert a dual effect in the pineal gland by enhancing melatonin 
synthesis and NA post-synaptic effects at low concentrations, and inhibiting sympathetic 
transmissions at high concentrations. It may even play a role in the transfer of light information, 
as administration of NPY to thtl SeN area causes phase shifts in the circadian rhythm (Harrington 
el aI., 1985). 
1.4.2.3 Substance P 
Substance P has been Utltecttll.l in thtl pineal gland of several mammals. Receptors for substance P 
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have been characterised in bovine pineals, but not in rat pineals (Govitrapong and Ebadi, 1986). 
1.4.2.4 Delta-sleep inducing peptide 
Delta-sleep inducing peptide (DSIP) is a presumptive peptide transmitter found in discrete 
populations of central synapses (Graf and Kastin, 1986). Various effects on sleep as well as other 
physiological functions have been reported for this peptide (Schoenenberger, 1984; Graf and 
Kastin, 1984). DSIP has been proposed as a ·programming substance for circadian rhythms" 
(Graf et al., 1982). It reduces the nocturnal increase in rat pineal NAT and also stimulation of 
NAT following a- and {3- adrenoceptor agonists, both in vivo and in vitro (Graf and Schoenberger, 
1986). DSIP, however, enhances the effect of NA on NAT through an al-adrenoceptor 
mechanism which will be discussed (Graf and Schoenenberger, 1987). 
1.4.2.5 Opioids 
Opioid synapses probably particip'ate in pathways controlling the nocturnal maximum of melatonin 
synthesis. This is revealed by the blocking effect of naloxone on the night-time peak melatonin 
production (Lowenstein et al., 1984) and its stimulatory effects on melatonin release in rats 
(Mouren et ai., 1986). 
Figure 1.5 shows some of the transmitters (many of them released from central pinealopetal 
fibres) which may playa role in the fme-tuning of melatonin synthesis. 
1.4.3 Radioligand binding sites identified 
Employing radioligand binding techniques, several nonadrenergic neurotransmitter- and 
neuromodulator acceptor sites have been described in the mammalian pineal gland. CI-/Ca2+-
dependent glutamate binding (Govitrapong et al., 1986), gamma-aminobutyric acid (GABA) 
binding (Ebadi and Chan, 1980), benzodiazepine (BZP) binding (Lowenstein and Cardinali, 1983, 
Matthew et aI., 1984; Basile et al., 1986), serotonin (52) (Govitrapong et aI., 1984) and 
muscarinic binding (Taylor et aI., 1980), VIP binding (Korf and Moller, 1984), and the binding 
of substance P (Govitrapong and Ebadi. 1986) and peptide N-terminal histidine C-terminal 
isoleucine (PHI) (Tsuchiya et al .• 1987) are known to occur in pineal subcellular fractions. 
Additionally. dopaminergic binding sites of the D2 subtype are detectable in bovine pineal 
membranes (Govitraprong et al.. 1984). For several of these sites a formal demonstration of their 
receptor nature is still lacking. Some of the putative transmitters mentioned can be localized in 
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central pinealopetal connections (for references see Korf and Moller, 1984, 1985; Shiotani et ai., 
1986). 
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Figure 1.5: Schematic representation of neural control mechanisms in the 
mammalian gland. 
KEY:AC= adenylyl cyclase, GC Guanylyl cyclase, 
CO = cyclooxygenase, LO = lipoxygenase, PLA2 = phospholipase A2, 
PLC = phosphlipase C, PKA = protein kinase A, PK-C = protein 
kinase C, LKs = leukotrienes, DG = diacylglycerol, IP = inositol 
mono phosphate, PI = inositol phospholipids, GLU = glutamate, 
ACB = acetylcholine, DSIP = delta-sleep inducing peptide, 
NPY = neuropeptide Y, pm = peptide N-terminal histidine C-
terminal isoleucine, SP = substance P, VIP = vasoactive intestinal 
peptide, BZP = benzodiazepine, DA = dopamine, PG 
prostaglandin. 
Except for NA, VIP and GABA, the receptor nature of the binding 
site is hypothetical (adaptedfrom Cardinali and Vacas, 1987). 
1.5 Pineal Adrenergic regulation 
The most abundant neurotransmitter released from the nerve endings is NA (Pellegrino de Iraldi 
and Zieher, 1966). NA, which also exhibits a circadian rhythm in the rat pineal (Wurtman and 
Axelrod, 1966), is released primarily during the scotophase of the light:dark cycle. Following its 
release, it acts on the adrenoceptors present on the pineal gland, initiating the cascade of events 
leading to the biosynthesis of melatonin, and the release thereof together with other indole and 
polypeptide compounds. 
The daily dark:light cycle of environmental light controls the stimulation of the pineal gland by 
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the sympathetic nerves. There is a decreased release of NA from the terminals during the light 
period, a consequence of the concomitant low activity of the adrenergic innervation. Sympathetic 
activity and NA release are increased during the dark phase (Taylor and Wilson, 1970; 
Brownstein and Axelrod, 1974). This is shown diagrammatically in Figure 1.6. 
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Schematic diagram of the light-induced changes in sympathetic activity 
and compensatory biochemical mechanisms in the pineal gland 
(Adoptedfrom Benfanati et al., 1986). 
Because of the reduced sympathetic activity, constant light induces a supersensitive state of the {3-
receptors, while a sub-sensitivity is observed for intact animals kept in constant darkness. Glands 
taken from animals exposed to light for 24 h have 70% more {3-adrenergic binding sites than 
glands removed from animals at the end of their 12 h dark period (Kebabian et ai., 1975). 
Similar alterations in the sensitivity of {3-receptors to adrenergic stimulation can be achieved by 
pharmacological manipulations and lesion studies. 
NA is a mixed Ct- and {3-agonist and can act via Ctl-' Ct2-' {31-' and {32-' receptors, although it 
is suggested that it may have more selectivity than adrenaline for the Ctl - and {31-
adrenoceptors (Ariens et aI., 1979; Fain and Garcia-Sainz, 1980). The Ctl- and {31-
adrenoceptors on pinealocytes have been fully characterized (Auerbach et ai., 1981; Sugden and 
Klein, 1983). Both are important to pineal functions, including cAMP-, cGMP-, NAT- and 
melatonin synthesis (Klein et al., 1983b; Vanecek, et ai., 1985). 
1.5.1 Pineal {3-Adrenoceptor-Mediated Activation 
The pharmacological characteristics of the rat pineal {3-receptors, as established by agonist-potency 
ratios and the use of selective antagonists, indicated a dominant {31-subclass (Dickenson et al., 
1986). They resembled {31-adrenoceptors found in the heart and brain in having a high affinity for 
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NA; they differed from .62-adrenoceptors, which mediate catecholamine metabolic effects in 
several tissues, and which exhibit a low affinity for NA (Weiner, 1980). A single peptide of 
M,.42,000 was detected after covalent labelling of rat pineal .61-adrenoceptors using a 
photoaffinity probe; this differs from the M,.6O,OOO peptide found in various other tissues 
(Dickenson et ai., 1986), 
.61-Adrenoceptor-mediated activation of pineal adenylyl cyclase enhances cAMP synthesis. the 
binding of cAMP to protein kinase A. phosphorylation of pineal proteins, protein synthesis and 
activation, and the de novo synthesis of enzymes (NAT and HIOMT) in the melatonin pathway 
(Axelrod, 1983; Ebadi. 1984). 
In contrast to that of the rat, the ovine pineal contains a mixed population of .61- and .62- receptor 
subtypes. This conclusion is supported by data from experiments where practolol inhibited NA-
stimulated cAMP accumulation by about 75 %, indicating a slight predominance of .61-receptors 
(Morgan et aI., 1988). 
More recent data have shown that the commonly accepted view that the pineal gland is controlled 
exclusively by .6-adrenoceptors is not valid, and that a-adrenoceptors are also present. 
1.S.2 The a-Adrenergic System. 
Originally demonstrated by Vacas et al. (1980) using biochemical means, the presence of al-
adrenoceptors has been confirmed in the rat pineal gland by Sugden and Klein (1984). Using the 
high-affinity ligand [125]iodo-2-LB-(4-hydroxy-phenyl)ethylalminomethyl] tetralone ([l25I]-HEAT) 
to label these receptors, Sugden and Klein (1985) found that, unlike the .6radrenergic receptors, 
the binding sites labelled by this ligand do not show a circadian rhythm. One difference from the 
.6 -adrenoceptors is that acute or chronic administration of aradrenoceptor agonists failed to 
change the number of specific binding sites. They also demonstrated that these aradrenoceptors 
are indeed under neuronal control, since an increase in the number of [l25J]HEAT binding sites 
was observed after ganglionectomy or three weeks constant light exposure (which blocks central 
stimulation of the gland). 
It would appear that the density of pineal al-adrenoceptors (==400 fmol! mg protein) is only 
slightly less than the density of .6-adrenoceptors in the gland (==600 fmol! mg protein) (Sugden 
and Klein, 1984). An exact comparison is difficult in view of the diurnal fluctuation in .6-
adrenoceptor density (Romero et aI .• 1975). The rapid nature of the elevation in pineal .6-
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adrenoceptor density at the end of the dark period (Romero et al., 1975), coupled to the inability 
of cycloheximide to block receptor loss after ISO treatment (Kebabian et al., 1975), suggest that 
the number of ,8-adrenoceptors may be regulated by an activation and inactivation process possibly 
involving internalization and recycling (Stadel et al., 1983), rather than the slower processes of 
synthesis and degradation. In contrast, the lack of a diurnal rhythm in pineal al -adrenoceptor 
density and the slow increase after interruption of neural input suggest that the number of these 
receptors may be regulated via synthesis and/or degradation (Sladeczek and Bockaert, 1983; 
Sugden and Klein, 1985). 
Further evidence suggests that these al-adrenoceptors are located postsynaptically, as their 
presence was still demonstrable after bilateral superior cervical ganglionectomy. This is in 
agreement with the work of Smith et al., (1979) which also showed the existence of postsynaptic 
a-adrenoceptors following treatment with 6-hydroxydopamine. 
1.5.3 a2 - Adrenoceptor 
It should be noted that presynaptic a2-receptors are also detectable in rat pineals by 
pharmacological means (Pelayo et al., 1977). NA release has been shown to be regulated via a 
negative feedback mechanism mediated via these receptors. Further work by O'Dea and Zatz 
(1976) suggests that increased cGMP levels may also be involved in this reduction in NA release. 
Of further interest is that NA has been shown to inhibit cAMP levels in chick pineal glands which 
have a high percentage of postsynaptic a2 -receptors (Naylor et al., 1982). Similarly, Bylund et 
ai., (1988) have shown a NA-induced inhibition of NAT activity in chick pineal cells: the 
receptors responsible were identified as belonging to the alp~A subtype. 
Pratt and Takahashi (1988) have shown that pertussis toxin-sensitive guanine nucleotide-binding 
proteins (G-proteins) were involved in the transduction of this postsynaptic a2 -adrenergic signal, 
and that pertussis toxin can in fact block the NA-mediated inhibition in this gland. 
1.5.4 Alpha-receptors and phosphatidylinositol turnover 
Ligand binding and pharmacological studies by Fain and Garcia-Sainz (1980) indicate that al-
adrenergic receptors can be divided into al and a2. al - Receptors mediate those metabolic 
effects of a catecholamines which involve phosphatidylinositol (PI) turnover and the release of 
bound intracellular Ca2+ as well as the entry of extracellular Ca2+. The a2 effects of 
catecholamines are due to non-specific inhibition of adenylyl cyclase through a mechanism 
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independent of Ca2+ . 
There is a significant correlation between hormone effects on PI turnover and elevation of 
intracellular Ca2+ (ICa2+]j). Available data suggest that the turnover in membrane-bound PI is 
involved in Ca2+ gating in rat hepatocytes, rat and hamster adipocytes and blowfly salivary 
glands. This effect has also been demonstrated in the rat pineal gland (Smith et al., 1979), but not 
in the ovine pineal gland (Morgan et aI., 1988). 
al - Receptors mediate effects secondary to an elevation of [Ca2+]j and involve increased 
turnover of PI. In contrast, the a2 receptors mediate effects which are due to inhibition of 
adenylyl cyclase. There is an additional complexity, since elevation of Ca2+ due to activation of 
aI-receptors can increase cAMP accumulation if cells contain an adenylyl cyclase which is 
activated by Ca2+. 
The hypothesis that al effects are due to elevation of cytosol Ca2+ and that a2 effects are due to 
adenylyl cyclase inhibition has also been suggested by Wikberg (1979), and supported by Sabol 
and Niremberg (1979). Jones and Michell (1978) suggested that aI-receptors are involved in 
elevation of cytosol Ca2+ and PI turnover. They ignored a2 effects and referred to postsynaptic 
al responses, as being a effects. 
The differentiation between al and ~ receptors is functional rather than anatomic. The difference 
between the two receptors is no more pre- versus postsynaptic than it is excitatory versus 
inhibitory. Rather, the classification reflects the difference between elevation of Ca2+ (via al) 
versus inhibition of adenylyl cyclase {via a~ (Fain and Garcia-Sainz, 1980). 
The role of PI turnover and Ca2+ in the pineal gland is fully discussed [§ 1.11]. 
1.6 Calciwn, the cyclic nucleotides, phosphoinositidyl turnover and the pineal gland 
The occupation of the cell-surface receptors leads to the generation of intracellular second 
messengers, e.g. cyclic nucleotides, Ca2+ and diacylglycerol (DG), which act as allosteric 
effectors to activate a variety of protein kinases (Shenolikar, 1987). 
Although Ca2+ levels' in human pineal glands vary widely, and remain poorly understood, 
experimental biochemical studies are revealing multiple contributions by Ca2+ to molecular 
control mechanisms within pineal tissue. These involvements of calcium pertain to: 1) closure of 
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pineal canaliculi (Allen et aI., 1981), 2) sensitivity of pineal .6-receptors (Zatz and Romero, 
1978; Wilkinson, 1978) and 3) the activation or induction of enzymes participating in pineal 
synthesis of catechol- and indoleamines. Such enzymes include adenylyl cyclase, 
phosphodiesterase (PDE) (Cheung, 1980), the CaM-activated tryptophan hydroxylase (Kuhn and 
Lovenberg, 1982), and N-acetyltransferase (Klein and Weller, 1970). 
1.6.1 Cyclic-AMP 
The pineal possesses a relatively high activity adenylyl cyclase, which catalyses the conversion of 
ATP to adenosine 3', 5'-monophosphate (cAMP). Activated by NA (released from the 
sympathetic nerve endings in the pineal gland) the activity of this enzyme system is influenced by 
the age and sex of the animal as well as by environmental lighting and neural activity (c.f. Strada 
et aI., 1972 and references therein). 
Activation of the .61 -adrenergic receptor elevates cAMP levels ca lO-fold within 10 min of 
stimulation, and the effect gradually decreases as a result of desensitization mechanisms (Vanecek 
et aI., 1985). NA however is active via both .6- and al-adrenoceptors, and when combined 
stimulation of both the .6- and aI-receptors by NA occurs, the rat pineal gland response measured 
in terms of cAMP is greatly potentiated, resulting in increases of between 30- and 100-fold 
(Klein, 1985; Reiter, 1991b). Thus al-adrenoceptor stimulation is able to potentiate .6-
adrenoceptor stimulation of pineal cAMP, when the two are combined. al -Adrenergic 
stimulation alone, however, has no effect on cAMP production in the pineal gland (Klein, 1985). 
1.6.1.1 Cyclic nucleotide-dependent protein phosphorylation 
The cAMP-dependent protein kinase from the rat pineal gland has been purified and characterized 
by Fontana and Lovenberg (1971). The gland is a rich source of this enzyme, which has an 
activity higher than that reported in brain tissue. Its role in pineal function is that of NAT 
induction (Benfenati et ai., 1986). Time taken between the activation of the cAMP-dependent 
kinase, transcription of mRNA, and the eventual rise in NAT varies between species. It is unclear 
whether new mRNA induces the de novo synthesis of NAT molecules or just stimulates a NAT 
activator protein. The former seem more likely (Reiter, 1991a; 1991b). 
Other phosphorylations have been reported, namely that of a specific nuclear protein (34 000 mol 
wt.) during NAT induction (Winters et ai., 1977), and a diurnal variation in the content of pineal 
synapsin I (Nestler et aI., 1982), an endogenous substrate for both cAMP- and Ca2+ I CaM-
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dependent protein kinases (Ueda and Greengard, 1977; Krueger et ai., 1977). 
1.6.1.2 Functional correlates 
NAT is controlled by the pineal sympathetic innervation and its activity also shows a light:dark 
cycle with maximal activity in the scotophase when .6-adrenergic stimulation is increased (Klein 
and Weller, 1970). 
Melatonin synthesis in the rat is critically dependent upon the production of cAMP as an 
intracellular second messenger (Morgan et ai., 1988). As cAMP rises, so must NAT activity, 
resulting in a decrease in HT and HT -oxidation products and an increase in aHT and ultimately 
aMT by mass-action effects (Klein and Weller, 1973; Klein et ai., 1978; Klein, 1985). 
Of interest is the inter-species variation in time taken from cAMP activation to the rise in NAT 
and the eventual melatonin peak. In the Djungarian hamster, peak pineal NAT activity and 
melatonin levels occur 1-2 h after the onset of darkness. However, in the pineal gland of the 
Syrian hamster, both cAMP and mRNA transcription have already peaked by 4 h (Gonzalez-Brito 
et al., 1990; Santana et al., 1990), while NAT activity and melatonin only peak after ca 8 h of 
darkness have elapsed (Panke et al., 1979). 
Another inter-species difference is the magnitude of the nocturnal rise in pineal NAT. Variations 
are seen from a low 2-fold increase to the high 50- to 100-fold increase found each night in the 
rat pineal gland (Rudeen et ai., 1975). 
These differences presumably account for the different patterns of melatonin biosynthesis seen 
between species, as shown in Figure 1.7. 
In vitro studies show that the addition of NA or ISO to pineals in organ culture canses an increase 
in NAT activity, while the addition of propranolol would antagonise the effect (Klein and Berg, 
1970; Deguchi and Axelrod, 1972b; Deguchi, 1973). These data have also been confirmed in 
in vivo studies (Deguchi and Axelrod, 1972a). Cholera toxin, an irreversible activator of adenylyl 
cyclase, and dibutyryl-cAMP are also able to increase the enzyme activity. The response to 
adrenergic stimulation is reduced in vitro when Ca2+ is removed from the medium (Zatz and 
Romero, 1978). Stimulation of NAT activity in vitro by forskolin, an agent which directly 
activates adenylyl cyclase, is found to be significantly reduced in pineals removed from rats that 
have been exposed to alcohol in utero (Rudeen et ai., 1987). 
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Figure 1.7: 
1.6.2 Cyclic-GMP 
Provisional classification (A,B, and C) of the melatonin rhythm in 
various mammalian species. The significance, if any, of the rhythms 
remains unknown. Regardless of the type of rhythm a species displays, 
if the daily dark period is increased the duration of elevated melatonin 
is likewise prolonged (A " B' and C'). Adaptedfrom Reiter (1987). 
Cyc1ic-GMP, whose concentration is elevated 400-fold in pinealocytes by NA, is regulated in a 
manner somewhat similar to cAMP (Vanecek et al., 1985). /3-Adrenergic activation is again a 
requirement, while Cil -adrenergic stimulation, by itself without significant effect, potentiates /3-
adrenergic stimulation (Klein. 1985). There are some marked differences though. Firstly, 
whereas /3-adrenergic stimulation produces lO-fold increases in cAMP levels, it produces only a 
twofold increase in those of cGMP. Secondly, whereas aI-adrenergic potentiation produces a 
seven to 10-fold increase in cAMP concentrations, it produces a 200-fold increase in those of 
cGMP, showing cGMP to be more dependent on aI-adrenergic activation. 
1.6.2.1 Functional correlates 
The role of cGMP in pineal functions has not yet been entirely elucidated. It is responsive to 
stimulation of the rat pineal e.g. in vitro exposure of the glands to NA, or to depolarizing 
concentrations of potassium (K+), increases cGMP levels (O'Dea and Zatz, 1976).' 
Some weak evidence associates cGMP with specific pineal functions: because cGMP is thought to 
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be involved in the regulation of the release of granules in other tissues (Kapoor and Krishna, 
1977), it is possible that it plays a similar role in pinealocytes. Granulated vesicles, an enigmatic 
feature of pinealocytes, are concentrated in stumpy projections called polar processes (Pevet, 
1979). The content of these vesicles is a mystery, but the commonly held view is that they contain 
peptides. It is of interest that the number of these granules appears to vary as a function of 
stimulation (Pevet, 1979). 
Secondly, a cGMP-dependent protein kinase does exist in the pineal and is active on the same 
protein substrates of the cAMP-dependent protein kinase. However, due to the narrow substrate 
specificity of the cGMP-dependent protein kinase, there is no evidence in the literature for the 
existence of endogenous substrates for both cAMP- and cGMP-dependent protein kinases in the 
brain, with the exception of histones and some peptides (Nestler and Greengard, 1984; Nairn 
et al., 1985). 
1.6.3 Subsensitivity and supersensitivity in cyclic nucleotide responses: 
see-saw signal processing. 
A fascinating feature of the pineal gland is that there are reciprocal changes in the magnitudes of 
cAMP and cGMP responses produced by changes in chronic neural stimulation (Deguchi and 
Axelrod, 1973; Klein et aI., 1981b). Following long periods of stimulus deprivation, produced 
by keeping animals in constant lighting or denervating the pineal gland, the cAMP response 
increases two-fold, an example of denervation supersensitivity. This is similar to what is 
generally seen in neural and hormonal regulation. In contrast, the pineal cGMP response exhibits 
the opposite, a denervation subsensitivity. Following constant light, superior cervical 
ganglionectomy or decentralization, the cGMP response to NA falls from a nearly 80-fold increase 
in concentration to less than a four-fold increase. These effects of a supersensitive cAMP 
response and a subsensitive cGMP response are termed ffsee-saw" signal processing. The 
importance of this has not been established, but it may have important implications because it 
shifts the pineal gland between a mono- and a bi-cyclic nucleotide second messenger system. 
Assuming that each regulates different processes, one can imagine that the two cyclic nucleotides 
might be responsible for turning "on" and "off" different hormone systems e.g. while cAMP 
controls aMT production, cGMP might regulate another hormone. 
1.6.4 Cyclic-nucleotides: protein regulation and phosphorylation 
Experiments designed by Benfenati and co-workers (1986) to study protein phosphorylation in 
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different physiological and pharmacological conditions affecting the adrenergic system, showed 
that changes in pineal function could be reflected by changes in the state of phosphorylation of 
substrate proteins. 
They further showed that the sensitivity of the pineal gland to {j-adrenergic stimulation seemed to 
be modulated at different levels of the recognition and transduction mechanisms. The observed 
results prove that the variations in cAMP-dependent protein kinase activity are mediated by {j-
adrenergic receptors, since the stimulatory effect induced by ISO can be blocked by the {j-receptor 
antagonist propranolol. On the contrary, Ca2+ -dependent protein kinase activity seems to be 
unaffected by environmental lighting and {j-adrenergic receptor systems. Thus the Ca2+-
dependent phosphorylating processes may be involved in different aspects of pineal function. 
As is customary in cell systems, the phosphorylation cannot continue unabated, but is curbed by 
the termination of its responsible cyclic-nucleotide. It is well·known that the physiological 
regulator of cAMP is cAMP-PDE. Work from Sugden and Klein (1987), suggests that the 
regulation of cGMP levels in the pineal gland involves an Ns-like GTP-binding regulatory 
protein. This is of interest because it is the first indication that cGMP is regulated by such a 
GTP-binding protein in nonretinal tissue. Although N s has been implicated in both receptor-
mediated ClCadrenergic and opiate stimulation of cGMP in hybrid NGI08-15 cells (Kurose and 
Ui, 1985), it remains to be seen if the mechanisms involved in the transmembrane regulation of 
cAMP and cGMP in any other tissues are similar. 
With seemingly only a single type of {j-adrenoreceptor ({jl) present on the rat pinealocyte 
membrane [§ 1.5.1], the stimulation of both cAMP and cGMP could be mediated by the same 
receptor. Such a receptor may be coupled not only to adenylyl cyclase, but also to a membrane-
bound guanylyl cyclase, via a common or related GTP-binding protein. 
The alternative to a GTP-binding protein, is the possible involvement of a CaM-sensitive cGMP-
PDE regulating pineal cGMP, as is the case in the retina. Support for this comes from the rmding 
that the mammalian retina and pineal share a number of unusual proteins (Axelrod and Weissbach, 
1962; Somers and Klein, 1984), some of which e.g. rhodopsin kinase (Somers and Klein, 1984) 
and S-antigen (Van Veen et al., 1986a) are involved in transmembrane signalling (Stryer, 1986). 
Rhodopsin activates the G-protein transducin, which in turn stimulates cGMP-PDE and although 
an immunoreactive transducin does not appear to be present in the rat pineal gland (Van Veen et 
al., 1986b), a related N-protein controlling a specific cGMP-PDE could be present (Sugden and 
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Klein, 1987). Graziano and Gilman, (1987) have reported the existence of a pathway consisting of 
rhodopsin, transducin and a cGMP-PDE. 
1.7 Calcium entry 
The major route of entry for Ca2+ ions is through the Ca2+ channel. In nearly all eukaryotic cells 
the Ca2+ permeability of the plasma membrane is low at negative membrane potentials. This 
permits the 10 OOO-foid concentration gradient, which is sustained by energy-consuming 
mechanisms. 
Depolarization of the plasma membrane leads to an increase in Ca2+ permeability by activation 
of voltage-dependent / voltage-operated Ca2+ channels (VOC). Besides regulation by the 
membrane potential, many types of ion channels are regulated by phosphorylation. The sheer 
diversity thus altered suggests that regulation of ion channel function by phosphorylation is a 
common and physiologically important property of many ion channels (Nestler et aZ., 1984). 
Electrophysiological studies of voltage-activated Ca2+ currents have demonstrated that the 
activity of Ca2+ channels can be modulated in vivo by cAMP-dependent phosphorylation; the 
precise nature of Ca2+ channels thus modulated cannot, however be established. ,a-Adrenergic 
receptor activation of cAMP-dependent protein kinase can increase voltage-dependent Ca2+ influx 
3- to 4-fold, while calcineurin, a Ca2+ and CaM-dependent phosphatase, accelerates Ca2+-
dependent inactivation. The question that remains is whether the response to phosphorylating 
agents reflects a direct action of the kinase on Ca2 + channels, or an indirect action mediated by 
other regulatory molecules whose own activity depends on phosphorylation (Armstrong and 
Eckert, 1987). 
The data of Rosenthal and Schultz, (1987) suggest that besides intracellular messengers, and 
protein kinases stimulated by intracellular messengers, G proteins constitute a third group of 
regulatory components capable of modifying the activity of VOCs. Thus extracellular signals 
acting via G protein-coupled receptors can also influence / modulate the activity of VOCs. 
This mechanism may be restricted to the membrane, for there is no evidence for the participation 
of protein kinases stimulated by cytosolic signal molecules, such as cAMP. So far, the only 
identified components of this signal transduction chain are receptors for extracellular signals and 
G proteins. In the heart, a Gs-protein which is activated by cholera toxin, stimulates cardiac Ca2+ 
channels without the involvement of a cAMP-dependent intermediate step (Rosenthal et at., 
-31-
1988). 
Until recently, the effects of guanine nucleotides on agonist binding were the only indications that 
a G protein may be involved in the action of Ca2+ -mobilizing receptors (Taylor and Merrit, 
1986), now G proteins appear to participate in the modulation of transmembranous Ca2+ fluxes. 
1.7.1 G proteins 
G Proteins act as transducers functionally coupling membrane receptors activated by extracellular 
. signals and enzymatic effectors controlling the concentrations of cytosolic signal molecules such 
as cAMP, cGMP, IF and Ca2+. The enzymatic effectors include adenylyl cyclase, the retinal 
light-sensitive cGMP-PDE, and hormone-sensitive phospholipases C and A2. 
G proteins are divided into 2 major groups (Gs and Gj), which differ in their Ct subunits (Cts and 
Ctj) and thus mediate the effects of receptors that stimulate or inhibit adenylyl cyclase (Taylor and 
Merritt, 1986). 
With retinal cGMP-PDE, stimulation of enzyme activity has been shown to be caused by direct 
interaction of G protein Ct subunits with the respective enzyme (for a review see Casey and 
Gilman, 1988). Similarly, Jj-adrenergic stimulation of the pinealocyte is known to activate 
adenylyl cyclase via a stimulatory guanine nucleotide-binding regulatory protein (Gs) (Spiegel, 
1989). In the rat pineal gland, the outcome is a mpid and large increase, up to 60-fold, in pineal 
cAMP (Reiter, 1991a). 
Ribosylation of the G-protein by cholera toxin can substitute for Jj-adrenergic receptor stimulation 
(Sugden, 1989a), and CtI-receptor stimulation can augment the stimulatory effect of cholera toxin 
(Ho et aI., 1987). Since CtI-receptor stimulation can also augment forskolin induced cAMP 
production, the interactive site for the CtI- and Jj-adrenergic mechanisms is clearly distal to the Jj-
adrenergic receptor (Chik and Ho, 1989). 
1.7.1.1 Modulation of ion channel activity by G proteins 
It has been demonstrated that G proteins mediate hormonal regulations of ion channel activity, 
apparently independently of intracellular receptors (cAMP, cGMP and Ca2+ ). Therefore, G 
proteins may interact directly with ion channels; alternately, there may be regulatory target 
molecules of G proteins, which once activated may interact directly with the VQC, either 
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stimulating or inhibiting it (Rosenthal and Schultz, 1987). 
In intact cells, the VOCs are presumably opened by the transient rise of cytosolic Ca2+ that 
follows receptor-mediated activation of PLC; activation of these VOCs may contribute to a 
maximal and sustained elevation of cytostolic Ca2+. resulting in full activation. Moreover. in a 
variety of cells, protein kinase C mimics, i.e. phorbol esters or synthetic diacylglycerols, increase 
or decrease transmitter release or the activity of transmembraneous ion currents, including Ca2+ 
and K+. 
By analogy with their role in receptor-mediated regulation of enzymes, G proteins may act as 
transducers between cell surface receptors and VOCs, mediating not only hormonal stimulation 
but also inhibition of ion channel activity (Rosenthal and Schultz, 1987; Rosenthal et al., 1988). 
1.8 Calcium channels 
Calcium channels play important roles in excitability, excitation-contraction coupling, excitation-
secretion coupling and other cellular functions (Hamilton and Perez, 1987). In fact, there is hardly 
a tissue where Ca2+ channels have not been postulated as an important part of the signal 
transduction mechanism. Voltage-operated calcium channels are a key component of all excitable 
cells which transduce electrical signals into biochemical events. In contrast, receptor-operated 
calcium channels (ROC) have not been detected by electrophysiological techniques to date 
(Hoffman et ai., 1987). 
A major distinction between excitable and non-excitable cells in terms of their modes of Ca2+ 
regulation is the presence in excitable cells (and absence in non-excitable cells) of voltage-
activated Ca2+ channels. Many (but not necessarily all) of these channels are potently inhibited 
by Ca2+ -channel blocking drugs, such as verapamil, diltiazem and nifedipine. Such channels are 
not present in non-excitable cells, and in these cells, Ca2+ -entry is activated by Ca2+ -mobilizing 
agonists, but not by membrane depolarization (Putney, 1987). Thus, in non-excitable cells, 
receptor regulation of Ca2+ mobilization is insensitive to inhibition by the CCBs. 
Because channel activity is altered by ,a-adrenergic agonists, 8-bromo-cAMP, intracellular 
injection of cAMP, or by injection of the Ctl-catalytic subunit of protein kinase (for references see 
Hamilton and Perez, 1987), a cAMP-dependent phosphorlyation reaction may well modify 
channel function. Supporting this, Gray and Johnston, (1987) reported that NA increased the 
activity of VOCs in granule cells of the hippocampal dentate gyrus. The action appeared to be 
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mediated by .8-adrenoreceptors and could be mimicked by cAMP. Results from Armstrong and 
Eckert, (1987) demonstrated that the dihydropyridine-sensitive class of VOC, or molecules closely 
associated with the channels in the membrane, had to be phosphorylated for the channels to open 
when the membrane was depolarized. Thus while phosphorylation through the cAMP-dependent 
protein kinase plays a role in the control of VOCs (Livitan, 1989), more recent evidence [§ 1.7] 
indicates that guanine nucleotide-binding (0) proteins are involved in both turning on and turning 
off Ca2+ channels (Stevens, 1986; Holz et al., 1986). One possible explanation is that the 0 
proteins directly couple channels and receptors. Such membrane· organization would have 
important implications to both Ca2+ channel organization and the definition of structure-activity 
relationships for ligand modulation of Ca2+ channels. 
The link between 0 proteins and VOCs was further strengthened by the work of Scott and 
Dolphin, (1987a) which demonstrated that the activation of a guanine binding (0) protein is an 
essential step in coupling certain receptors to the inhibition of VOCs. A residual sustained L-type 
component of the Ca2 + -channel current was resistant to inhibition by. internal guanosine 5' -0-3-
thiotriphosphate (OTP--y-S) (Dolphin snd Scott, 1987b). Because Ca2+ -channel antagonists such 
as D600, nifedipine and diltiazem inhibit L currents (Nowychy et al., 1985; Rogart et aI., 1985), 
they examined their effect on OTP--y-S-modified currents. The results represented the first 
electrophysiological evidence that guanine nucleotides are able to influence the cellular responses 
to Ca2+ -channel ligands. 
1.8.1 Classification of channels 
In an attempt to classify the different types of Ca2+-channels, Hamilton and Perez (1987), made 
use of specific toxins. However, a new classification was recently adopted which brings into 
focus many earlier anomalies (Spedding, 1987). Voltage-operated calcium channels have been 
differentiated into T (transient), N (neuronal) and L (long lasting) channels. 
A small transient current is carried by the T channel which is activated from quite negative 
membrane potentials. A larger current is carried by N- channels, found only in certain neuronal 
cells (controlling neuro-transmitter release) T- and L- channels have been identified in most cells 
tested (L- channels being found predominantly on cell bodies). 
The third class of channel - the L-channel- corresponds to the channel described by Reuter in 
1967. This slowly inactivating channel, which is only activated from relatively depolarized 
membranes, is the site of action of verapamil and diltiazem analogues and of the dihydropyridines. 
The new classification partially explains the anomaly that although there were many L-type 
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channels and dihydropyridine binding sites in the brain, dihydropyridines had little effect on 
neurotransmitter release. 
There are at least four binding sites for the drugs in the L-channel. Binding to these is critically 
dependent on the state of the channel and hence on membrane potential. 
The cardiac L-type calcium channel was the first channel known to be modulated by hormones 
(Reuter, 1984; Tsien et ai., 1986). ,a-Adrenergic receptors which activate the cAMP-dependent 
protein kinase can increase by 3- to 4-fold, voltage-dependent Ca2+ influx via the VOC while 
cGMP lowers the cAMP levels via the activation of a cGMP stimulated cAMP-PDE (Hartzell and 
. Fischmeister, 1986). Both mechanisms result in a dephosphorylation of the channel and thereby 
decrease the open state probability. The dihydropyridines are highly specific for L-type calcium 
channels (Miller, 1987; Triggle and Janis, 1987), and the dihydropyridine Ca2+ -agonist Bay 8644 
strongly increases the probability of opening of L-, but not N- or T-type channels (Nowycky 
et al., 1985). 
Activators of protein kinase C increase L-type calcium channel current in both Swiss mouse 3T3 
and human fibroblasts. Inositol-1,4,5-triphosphate (IP3) and the inositol- tetraphosphate derivative 
(IP.0 activate directly a plasma membrane localized calcium channel in T lymphocytes and 
possibly in other tissues. It is possible that IP 4 is the true and direct activator of the channel since 
many cells can phosphorylate IP3 to IP 4. 
1.8.1.1 Biochemistry of L-type calcimn channels 
The L-type calcium channel has been identified in vitro by three of its drug binding sites which 
are specific for dihydropyridines (e.g. nifedipine), phenylalkylamines (e.g. verapamil) and 
benzothiazepines (e.g. diltiazem)(Ruth et al., 1985; Triggle and Janis, 1987). These 
stereospecific sites have a high affinity for each respective group. The binding to one site is 
regulated allosterically by i) the occupation of the other sites, ii) by divalent cations and iii) by 
temperature. An example of the three distinct receptor sites and the allosteric reciprocal 
interaction between them and divalent cation binding sites is shown in Figure 1.8. 
In addition to these high affinity sites, most tissues contain low affinity, high capacity binding 
sites for calcium channel blockers which are not located on the L-channels (Oeken et al., 1986; 
Hofman et al., 1987.) 
Figure 1.8: 
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e 
Calcium channels three distinct receptor sites. The allosteric 
reciprocal interaction (arrows) between the receptor sites and 
divalent cation binding sites oj the channel (adapted from Glossman 
et al., 1985). 
1.8.2 The L-channel, the CCBs and the pinealocyte 
G proteins are involved not only in the hormonal modulation of Ca2+ -channel activity, but can 
apparently also modify the effects of Ca2+ -channel ligands such as D600, nifedipine, and 
diltiazem on Ca2+ currents (Scott and Dolphin, 1987). 
These findings raise the question of whether CCBs interact exclusively with the channel protein or 
if, in addition, they interact with G proteins or other components that participate in the 
modulation of VOCs. In spite of this uncertainty, the CCBs have been used previously in studies 
involving melatonin and the pineal gland. 
Meyer et aI. (1986), studied the effects of two dihydropyridines on night-time melatonin serum 
levels, while more recently Zatz and Mullen, (1988) used CCBs to study the nocturnal release of 
r14C]-aMT by chick pineal cells cultured in a (LD 12: 12) cycle. At 1 JLM the dihydropyridines, 
nitrendipine and nifedipine, were most effective (virtually abolishing the nocturnal rise in 
melatonin output). Verapamil inhibited the increase about 50%, and diltiazem had little effect. At 
higher concentrations [lOJLM] , diltiazem did inhibit the nocturnal rise (about 50%), whereas 
verapamil and the dihyropyridines lowered melatonin output to well below daytime levels. 
However the simplest test of a role for Ca2+ -influx remains the omission of Ca2+ from the 
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medium. The result of this test was the prevention of most of the nocturnal rise in [14C]-aMT 
output. 
The results of these experiments strongly suggest that influx of Ca2+ through VOCs is important 
in the regulation of melatonin production by chick pineal cells. Again it should be noted that 
melatonin output reflects synthesis of the lipophyllic hormone, rather than exocytotic release of 
stored material (Zatz, 1982; Klein, 1985). 
Omission of Ca2+ from the medium, or addition of inorganic Ca2+ channel blockers inhibited 
the melatonin output. This suggests a requirement for extracellular Ca2+. 
Electrophysiological studies have demonstrated the presence of sustained (L-type) and transient 
(N-type) Ca2+ currents in these cells (Harrison et ai., 1987). Nitrendipine, a potent and specific 
blocker of L-type Ca2+ channels (Miller, 1987; Triggle and Janis , 1987), was potent and 
effective in reducing melatonin output, whereas Bay K 8644, a potent and specific 'agonist' for L-
type Ca2+ channels, was potent and effective in increasing melatonin output. These results 
suggest that it is the L-type Ca2+ channels that mediate most of the effects of Ca2+ on melatonin 
output. Since nitrendipine and Bay K 8644 were effective at all phase points, it appears that 
Ca2+- channels in the chick pineal cells are neither maximally 'open' nor maximally 'closed' at 
any time in the melatonin cycle (Zatz and Mullen, 1988). 
1.9 Calcium ion antagonists 
A number of phenomenological criteria are used in identifying Ca2+ currents. Amongst these are: 
that the action potential should be able to be blocked by the metal cations like cobalt (C0 2+), 
lanthanum (La3+) and manganese (Mn2+), or organic Ca2+ channel blockers such as verapamil, 
diltiazem and nifedipine at reasonable concentrations (Hagiwara and Byerly, 1981). According to 
Fleckenstein, (1977) a calcium antagonist is a drug whose predominant action is the inhibition of 
Ca2+ current in a dose dependent manner. 
Since the selective inhibition of the inward Ca2+ current is most characteristic of the organic 
members of the groups of calcium antagonists, and is a better description of their role than the 
mere antagonism of calcium ions, the terms calcium entry blockers and calcium channel blockers 
(CCB) are more favoured for this subgroup (Van Zwieten and Timmermans, 1983). The structures 
of some groups of calcium active drugs and examples thereof discussed in this chapter and used 
later are shown in Figure 1.9a-h. 
1.9a 
1 .9b Diltiazem 
1.9d 
1.9c Nifedipine 
CH,OOC 
CH) 
NO, 
COOCH, 
CH, 
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Generalized structural characteristics of calmodulin inhibitors. 
Note the similarity to trifluoperazine (1.ge). 
1.9f A23187 
Figure 1 .9a-h: 
M&B 22948 
The structures of some groups of calcium active drugs and examples 
thereof 
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1.9.1 Inorganic Ca2+ -antagonists 
Metal cations like cobalt (Co2+), lanthanum (La3+), manganese (Mn2+) and nickel (Ni2+) have 
the ability to block several Ca2+ -dependent processes, including the Ca2+ channel (Triggle, 
1981). This appears to be as a result of their ability to substitute on Ca2+ binding sites (Triggle 
and Swamy, 1983). 
1.9.2 Organic Ca2+ -antagonists 
The subgroup of compounds collectively known as calcium channel blockers (CCBs) blocks 
. voltage-dependent calcium channels in a variety of cell types. Of these compounds, the 1,4-
dihydropyridines, such as nifedipine and nitrendipine, have become widely used tools to study 
calcium channels both functionally and biochemically (Brush et aI., 1987). Thus while the VOCs 
have been reclassified, the concept of calcium antagonists blocking Ca2+ entry into cells by 
interacting with voltage-operated Ca2+ channels (VOCs or L channels) is still valid. 
Following on from the work of Albert Fleckenstein, several groups of compounds were developed 
that acted reasonably specifically to block Ca2+ -channels. These compounds have become known 
as Ca2+ -channel blockers although certain of them (e.g. diphenylalyamines, such as prenylamine) 
can exert additional pharmacological effects (Stanfield, 1986 and references therein). 
There are three primary groups. These are the phenylalkylamines, such as verapamil (Figure 
1.9a) (and its analogues D600 or methoxyverapamil), the benzodiazepines such as diltiazem 
(Figure 1.9b), and the dihydropyridines, such as nifedipine (Figure 1.9c) and nitrendipine. 
1.9.2.1 Binding Sites 
Debate continues as to whether the first two groups act at the same site or at a different site in the 
Ca2+ -channel, even though verapamil competitively inhibits diltiazem binding in certain tissues 
(Murphy et ai., 1983). The differences to pH, temperature, thiol-reagents, and 1,4-
dihydropyridines in the sensitivity of binding of these two ligand classes make the suggestion of a 
common site unlikely (Triggle and Janis, 1987). Several studies on purified membranes from 
skeletal and cardiac muscle (Garcia et ai., 1986; Erlich et aI., 1985) reveal three distinguishable 
sites for Ca2+-channel ligands, one each for l,4-dihydropyridine, verapamil, and diltiazem 
analogs, and indicate the ratio of these binding sites to each other as being 1:1:1. Less-pure 
membranes however yield different stoichiometries (Glossman and Ferry, 1985; Reynolds et ai., 
1986). Both ligands show a substantial use-dependence in their action. Both affect the binding of 
the third group to the VOC, verapamil reducing and diItiazem enhancing the binding of 
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nitrendipine (Murphy et aZ., 1983). The inhibitory effect ofverapamil on nitrendipine binding is 
non-competitive and is believed to involve allosteric effects within the channel protein, the 
binding site of nitrendipine being separate from that of the two other drugs. 
1.9.2.2 Use dependence and allosteric inhibition 
The actions of verapamil and diltiazem are use-dependent. On application of the drug there is 
little or no blockage of Ca2+-current until stimulation has opened channels (Pelzer et aZ., 1982; 
Lee and Tsien 1983). The onset of blockage then increases in rate with increasing frequency of 
stimulation. 
The hypothesis of a modified receptor, where the affinity of the channel for a drug depends on the 
state (open, closed or inactivated) of the channel, is also necessary to account for the action of 
dihydropyridines, which are lipid soluble compounds acting primarily on L-type channels. 
Antagonists among this group appear to bind preferentially to the inactivated state, and the 
difference in affinity between inactivated and closed (that are ready to open) Ca2+ -channels is 
very large (Stanfield, 1986 and references therein). 
The binding sites are allosterically coupled such that at 37°C 1,4 dihydropyridine antagonists and 
diltiazem reciprocally stimulate binding. Verapamil (and phenylalkylamines) and 1,4 
dihydropyridines are mutually inhibitory, independent of temperature. 
Diltiazem and verapamil also show mutual inhibition of binding. In contrast to the effects of 1,4 
dihydropyridine antagonsits, activators such as Bay K 8644 inhibit diltiazem binding in heart 
membranes (Garcia et aZ., 1986) and stimulate it in brain membranes, but only at high 
concentrations (Triggle and Janis, 1987 and references therein). 
1.10 Intracellular Calcium receptors 
The possibility that the intracellular effects of Ca2+ might require the presence of a binding 
protein was first mooted by Meyer et al., (1964). The discovery of more calciproteins (other than 
troponin C) i.e. proteins that bind Ca2+ with an affinity constant with the role of intracellular 
receptor, shows the wide range of events triggered by Ca2+ (StocIet, 1981). Some of these 
proteins ineluded parvalbumin, calsequestrin and vitamin D-dependent calcium binding protein. 
The low intracellular [Ca2 +]j is maintained by intracellular buffers as well as the 
plasmamembrane. Several intracellular structures can take up and bind Ca2+. The mitochondria 
can take up large amounts of Ca2+ and are considered to be buffers of Ca2+. but while this buffer 
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may act in the short term. proper balancing of extrusion versus Ca2+ -entry must still occur 
(Godfraid, 1980). 
1.10.1 Calbindin-27 kDa 
This calcium binding protein was first reported by Wasserman and Taylor in 1966. The exact role 
of calbindin-27 kDa or vitamin D-dependent calcium binding protein is not clearly established, 
but the present view is that it acts as a buffer to take up the increased Ca2 + levels occuring in 
response to physiological stimuli. Its presence has been demonstrated in both the pineal organ and 
retina of humans (Roman et al., 1988). 
A study by Krstic (1988) showed a lack of calbindin-immunoreactivity in the pineal bodies of the 
Mongolian gerbil (known to form acervuli), but a considerable amount of calbindin-reactive cells 
in the pineal bodies of rats (which do not form acervuli). He suggested that calbindin might have a 
special role in the pineal gland, namely the removal of Ca2+ which enters during stimulation. 
1.10.2 Calmodulin 
While the above proteins appear as specialized molecules, one calciprotein has retained its 
structure and is found in both the plant and animal kingdoms. Calmodulin is an ubiquitously 
occuring, thermally stable, Ca2+-binding protein of 16,500 daltons, containing 148 amino acid 
residues in a single polypeptide chain. It has now been implicated in conferring calcium 
sensitivity (i.e. Ca2+-dependent activation) to ca 30 different target proteins (for reviews see 
Means and Dedman, 1980; Cheung, 1980; Stoclet, 1981; Manalan and Klee, 1984), and thus 
plays the role of multifunctional intracellular Ca2+ receptor. 
In purification procedures, use is made of its thermal stability in the presence of Ca2+ and its 
acidic nature. It is in fact these properties which lead to its discovery [§ 5.1.3]. 
It is well established that calmodulin contains four calcium binding sites (Dedman et al., 1978) 
with a dissociation constant within the range of 1O-6M (Klee, 1977; Wolff et ai., 1977). 
On calcium binding (two Ca2+ ions per mole) to the four Ca2+-binding sites, large structural 
changes, which include increases in a-helix and intrinsic tyrosine fluoresence, occur. This results 
in the exposure/fonnation of hydrophobic drug/protein-binding sites (LaPorte et al., 1980; Johnson 
and Wittenauer, 1983), probably the most significant calcium-dependent event to occur on the 
surface of calmodulin. 
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These resultant interfacial sites are thought to be the sites where CaM interacts with its target 
proteins and with inhibitory drugs (calmodulin antagonists). 
1.10.2.1 Allosteric control 
The work by Johnson (1983) was the first to show that CaM was an allosteric protein with respect 
to its drug/protein binding site. Using felodipine, which fluoresces on binding to the sites, he was 
able to show other drugs e.g. R24571 and prenylamine binding to- and enhancing felodipine. In 
the case of CaM drug-induced potentiation of felodipine binding, the potentiating drugs bind to 
CaM only in the presence of Ca2+, and produce their potentiated state by binding to sites which 
. are distinct from the calcium-binding sites on CaM (Johnson, 1983; Mills and Johnson, 1985). 
The two Ca2+ -dependent hydrophobic domains exert allosteric control over one another. 
Consistent with these findings, Inagaki and Hidaka (1984) have suggested that prenylamine and 
butaclamol bind to one class of binding sites on calmodulin, while trifluoperazine binds 
preferentially to a distinct site. It is apparent that some, but not all, of the drug binding sites on 
calmodulin and its target protein binding sites are mutually exclusive. Although the relationship 
between the interaction site(s) is unclear (Johnson and Mills, 1986), it is thought that allosteric 
control may provide one mechanism by which CaM can control so many other enzymes. 
Mills and Johnson, (1985) have also done an interesting study on capital (C) and auxiliary (A) 
sites. For the binding of the l,4-dihydropyridine derivative - felodipine - to occur, the Ca2+-
binding (C) sites must be filled, leading to the formation of the allosteric conformer. A further 
requirement is that the A sites are also occupied. Occupancy of A sites in the resting cell (empty 
C sites) induces subtle conformational changes which could abolish certain hydrophobic 
interactions of CaM (Milos et aI., 1987). In the presence of Ca2+ (filled C sites) occupancy of 
the A sites seems to modify the mode of interaction of CaM with drugs and enzymes (Mills and 
Johnson, 1985). This therefore suggests a further means of control (Cox, 1988). 
An intriguing possibility is that these interactions stabilize a preformed complex between CaM, an 
adjacent enzyme, and its substrate, and would facilitate rapid activation in response to increased 
Ca2+ concentration. Most models accounting for modulation of the Ca2+ signal by CaM, 
involve the implicit assumption that free CaM is present in some tissues in a limited amount. 
Despite this, estimates of the total levels of CaM-binding proteins in these tissues are high. There 
is additional evidence suggesting that a redistribution of CaM or its target proteins from one 
cellular compartment to another may play an important role in mediation of the Ca2+ signal 
(Nehmad et aI., 1982; Saitoh and Schwartz, 1983). This difficulty in knowing exactly where the 
CaM is present, makes any inferences concerning local concentrations rather difficult (Manalan 
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and Klee, 1984). 
1.10.2.2 Ordered calcium binding hypothesis for calmodulin 
The mode of action of CaM was first established with the phosphodiesterase system. Calmodulin 
itself is not active; its active form is the CaM-Ca2+ complex. Once bound to Ca2+, CaM 
assumes a more helical conformation to become the active species, which binds reversibly to the 
apoenzyme of PDE, resulting in the formation of an active holoenzyme (Haiech et al., 1981). 
The sequence of events associated with the stimulation of PDE by calmodulin may be depicted as 
follows: 
(calmodulin)inactive + Ca2+ # (calmodulin *.Ca2+ )active (1) 
(E)less active + (calmodulin*.Ca2+ )active # {E*.calmodulin*.Ca2+ )active (2) 
where E stands for the apoenzyme and the asterisk (*) for a new conformation. According to this 
scheme, the cellular flux of Ca2+ plays a crucial role in regulating PDE activity. 
1.10.2.3 Calmodulin as dual regulator of adenylyl cyclase and cAMP-PDE 
Amongst the many enzymes activated by CaM, are both adenylyl cyclase and cAMP-PDE. It 
appears odd that the same activator can be required for both activation and destruction within one 
system. It appears however, that the activation of adenylyl cyclase takes place at much lower 
concentrations of Ca2+ than those required for the activation of cAMP-PDE. Thus once the 
optimal Ca2+ concentration for PDE activation is reached, adenylyl cyclase is already being 
inhibited. As shown in Figure 1.10, there is also a partly sequential effect. Adenylyl cyclase is 
located in the plasma membrane and is thus activated as the first Ca2+ influx occurs. The Ca2+ 
must then penetrate to the cytoplasm to reach the PDE found there (Marme, 1981; Boehringer, 
1983). 
, 
Ca2+ + 
• CYTOPLASM ~ 
Ca2+ + 
Figure 1.10: 
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The sequential activation of adenylyl cyclase and cAMP-PDE in 
response to Ca2+ illflw: through the plasma membrane and into the 
cytoplasm. (Adaptedfrom Cheung, 1982). 
1.10.2.4 Cabnodulin antagonists 
Because of the increasing interest in CaM and the enzymes it controlled, several approaches were 
used to prove its control, with varying degrees of success. 
Cheung (1980), proposed several criteria to prove that a process is CaM-regulated: 1) the tissue or 
cell must possess sufficient CaM in the appropriate locale, 2) depletion of endogenous CaM 
should render the experimental system susceptible to exogenous CaM, 3) sequestering Ca2+ in the 
reaction system should return the CaM-induced activity to basal level, 4) addition of 
trifluoperazine should return the CaM-dependent activity to the steady-state level, and 5) the effect 
of CaM should be reversed by i'ts antibody (Kranias et ai., 1980). 
However, because of the nature of the binding sites, a number of different types of pharmaca have 
been found to bind to CaM in a Ca2+ -dependent manner. These include phenothiazines, tricyclic 
antidepressants and naphthalene. 
1.10.2.4.1 Calion binding and antagonism 
In addition to drug-binding sites, CaM has metal-binding sites. Not only calcium but lanthunum 
(La3+), terbium (Tb3+), lead (Pb2 +), samarium (Sm3+), strontium (sr2+), mercury (Hg2+), 
cadmium (Cd2+), zinc (Zn2+), and manganese (Mn2+) have been shown to interact with 
calmodulin (Wallace et ai., 1982; Wang et ai., 1984; Chao et ai., 1984). Some of these metals 
can compete for the Ca2+ binding sites on CaM while others may have effects on CaM's 
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conformation beyond those produced by Ca2+ alone e.g. magnesium (Mg2+), nickel (Ni2+), 
C02+ and barium (Ba2+) do not activate CaM, but La3+, Sm3+ and TbH are effective 
activators (Luchowski et al., 1984). 
The ability of metal cations to inhibit Ca2+ binding is related to their ionic radii. In general, the 
closer the radius of a metal cation was to that of Ca2+ , the more effective was that cation as a 
substitute for Ca2+. The range of effective ionic radii was approximately 1 ± 0.2 It CaM-
stimulated PDE activity by the cations can be reversed by trifluoperazine (TFP), an antagonist of 
CaM (Chao et ai., 1984). 
1.10.2.4.2 Trifluoperazine 
Since the initial observation by Weiss et al. (1974) on the interaction of TFP with CaM, this drug 
has been used frequently to prove the role of CaM in cell processes. The weakness of such 
evidence is that high concentrations [1O-5]M are needed, and these are several orders of magnitude 
greater than the drugs affInity for dopamine and serotonergic receptors (Landry et ai., 1980; Van 
Belle, 1981). 
The development of specifIc inhibitors of either CaM or PK-C activity is needed to elucidate the 
physiological role of each pathway in response to different external stimuli. 
Although the interaction of neuroleptic agents such as TFP with CaM is unrelated to the clinical 
efficacy of these agents (Norman et ai., 1979), this observation has provided investigators with a 
probe for CaM function in isolated cell systems. However, when Schatzman et ai., (1981) 
reported that TFP as well as other neuroleptic agents are inhibitors of PK-C activity, its use 
declined (Norman et ai., 1986). 
1.11 Introduction to the Potentiation and Ca2+ phenomenon 
Interest in Ca2+ and its growing role in the physiological regulation of pineal function by NA 
resulted in much new research (Vanecek et al., 1985; 1986, Sugden et al., 1985; 1986), 
especially because of the unusual synergistic mechanism involving al - and {3- adrenoceptors, 
through which NA regulates pinealocyte cAMP and cGMP (Klein et al., 1983; Vanecek et ai., 
1985). {3-Adrenergic stimulation is an absolute requirement in both cases, alone producing a 10-
fold increase in cAMP and a 3-fold increase in cGMP. aI-Adrenergic activation alone produces 
no detectable change in either cyclic nucleotide. It potentiates {3 -adrenergic stimulation of cAMP 
about lO-fold, apparently through a Ca2+ - / phospholipid-dependent protein kinase - PK-C -
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(Sugden et al., 1985), and that of cGMP, about lOO-fold. 
Both ill vivo and in vitro experiments with the Cti-agonist phenylephrine (PE) in the rat pineal 
gland demonstrated potentiation and prolongation of the stimulating effect of the l1-agonist ISO on 
NAT activity (Klein et al., 1983; Alphs and Lovenberg, 1984), cAMP (Vanecek et al., 1985) and 
cGMP accumulation (Vanecek et al., 1986), and even low Km cAMP-PDE (Vacas et ai., 1985). 
Two other Ctl -adrenoceptor agonists were tested to see if other more specific Ctl-agonists (apart 
from PE) would also potentiate l1-adrenergic stimulation. 6-Fluoronorepinephrine and cirazoline 
were chosen. Results obtained with these two drugs confirmed that NA-regulated indole 
m~tabolism could be mimicked by other Ctl-adrenoceptor agonists (Sugden et at., 1984). 
This potentiation was found even after degeneration of the pineal sympathetic nerves, thus 
indicating it's essentially postsynaptic nature. 
1.11.1 Essential role of Ca2+ influx in the pineal 
Work by Sugden and co-workers, (1986; 1987) showed an essential role for Ca2+ influx in the 
adrenergic regulation of both cAMP and cGMP. Chelation of external Ca2+ with EGTA, or 
inhibition of Ca2+ influx with inorganic Ca2+ channel blockers (La3+, C02+ or Mn2+) reduced 
the cyclic nucleotide response to NA. but not to ISO, a l1-adrenergic agonist. Cti-Adrenergic 
effects could be mimicked by agents which elevated cytostolic Ca2+ levels, e.g. A23I87, when 
used together with l1-adrenoceptor stimulation, while these agents had no effect alone. 
They concluded that [Ca2+]j was raised, not from internal Ca2+ supplies, but that external Ca2+ 
supplies crCa2+]J were required. They demonstrated unequivocally that pinealocyte [Ca2+]j was 
increased 7-fold as a result of a net influx of Ca2+, brought about by a mechanism involving NA 
acting through Ctl -adrenoceptors: prazosin was able to block the Ctl effect, while yohimbine did 
not influence the effect. 
Initial support for a role of Ca2+ in pineal adrenergic regulation had come from observations in 
in vitro glands which showed that i) the removal of Ca2+ from the culture medium resulted in the 
inhibition of the NAT and cAMP increases which would normally follow adrenergic stimulation 
(O'Dea and Zatz, 1976; Zatz and Romero, 1978), ii) the calcium ionophore A23187 was able to 
mimic the effects of Cti-adrenergic stimulation on the cyclic nucleotides in rat pinealocytes 
stimulated with ISO (Vanecek et al., 1986), and iii) the potentiation of cAMP was dependent on 
the activation of the Ca2+-regulated PK-C (Sugden et aI., 1985). 
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Sugden et aI. (1987), suggested the Ca2+ concentrations in rat pinealocytes were influenced by 
two NA-refractory mechanisms, namely, voltage-dependent calcium channels and the Na+/Ca2+ 
exchange. Previously, Meyer et al., (1986) had demonstrated that the in vivo injection of 
dihydropyridine calcium antagonists was able to decrease the amplitude of the nighttime melatonin 
rise in baboons, thus supporting the possible role of a VOC. 
In experiments to examine whether the effects of A23187 and K+ were dependent upon Ca2+ 
influx, [Ca2+]o was reduced by adding EGTA. This blocked the effects of A23187 on PK-C 
redistribution, as well as cAMP and cGMP accumulation in ISO-treated cells. Secondly, voltage-
sensitive Ca2+ channels were blocked with nifedipine, which has been found to block the 
stimulatory effects of K+ on [Ca2+]j in pinealocytes (Sugden et al., 1987) and to inhibit the 
amplifying effects of K + on cAMP and cGMP levels in ISO-treated pinealocytes (Sugden et al., 
1986). Nifedipine was able to block the K+-mediated redistribution of PK-C. EGTA and 
nifedipine were more potent in inhibiting the cGMP response than the cAMP response, reflecting 
the greater Ca2+ dependency of the cGMP response, which is probably not related to PK-C (Ho 
et al., 1988). 
Although it appeared that PK-C was involved in the ell-adrenergic potentiation of .6-stimulated 
cAMP, the same did not seem to apply to cGMP (Sugden et al., 1985). Ho et al., (1987), 
investigated this and found that cGMP levels could be potentiated in .6-stimulated pinealocytes, 
with the PK-C activator 4.6-phorbol 12-myristate 13 acetate (PMA), provided that Ca2+ levels had 
been raised with e.g. A23187. Similarly PMA stimulated cGMP levels in cells treated with cholera 
toxin and A23187, but not in cells treated with just cholera toxin. Thus it seemed that PK-C 
mediated (at least in part) the ell-mediated potentiation, and that Ca2+ was also necessary for 
cGMP potentiation. 
Arachidonic acid (AA) production also appears necessary for cGMP stimulation, as the 
phospholipase A2 inhibitor, mepacrine, blocks the adrenergic stimulation of cGMP, but not that 
of cAMP (Vanecek et aI., 1986). Of further interest is i) that stimulation of AA production by 
NA is Ca2+ -dependent (Gilman, 1984) while ii) the metabolism of AA in the pineal is unusual in 
that it generates lipoxygenase products at 20-fold higher rates than other tissues (Yoshimoto et aI., 
1984). Although roles have been suggested for prostaglandins in NA-induced melatonin 
synthesis, the exact role of the lipoxygenase pathway is not that clear (Vacas et al., 1987). 
Inhibition with the lipogenase inhibitor NDGA, suggest that it is involved. However this may 
also inhibit other systems e.g. cyclooxygenase. As indomethacin has been shown to impair pineal 
activation (Cardinali et al., 1982), this may only be a partial effect. Rozengurt et aI., (1983) 
have shown indomethacin to inhibit the conversion of AA to prostaglandin E in 3T3 cells, hence 
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inhibiting the normal increase in cAMP in these cells. 
The fact that PK-C activators could potentiate the effects of cholera toxin stimulation of cGMP 
suggests that the PK-C acts with the cGMP system at a point distal to the adrenoceptor, bringing 
in the possibility of the GTP-binding protein having a role in cGMP levels. .6-Adrenergic 
stimulation of pinealocyte cAMP is known to involve Ns (Minneman and Iverson, 1976; Vanecek 
et al., 1986), the stimulatory GTP-binding regulatory protein which couples receptor occupation 
to the activation of adenylyl cyclase (Hurley et al., 1984). Cyclic-GMP is probably regulated by 
the Ct subunit of a related GTP binding protein, GsCt (Sugden and Klein, 1987). 
1.11.2 
1.11.2.1 
The role of phosphoinositides in signal transduction 
Introduction 
A compelling amount of evidence indicates that the ubiquitous inositol lipid signalling pathway 
has a key role in neuro-transmission and neuro-modulation initiated by Cti-adrenoreceptor with the 
cell membrane (Exton, 1985). 
Bob Michell (1975) first called attention to two points of circumstantial evidence that suggested a 
causal role for the inositol lipids and the mobilization of cellular Ca2+: 1) whenever receptors 
were linked to PI turnover, these same receptors were also known to activate Ca2+ mobilization 
- PI turnover never, for example, occurred when receptors activated adenylyl cyclase; and 
2) activation of PI turnover itself did not appear to be a consequence of Ca2+ mobilization, as 
evidenced by the relative insensitivity of the process to experimental regimens which depleted 
cellular Ca2+, and by the inability of the Ca2 + ionophores to stimulate turnover. A characteristic 
feature of this inositol lipid receptor mechanism is that the transduction process has a bifurcation 
point leading to the generation of two intracellular second messengers. The widely-accepted 
cascade is thus: the precursor lipid (phosphatidylinositol 4,5-biphosphate IP3), located within the 
inner leaflet of the plasma membrane, is cleaved in response to Cti-agonists (by the receptor-
activated phospholipase C [PLC] in the plasma membrane which hydrolyses the PI) to yield the 
second messenger couple of sn-l 2-diacylglycerol (DG) and inositol l,4,5-triphosphate (IP3). 
The latter -IPr has been identified as a signal for intracellular Ca2+ mobilization (Berridge, 
1984)(probably from within the endoplasmic reticulum), whereas DG is known to activate PK-C 
(Nishizuka, 1984). Additionally, increases in Ca2+ influx, either through the opening of a Ca2+ 
"gate" in the cell membrane (as seen in smooth muscle) or through an ouabain-sensitive 
Na + ICa2+ exchange mechanism, have been described in most tissues after Cti-adrenergic 
stimulation (Exton, 1985). 
-48-
The IP3 and DG branches of the phosphoinositide cascade appear to act synergistically to 
phosphorylate proteins, the former by elevating Ca2+ to activate calmodulin-dependent protein 
phosphorylation and the latter to activate PK-C, which phosphorylates a different set of proteins 
(Seiler et ai., 1987). The elevated Ca2+ may also activate reactions not dependent on calmodulin 
(Sekar and Hokin, 1986). The predominant event; the rises in IP3 and DG apppear to be necessary 
for maximal responses. 
1.11.2.2 Events in the pineal 
Thus, while this gives an outline of the events, there are several reviews dealing with the various 
aspects of polyphosphoinositide metabolism and its significance vis-a-vis receptor activation (for 
references refer to Sekar and Hokin, 1986). It would however, still seem pertinent to briefly 
cover those aspects relevant to the pineal gland, and the possible mechanisms involved in its 
observed potentiation. 
Briefly, a I-adrenergic stimulation has been shown to potentiate ,6-adrenoceptor stimulation by a 
variety of complex mechanisms. Some of those implicated (and which are present in the pineal) 
are an increase in intracellular Ca2+ levels which is associated with, or may even be essential to, 
i) the activity of pineal phospholipase C (Smith and Hauser, 1981), ii) the activity of 
phospholipase A2 (Ho and Klein, 1987), and iii} the translocation and activation of PK-C (Sugden 
et al., 1985). Figure 1.11 shows a diagrammatic representation of the presumed signal 
transduction mechanisms. 
Reports that the activation of the aI-adrenergic receptors induced changes in PI turnover 
originated some time ago (Hauser et ai., 1974; Ni.ijar et aI., 1980). The mechanism through 
which the aCadrenoceptor induced potentiation occurred appeared to involve a net Ca2+ influx 
and the phospholipids. 
The net influx of Ca2+ into the pinealocyte has already received much attention. al-Adrenoceptor 
stimulation also leads to PI turnover, an increase in the activity of PLC, and the generation of the 
intracellular messengers DG (Smith et ai., 1979; Zatz, 1985) and inositol phosphates (Berridge, 
1986). 
The direct demonstration of receptor-mediated increases in inositol phosphates is facilitated by the 
use of the anti-manic ion, lithium. This blocks the breakdown of inositol monophosphate and 
subsequent recycling, permitting direct measurement consequent to phospholipid breakdown 
(Hancher and Sherman, 1980; Zatz, 1985). 
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Diagrammatic representation of the presumed signal transduction 
mechanisms between the postganglionic sympathetic neurons and the 
mammalian pinealocyte. 
KEY: AAAD = I-aromatic amino acid decarboxylase, AC = adenylyl 
cyclase, ATP = adenosine triphosphate, cAMP = adenosine 3':5'-
mono phosphate, DG = diacylglycerol, G = guanine nucleotide-
binding protein, Gs = stimulatory G, mOMT = hydroxyindole-O-
methyltransferase, IP = inositol phosphate, MAO =monoamine 
oxidase, NAT = N-aceryltransferase, NE = noradrenaline, PI = 
phosphatidylinositol, PK-C protein kinase-C, PLA2 
phospholipase A2, PLC = phospolipase C, TH = tryptophan 
hydroxylase, aI- = a-adrenoceptor and {3- = {3-adrenoceptor. 
(Adaptedfrom Reiter, J99Ja). 
In the pineal the increase in [Ca2+]j and DG are thought to translocate and activate PK-C 
(Nishizuka, 1984). Sugden and co-workers, (1985) proposed that DG might be the second 
messenger mediating this effect, their reason being that a synthetic DG, 1-01eoyl-2-acetylglycerol 
(OAG), was able to mimic the aI-adrenergic stimulation. The site of potentiation appeared to be 
after {3-adrenoceptor activation, as a similar potentiation could be produced by PE in cells 
stimulated with cholera toxin. Phorbol esters are also able to potentiate the effects of the cholera 
toxin (Klein, 1985). The phorbol ester, PMA, which can directly activate PK-C, is able to mimic 
the potentiating effects of al-agonists (Sudgen and Klein, 1988). 
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1.11.3 Translocation 
Following the demonstration of translocation / redistribution it became of interest to determine the 
subtype of adrenoceptor involved in the adrenergic translocation (increased membrane association) 
of PK-C. Four adrenergic agonists were tested, including the mixed al-' fj-adrenergic agonist NA 
and the aI-adrenergic agonist phenylephrine (PE). The findings were consistent with the 
interpretation that al-adrenoceptors were involved (Sugden et aI., 1985). 
The mechanism involved in translocation by NA, K+, and A23187 does not appear to be precisely 
th~ same. In the case of al-adrenoreceptor-mediated translocation, it appears that translocation 
may occur as a result of both the increase in Ca2+ influx and in DG production. 
There are two lines of evidence that suggest DG is involved. Firstly, in prior studies 
aI-adrenergic activation of the pineal gland has been found to produce a gradual increase in PLC 
activity (Zatz, 1985; Ho et ai., 1987) and secondly, it was found that NA caused a gradual 
increase in eHJ-diacylglycerol kinase. Thus it appears reasonable to suspect that both the 
increases in Ca2+ and in DG accumulation could be important for translocation of PK-C by 
adrenergic agonists, and that Ca2+ and DG act synergistically to regulate PK-C, as seen in cell-
free systems. 
From the above data, it seems most conservative to assume that at least two classes of PK-C 
translocating agents exist. One acts through an increase in Ca2+ influx and is characterised by 
A23187 and K+. The second depends upon both an increase in Ca2+ influx and in DG levels and 
could include NA and PE. 
The fact that Ca2+ influx alone can trigger redistribution of PK-C in the intact cell, is of 
fundamental importance because it emphasizes that PK-C may be activated in many systems by 
transmitters, hormones, or other agents which elevate Ca2+ influx, but which may have no other 
direct effects. Thus, Ca2+ influx might be the critical element regulating the degree of 
membrane association of PK-C. Accordingly, results obtained from studies in which cells are 
treated with agents that increase Ca2+ influx must be interpreted with this in mind (Ho et ai., 
1988). 
1.11.4 
1.11.4.1 
The individual participants in the cascade 
Protein kinase C 
Protein kinase C is the enzyme most linked to the potentiation. The reasons for suspecting this 
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come from the fact that i) PE has been shown to translocate PK-C (Sugden et ai., 1985), ii) 
activators of PK-C mimic the potentiating effects of PE (Ho et ai., 1987), and iii) that an inhibitor 
of PK-C inhibits the potentiation (Ho et ai., 1988). 
When PK-C was first found, in 1977, as a proteolytically activated protein kinase in many tissues, 
it had no obvious role in signal transduction (Inoue et ai., 1977). Later, it was shown to be a 
Ca2 + -activated, phospholipid-dependent enzyme (Takai et ai., 1979), and was firmly linked to 
signal transduction. This was demonstrated by the fact that DG, one of the earliest products of 
signal-induced inositol phospholipid breakdown, greatly increased the affinity of PK-C for Ca2+, 
th~reby rendering it fully active (Nishizuka, 1984), without a net increase in Ca2+. Thus the 
activation is biochemically dependent on Ca2+, but physiologically independent of Ca2+ 
concentration (Kikkawa and Nishizuka, 1986). 
During cell stimulation, PK-C is transiently activated by the DG produced in the membrane 
during signal-induced PI turnover. (Similarly, PMA and other tumour-promoting phorbol esters 
may directly stimulate PK-C). During such activation PK-C, which is mainly a cytosolic enzyme, 
is translocated to the cell membrane (Sekar and Hokin, 1986). 
Sugden (1989b), studied the developmental appearance of PK-C in the rat pineal gland. He found 
it to be already detectable before birth in both cytostol and membrane fractions, reaching full 
activity ca 30 days post natally. His study further indicated i) that the PK-C was located in the 
pinealocyte and not the presynaptic adrenergic terminals, and ii) that adrenergic stimulation was 
not required to maintain high levels of PK-C activity within the pineal. 
Phenylephrine is known to stimulate the translocation of PK-C in rat pinealocytes (Sugden et ai., 
1985). 
Activation of the latter receptor is also known to produce a sustained increase in [Ca2+]j by 
increasing net influx (Sugden et ai., 1985), pointing to the possible importance of Ca2+ influx 
in the subcellular redistribution (activation) of PK-C in intact cells. Ho et ai., (1988), in fact 
established that an increase in Ca2+ influx was sufficient to trigger translocation of PK-C. In 
addition, a very close correlation existed between the translocation of PK-C by PE, K+, and 
A23187 and their ability to potentiate l1-adrenergic stimulation of cAMP and cGMP accumulation. 
This adds further support to the proposal that the translocation of PK -C is required for the 
potentiation of l1-adrenergic stimulation of pinealocyte cAMP and cGMP accumulation. 
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1.11.4.2 Diacylglycerol 
The neutral lipid diacylglycerol is normally absent from membranes. On receptor stimulation, it 
appears transiently and disappears within seconds, due to its conversion back to inositol 
phospholipids and its degradation to arachidonic acid (AA), which in tum can generate other 
messengers e.g. the prostaglandins. 
Synthetic DGs having the 2,3-sn configuration are not active in intact cell systems (Nomura et at., 
1986). Tumour-promoting phorbol esters have a 1,2-sn configuration, similar to DG, and are 
thus able to activate PK-C on a 1: 1 basis (Kikkawa et al., 1983). 
The DG formation resultant from PI breakdown, following aI-adrenergic stimulation, and the 
subsequent effects on cyclic nucleotides (Sugden et ai., 1985b) and NAT activation (Zatz 1985b) 
have been adequately demonstrated in rats. Both cyclic nucleotide-dependent and Ca2+-
dependent protein phosphorylation takes place in rat pineal glands (Cimino et al., 1987). 
1.11.4.3 Phorbol esters 
Studies from Nishizuka (1984) and Castagna et ai., (l982). have shown the PK-C is a target for 
phorbol esters because the tumour promoters can substitute for DG and directly activate PK-C. 
It appears that tumour-promoting phorbol esters e.g. PMA, as well as 1-0Ieoyl-2-acetyl-sn-
glycerol (OAG), can activate the DG site of PK-C in intact cells. This has facilitated the probing 
of PK-C function (Sekar and Hokin. 1986). These esters have been shown to activate PK-C in the 
pineal gland as well. 
1.11.4.4 Phospholipase A2 
Another well-studied consequence of increased [Ca2+]j levels is the activation of phospholipase 
A2 (Exton, 1985). Several of the arachidonic acid (AA) metabolites produced by this enzyme 
after the cleavage of inositol phospholipids, e.g. prostaglandins (PGs), thromboxanes. and 
leukotrienes. may participate in mediation or modulation of the final response of the pineal cells to 
the aI-adrenergic transmitter. For example, inhibition of PLA2 by mepacrine blocked NA 
stimulation of cGMP but enhanced NA stimulation of cAMP in rat pinealocytes (Vanecek et at., 
1986). 
An interesting possibility is that while both a I-adrenergic agonists and PK -C activators stimulate 
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PLA2 and AA generation, only ell-adrenergic agonists (but not PK-C activators) can stimulate the 
conversion of AA to an active metabolite through a Ca2+ -dependent mechanism. This is 
especially attractive because Ca2+ -dependent processes appear to playa larger role in the pineal 
cGMP response to NA than the cAMP response (Sugden et al., 1986). If this explanation is 
correct, it should be possible to experimentally potentiate the cGMP response to PK-C activators 
in .6-adrenergically treated pinealocytes with agents that elevate [Ca2+]j. 
In addition to these PK -C-dependent mechanisms, it is possible that NA stimulates PLA2 through 
mechanisms which do not involve PK-C. One possible such mechanism involves an increase in 
[C~2+]i' Pinealocyte [Ca2+]j is increased by NA acting through ell-adrenoreceptors (Sugden 
et al., 1987). The studies reviewed above clearly indicate that the NA stimulation of pineal PLA2 
activity is Ca2 +-dependent and can be elicited by a Ca2+ ionophore. Phospholipase A2 is known 
to be a Ca2+ -dependent enzyme (Van den Boch , 1980), and it is thus not impossible that an 
increase in [Ca2+]j is involved in the NA stimulation ofPLA2 activity. 
In summary, the evidence presented indicates that NA stimulates the pineal PLA2. The sequence 
of events appears to be aI-receptor elevation of Ca2+ influx and PLC activation, leading to an 
elevation of [Ca2+]j and DG. These events together seem to activate PK-C, which could activate 
PLA2 by phosphorylating lipocortin (Touqui et al., 1986), and thus removing the inhibitory effect 
of this PLA2 regulator, or by stimulating Na+/H+ exchange (Besterman et aI., 1985), or a 
combination of these effects. In addition, the increase in [Ca2+]j produced by NA may be 
involved in the stimulation of PLA2 through PK-C-independent mechanisms (Ho and Klein, 
1987). 
1.11.4.5 Phospholipase-C 
Another enzyme associated with phospholipid metabolism and transmitter receptors IS 
phospholipase-C (PLC) (Berridge, 1984). 
aI-Adrenergic stimulation increases PI turnover (mainly inositol monophosphate) in rat 
pinealocytes (Zatz, 1985a). Ho et ai., (1987) in work with rat pinealocytes have shown this to be 
mediated via the Ca2+ -dependent activation of PLC. 
Stimulation of this Ca2+ -dependent enzyme catalyses the conversion of PIP2 to IP3 and DG. As 
with the cyclic nucleotide system, the receptor-mediated stimulation of PLC is probably associated 
with a guanine nucleotide binding protein (Wallace and Fain, 1985). 
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Once formed, IP3 and DG serve as second messengers, with the former liberating intercellular 
stores of calcium ion and the latter stimulating the calcium-activated, phospholipid-dependent 
enzyme, PK-C. Like the cAMP-dependent protein kinase, PK-C modifies cellular activity by 
catalysing the phosphorylation of various substrates. 
Studies by Ho et ai., (1987), studied the effect of ouabain on PLC activity ill dispersed 
pinea1ocytes, because of the reported increase in Ca2+ influx and PLC activity. Smith et aZ., 
(1978) have previously reported that NA can stimulate PLC via an action on the aj-adrenoceptor, 
hence ouabain was compared to NA, but proved about IO-fold less potent. Prazosin however 
bl~cked NA effects, but not those of ouabain, showing that different mechanisms were involved. 
EGTA prevented both treatments working, confirming the Ca2+ dependence of PLC. One 
implication of this study is that if high levels of ouabain are employed experimentally, activation 
of PLC could occur, with subsequent generation of the second messengers DG and the inositol 
phosphates, and possibly even PK-C. 
1.11.5 
1.11.5.1 
Interaction with other signalling systems 
Classes of signalling systems 
Signalling systems can be sub-divided. One class depends only on cAMP generation as its second 
messenger, while the other induces PI turnover and Ca2 + mobilization. This then leads to the 
release of arachidonate (AA) and increases in cGMP. Thus PK-C activation, Ca2+ mobilization, 
AA release and cGMP formation appear to be integrated into a single receptor cascade (Kikkawa 
and Nishizuka, 1986). 
In bidirectional control systems the two classes of receptor system counteract each other, whereas 
in monodirectional systems, the one class of receptors may potentiate the other. The pineal is 
considered to belong to the latter group of control systems. This is supported by work from Zatz 
(1985), which showed that the phorbol esters could mimic aj-adrenergic stimulation in the pineal, 
supporting the role of PI turnover and PK-C in the al-adrenoceptor stimulation. He favours a 
feedback mechanism to ,8-adrenoceptors, as PE and PMA potentiate rather than stimulate, and 
under conditions of maximal stimulation, they fail to potentiate, suggesting a convergent system. 
The PK-C presumably potentiates the adenylyl cyclase system, or acts co-operatively with protein 
kinase A. Arachidonate is derived from phospholipids, initially through a PLC mechanism and 
subsequently a PLA2 mechanism. 
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1.11.5.2 Phospholipase A2 and Protein kinase C 
Enna and Karbon, (1987) suggest that PLA2 and PK-C may be linked, especially because of the 
finding that ClI-adrenergic agonists stimulate both PI turnover and augment ,6-adrenergically 
mediated cAMP in rat pinealocyes. A variety of fatty acids including AA are capable of directly 
stimulating PK-C (McPhail et ai., 1985; Murakami and Routtenberg, 1985). If this occurred 
in vivo, then stimulation of PLA2, and the liberation of AA, could activate PK-C, which in turn 
may mediate the cAMP augmenting phenomenon. PK-C is thus the common link to cAMP 
augmentation; its activation resulting either from stimulation of PLC leading to DO and IP3 , or 
stimulation of PLA2, and the release of AA. 
PK-C can regulate cAMP accumulation via the 0 protein (Figure 1.12) Firstly it could 
phosphorylate Os' thereby increasing its activity and hence that of adenylyl cyclase. Alternately, 
PK-C may catalyse the phosphorylation of Gj , thus reducing the latter's inhibitory capacity on 
adenylyl cyclase, and increasing the system's response to Os' 
PhOSPh~liPi1 
mepscnne 
glUCOCClticC!ids r 
+ 
Figure 1.12: 
Lysophospholipid DG 
+ 
arachidonic acid 
ct~o 
phO/bol esters 
A model descihing the possible interaction between phospholipid 
metabolism and the cAMP generating system in the brain. 
KEY: GABA = "{-aminobutyric acid, NE = noradrenaline, Ach = 
acetylcholine, PLA2 = phospholipase A2, PLC = phospo/ipase C, Gs 
alld Gj = the stimulatory and inhibitory guanine nucleotide binding 
proteills, respectively, C = the catalytic unit of adenylyl cyclase, CO = 
cyclooxygellase, LO = lipoxygenase, PIP2 = phosphatidylillositol 4,5-
biphosphate,IP3 = inositoitriphosphate, DG = diacylglycerol, ATP = 
adenosine 5'-triphosphate, cAMP = adenosine 3 ':5 '-mollophosphate, 
P = phosphate trallSfer catalysed by protein kinase C, + =acrivation 
(adapted from Enna and Karbon, 1987). 
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Whatever the end result, the data indicate that activation of PK-C, through stimulation of PI 
turnover or an increase in the availability of AA, may be the critical step that subserves the 
Cll-adrenergic and GABAB receptor regulation of cAMP responses in brain and rat pineals (Enna 
and Karbon, 1987). Reiter, (1991b) suggests that the resultant activation of PK-C increases the 
efficiency of activation of adenylyl cyclase most probably through phosphorylation of the cyclase. 
1.12 Summary of the potentiation 
In summary, the amplification mechanism appears to involve a positive effect of Ca2+ - / 
phospholipid-dependent protein kinase (PK-C) [§ 1.11.4.1]. Activation of the pinealocyte 
Cll-adrenoreceptor rapidly translocates this enzyme by increasing ICa2+]j I§ 1.11.3] a 
correspondingly rapid increase in DG generation appears to be totally dependent on extracellular 
Ca2+ I§ 1.11.3]; there is no indication that adrenergic agents alone increase the production of IP3 
(Zatz, 1985; Sugden et al., 1988) or that IP3-dependent mobilization of Ca2+ occurs (Sugden 
et al., 1987). 
Protein kinase C activation appears to enhance cAMP and cGMP synthesis at a step beyond 
{3-adrenoreceptor activation, by phosphorylating Gs or the adenylyl cyclaseand guanylyl cyclase 
I§ 1.11.1]. In the case of cGMP, the increase in [Ca2+]j also appears to be important for 
activation of processes independent ofPK-C [§ 1.11.S.2]; these processes may involve activation of 
phospholipase-A2 [§ 1.11.4.4] and the arachidonic acid cascade and are required for full 
potentiation of {3-adrenergic stimulation (Vanecek et al., 1986). 
The intracellular mechanism involved in the VIP and Cll-adrenergic interaction might resemble the 
mechanism involved in the interaction of Cll- and {3-adrenergic receptors which stimulates 
cGMP. These mechanisms are perhaps similar, as VIP and {3~adrenergic receptors can activate 
adenylyl cyclase. probably by acting via GsCl, the GTP binding protein which regulates this 
enzyme; additionally the effects of {3-adrenergic stimulation appear to be mediated by a GSCl-like 
protein. Thus, it seems reasonable to entertain the hypothesis that {3-adrenergic and VIP receptors 
activate a membrane-bound guanylyl cyclase via this protein (Ho et al., 1987). 
1.12.1 A desensitization mechanism is present in the pinealocyte. 
As is usual in biological systems, a control system also appears to be present. Just as cAMP can 
not rise without the activation of its terminator cAMP-PDE, so a desensitization mechanism 
appears to be present here too. 
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One factor contributing to the differences in the time courses for these events is that stimulation 
by NA. A23187, and K+ may be subject to PK-C-dependent feedback inhibition, and that the 
effects of PK-C activators are less sensitive to this. For example, NA activates PLC and increases 
Ca2+ influx: effects required for NA to activate PK-C. However, PK-C activation also leads to 
an eventual inhibition of receptor stimulation of PLC and Ca2 + influx (for references see Ho and 
Klein, 1987). As a result, the NA stimulation of PK-C would not be sustained, and would 
gradually diminish as a result of this feedback mechanism. 
In contrast, the effects of PMA do not depend upon an increase in PLC of Ca2+ influx, and the 
effects of PMA on activation of PK-C would not be subject to this type of feedback inhibition. In 
addition to these effects on NA-stimulated events, PK-C has been found to inactivate voltage-
gated Ca2+ channels (Di Virgilio et ai., 1986). These channels are present in the pinealocyte and 
are involved in the effects of K+ (Sugden et ai., 1986, 1987). Accordingly, it seems reasonable 
that the activation of PK-C by NA and other agents that increase [Ca2+]j may induce feedback 
inhibition, and that feedback inhibition explains in part the more transient nature of their 
stimulation of PLA2, as compared with that of PMA. The eventual decrease in PLA2 activation 
seen with all activating agents might be explained by enzymatic inactivation of PK-C by a 
common mechanism. 
Taken together, these findings indicate that a desensitization mechanism is present in the 
pinealocyte. The hypothetical sequence of events is: Oil-adrenergic activation elevates influx of 
Ca2+, which increases [Ca2+]j; the increase in [Ca2+]j activates PK-C (Ho et ai., 1988). The 
activated enzyme potentiates t1-adrenergic stimulation of cAMP and cGMP (Vanecek et at., 1985; 
Ho et ai., 1987). In addition, it reduces the Oil-adrenergic elevation of [Ca2+]j. As a result, 
activation of PK-C is attenuated, and the Oil-adrenergic potentiation of t1-adrenergic cAMP and 
cGMP production decreases (Sugden et aI., 1988). 
1.13 
1.13.1 
Involvement of phosphoinositides in hypertension 
Introduction 
Although this does not relate strictly to the pineal, it does involve the CCBs in their therapeutic 
role, phosphoinositide metabolism, Ca2+ influx and the catecholamines. 
1.13.2 Therapeutic. use 
The first CCBs were characterized as coronary vasodilators and were introduced initially in the 
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treatment of angina pectoris (Buhler et al., 1982). Use of verapamil in hypertension therapy was 
first proposed in 1968 by Hagino. Use of the remaining CCBs rapidly ensued. 
1.13.2.1 Hypertension 
Two processes appear to be at work in hypertension; there is an initiating abnormality specific to 
each form of hypertension, which in tum is linked to a "slow" process capable of amplifying 
arterial pressure (Lever, 1986). Structural changes (e.g. atherosclerosis) occurring in the blood 
vessel can considerably elevate pressure by increasing arterial resistance (Takeshita et al., 1982). 
The amplification of pressor mechanisms further raises blood pressure (Lever, 1986). 
Atherosclerosis is reported to change the reactivity of blood vessels to pressors (Resink et al., 
1987). The enhancement of the vasoconstrictor effect of serotonin was one of the first such 
changes reported (Henry and Yokoyama, 1980). 
Studies of the pathogenesis of atherosclerosis suggest several factors are involved including 
enhanced arterial permeability to lipoproteins, smooth muscle cell (SMC) migration and 
proliferation, and platelet deposition .cRoss, 1986). 
Several arguments suggest that the phosphoinositide pathway is involved in hypertension 
(Baudouin-Legros and Meyer, 1990). 
1) The phosphorylation of membrane PI has already been covered at length. Of the two products 
produced by PL-C activation, the water soluble product IP3 is released into the cytoplasm 
inducing the release of Ca2+ from a nonmitochondrial vesicular pool while the lipophilic product 
DO activates a phospholipid and Ca2+-dependent protein kinase, which controls the Na+/ H+ 
membrane-exchange system (Weinstein and Heider, 1988). 
2) SMC proliferation appears to be induced by intracellular Ca2+ transformation triggered by 
phosphoinositide metabolism. Coupled to this, studies have found patients with essential 
hypertension showed increased free platelet Ca2+ and increased PL-C activity (Erne et ai., 1984). 
3) The constrictor agents mediate their effects via PL-C activation e.g. agents such as angiotensin 
II, serotonin and the catecholamines acting via postsynaptic aI-receptors can be shown to increase 
free Ca2+, IP3 and DO. It is accepted that the contractile effect stems largely from the 
translocation of Ca2+ brought abought by IP3 (Owen, 1986). 
The CCBs prevent the increase of a stimulated influx of Ca2+ through VOCs, irrespective of the 
-59-
stimulus that elicits opening of the L-channels. Hence, they are capable of antagonizing 
vasoconstriction in those blood vessels where the activating stimulus is associated with 
depolarization and L-channel activation (Baudouin-Legros and Meyer, 1990). 
Of further interest are the fmdings that the major classes of CCBs show an antiatherosclerotic 
activity albeit more effective prophylactically. Some evidence shows regression of lesions when 
administered in combination with an appropriate diet. 
However, smce the activity is observed with representatives of all the classes of CCBs, 
inqependent of their disparate nonspecific effects, it is tempting to consider Ca2+ antagonism the 
common denominator for the activity, as suggested by Fleckenstein and co-workers (1987). 
Could it be that the target cells show differential sensitivity toward the different CCBs, e.g. the 
l,4-dihydropyridine derivative isradipine is active at very low doses, while the other members 
require much higher doses than used for mere L-channel blockade? 
The usefulness of the CCBs in hypertension and their potential to prevent or slow the development 
of atherosclerosis is certainly interesting, as are the basic links to Ca2+ handling. 
1.14 Calciwn and the pineal gland: a relationship? 
The relationship between cations and the pineal gland remains vague, in spite of much literature 
suggesting such a connection. Melatonin synthesis has been shown to be dependent on calcium 
ions, and studies have shown a diurnal rythym in both melatonin production and cation levels. 
Calcium also has strong links to the reported ell-receptor mediated potentiation in the pineal. The 
calcium channel through which calcium enters has also been the focus of attention in this field, 
with Morton and co-workers (1989) suggesting a possible role for the channel itself in melatonin 
secretion. The role of calcium in the function of the pineal gland remains an open and interesting 
topic which warrants further investigation. 
2 
2.1 
CHAPTER 2 
ORGAN CULTURE STUDIES 
INTRODUCTION 
The role of calcimn in cell regulation and the pineal gland 
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An increase in the free calcium ion concentration, ICa2+]i' within stimulated cells underlies 
several important biological processes e.g. muscle contraction (Ebashi and Endo, 1968; Allen and 
Kurihara, 1980), the regulation of enzyme activities (Cohen, 1982), the control of membrane ion 
permeabilities (Meech, 1978; Colquhoun et al., 1981; Maruyama and Petersen, 1982) and the 
secretion of transmitters and hormones (Katz, 1969; Baker and Knight, 1981). The secretion of 
the pineal hormone, melatonin, is also influenced by Ca2+ levels [§ 2.5.1.2]. The [Ca2+]j in 
resting (unstimulated) cells is in the region of 0.05,uM to 0.5,uM, while that of the extracellular 
fluid is from l,uM to 10,uM. The calcium concentration outside the cell is some 10000 times 
greater than that inside the cell, providing the equivalent of sink conditions, the importance of 
which will be discussed later. Although the concentration of calcium seems low, it must be noted 
that this is free Ca2+, the Ca2+ to which calcium-dependent and calcium controlled enzymes 
respond (Irvine, 1986). On stimulation, either chemical or electrical, the ICa2+]j rises some two 
orders of magnitude either as a result of Ca2+ influx across the membrane of the cell. or through 
the release of Ca2+ from intracellular stores, or both (Reuter, 1983). 
It is an inescapable fact that the ultimate control of the overall Ca2+ levels is vested in the plasma 
membrane, for only this membrane has access to sink conditions, i.e. the "bottomless" supply of 
Ca2+ present in the extracellular fluid. 
In view of the importance of Ca2+ ions in the control of cellular functions it will be of 
considerable interest to explore the calcium fluxes through which the cells are regulated. Both the 
voltage operated channel (VOC) and the Na+ ICa2+ exchange have been implicated in the changes 
in ICa2+]j in the pinealocyte (Sugden et al., 1987). The organic calcium channel blockers (CCBs) 
represent a class of drugs which were suggested to act by the selective inhibition of Ca2+ influx 
through cell membranes (Fleckenstein, 1977). As such, they have long been suggested as being 
useful probes for the study of hormone mediated effects associated with calcium fluxes (Ehlert 
et ai., 1982; Millar and Bramley, 1984; Millar and Struthers, 1984; Lamers et ai., 1985). The 
rat pineal gland lends itself to pharmacological investigation, because of the relative ease with 
which the gland can be removed, and its ability to survive in explant culture (Zatz, 1981) where, 
as with all isolated organ studies, various pharmacological manipulations can be performed 
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without the complexity of the in vivo milieu. It is therefore not surprising that several researchers 
have developed organ culture systems that allow them to monitor the well-characterised synthesis 
of indoleamines in the pineal for changes brought about by various experimental manipulations. 
2.1.1 Organ culture 
"Organ culture" has its origins in the Strangeways Laboratory, some 60 years ago (Strangeways 
and Fell, 1926; Fell and Robinson, 1929). At that time the technique was restricted to the culture 
of embryonic organ rudiments mainly because those were small enough to be cultured in their 
entirety. The technique was later modified by Trowell (1959), so that in vitro cultures of an 
organ (or part thereot) was possible i.e keeping the organ viable without either further growth or 
dedifferentiation thereof. He also introduced the concept of stabilizing the culture medium's 
alkalinity by including 5 %C02 with the 02' Using these modifications he was able to keep pineal 
glands viable in culture for a minimum of 6 days. This was later confirmed by Klein (1969). 
Several pinealologists have since developed their own versions of organ culture (Axelrod et al., 
1969; Klein and Rowe, 1970; Parfitt et aI., 1976; Alphs et al., 1980; Cardinali et ai., 1981; 
Yuwiler. 1987). In this laboratory Daya (1982) developed a system of culturing 4 pineal glands 
in culture vessels made from ampoules. Morton (1982) started culturing pineals individually in 
culture tubes, a technique later employed succesfully by both Skene (1985) and Daya and Fata 
(1986), and discussed in I§ 2.2]. 
2.1.2 Theory of Assay 
Pineal glands co-incubated with a suitable precursor (tryptophan. 5-hydroxytryptophan or 
serotonin) will take it up and synthesize the indole metabolites associated with pineal metabolism. 
These are then secreted back into the culture medium. It is usual to incubate rat pineal glands for 
24 h, after which the incubation is terminated by the removal of the gland from the medium. 
Aliquots of the medium are then spotted onto thin layer chromatography (TLC) plates and the 
metabolites separated. 
If a radioactive precursor is used, the labelled indole metabolites formed may be separated by TLC 
and quantitated by liquid scintillometry. This method provides a more quantitative picture of 
pineal indole metabolism and has been shown to be sensitive to pharmacological manipulations 
(Klein and Rowe, 1970; Balemans et al., 1983b; Voisin et al., 1983; Daya and Potgieter, 1985) 
as well as adequately reflecting changes in pineal indole metabolism (Daya and Fata. 1986). 
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2.1.3 Objectives 
In the following section, the general technique for pineal gland organ culture, TLC separation of 
the pineal indoles and measurement of the [l4C]-serotonin metabolites is outlined. A full 24 hour 
profile of pineal indole metabolism is also shown in validation of this technique. Variations from 
this general outline, where required for different experimental applications, are listed in the 
respective methods sections succeeding this. 
2.2 
2.2.1 
2.2.1.1 
ORGAN CULTURE TECHNIQUE 
Materials and Methods 
Chemicals, drugs and reagents 
5-Hydroxy [side-chain-2-14CJ tryptamine creatinine sulphate (57 mCi/mmol) was purchased from 
Amersham Laboratories, England; the synthetic indoles serotonin, 5-hydroxytryptophol, 
5-hydroxyindoleacetic acid, melatonin, N-acetylserotonin, 5-methoxytryptophol, 
5-methoxyindoleacetic acid. and 5-methoxytryptamine were obtained from Sigma Chemical Co., 
USA and BGJb culture medium from Gibco, Europe. Benzylpenicillin sodium, streptomycin 
sulphate and amphotericin B were obtained from local sources. All other reagents used were of 
analytical grade, from commercial sources. 
2.2.1.2 Animals 
Because of the reported variation in HIOMT sensitivity to oestradiol during the estrus cycle of 
female rats (Cardinali et ai., 1981; Daya, 1982), male Albino Wi star rats were used throughout 
the organ culure studies. The rats (200-250 g b. wt) were housed six per cage in a temperature 
controlled room (20-21°C) under a fixed lighting cycle of LD 12: 12 (lights on 06:00). Cool-
white fluorescent tubes provided an average light intensity of 1800 lux during the light phase. 
The rats had free access to food and water. They were sacrificed between 09hOO and 09h30 by 
neck fracture. 
2.2.1.3 Pineal glands 
After decapitation, the rat pineal glands were exposed by making an incision through the bone (on 
either side of the parietal suture) from the foramen magnum to near the orbit, and by removing the 
calvarium with forceps. The pineal glands were swiftly removed using sterile dissecting forceps, 
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cleaned and placed into organ culture tubes as described in [§ 2.2.1.4]. 
2.2.1.4 Organ Culture of Pineal Glands 
Following decapitation, the rat pineal glands were exposed as described in [§ 2.2.1.3]. They 
were immediately removed, placed on a cold stainless steel spatula, and dissected free of the 
pineal stalk and any adhering tissue. They were transferred to sterile (borosilicate 75 x lOmm) 
culture tubes containing 52ftl culture medium. The culture medium consisted of Dr Fitton-
Jackson's modification of BGJb medium, further supplemented with benzylpenicillin sodium, 
streptomycin sulphate and amphotericin B. The components of the culture medium and their 
respective concentrations are listed in Table 2.1. Each culture tube thus contained 1 pineal which 
floated just below the surface of the medium. To this, 8ftl of the substrate [14C]-serotonin 
(O.4ftCi) was added. The air in the tube was displaced with carbogen (95 % °2/5 % CO2), and 
once the atmosphere was saturated the tubes were tightly sealed with Parafilm ® . The culture 
tubes were placed in a Forma Scientific® model 3028 incubator and the pineals were incubated in 
the dark at 37 D C for 24 h. 
2.2.1.5 
2.2.1.5.1 
Thin Layer Chromatography 
Separation of the [14C]-Indoles 
This TLC technique is based on the method developed by Klein and Notides (1969). After 24 h in 
culture the reaction was stopped by removal of the pineal glands from the culture tubes. A lOftl 
aliquot of the culture medium was spotted onto TLC plates (silica gel 60, type F254, 0.25mm x 
20cm x 20cm aluminium plates, cut to 10 x 10cm from Merck, West Germany.) 
Following this, standards of all the pineal serotonin metabolites measured, were spotted on top of 
the culture medium spot. A total of lOftl of a solution containing O.2mg/1ml of each standard was 
spotted. The solution containing the standards was made up as follows:- 1mg of each of the 8 
standards used was dissolved together in a test tube containing 2,5ml of 95 % ethanol. To this, 
2,5ml of a solution of 1 % ascorbic acid in 0,1 N HCI was added. The ascorbic acid was included 
by Klein and Notides (1969) to protect the indoles against oxidation. The standards used are 
listed in Figure 2.1. This reference solution was stored in a light-resistant container at -20D C, and 
remained stable for the six months of the study despite the warning that the ascorbic acid might 
increase decomposition of the indoles by catalysing aromatic hydroxylation (Udenfriend et aI., 
1954). The plates were spotted in a room under subdued light. At all times while spotting the 
plates, a gentle stream of nitrogen was used to dry the spots, which were no larger than 0,5cm, as 
Table 2.1: The constituents of BGJb culture medium, (Fitton-Jackson Modification) 
Components ~ Components 
Inorganic Salta mg/L Amino Acid. 
NaH,PO.·H,O 90.00 L·Alanine 
MgSO.·7H,O 200.00 L·Arginine 
KCl 400.00 L-Arginine HCI 
KH,PO. 160.00 L-Aspartic acid 
NaHCO, 3.500.00 L-Cysleine HCI.H,O 
NaCJ 5.300.00 L-Glulamine 
Glycine 
Olh;et Components L·Histidine 
Calcium lactate 555.00 L-Histidine HCI.H,O 
Glucose .10.000.00 L-lsoleucine 
Phenol red 20.00 L-Leucine 
Sodium acetate (anhyd) SO.OO L-Lysine 
L·Lysine HCI 
Vitamins 
L-Methionine 
L·Phenylalanine 
Alpha tocopherol phosphate. 1.00 L·Proline 
(dlsodlum salt) L·Serine 
Ascorbic acid SO.OO L· Threonine 
Biotin 0.20 L-Tryptophan 
o.caJdum pantothenate 0.20 L-Tyrosine 
SO.OO Choline chloride 
FolIc acid 
l~nositDI 
Nicotinamide 
Para aminobenmic acid 
Pyridoxal phosphate 
Riboflavin 
Thiamine hydrochloride 
Vitamin Bn 
OL·VaJine 
0.20 
0.20 
20.00 
2.00 
0.20 
0.20 
4.00 
0.04 
This medium has a mean tonicity of 390 milliosmoles. Where 
appropriate the following drugs (in the listed concentrations) were 
added to the medium to protect it against microbial contamination. 
Benzyl Penicillin 100 units/ml 
Streptomycin Sulphate 0.1 mg/ml 
Amphotericin B 2.5,ug/ml 
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£2!lE: 
mg/L 
250.00 
175.00 
150.00 
101.00 
200.00 
800.00 
150.00 
30.00 
SO.OO 
240.00 
50.00 
50.00 
400.00 
200.00 
75.00 
40.00 
40.00 
65.00 
well as to prevent atmospheric oxidation of the indole metabolites. Morton (1982) reported no 
difference between plates spotted and run in normal light, as opposed to those spotted and run in 
the dark (as suggested in the original method). 
Once the plates were spotted, they were put in TLC tanks containing solvent A: chloroform-
methanol-glacial acetic acid (93:7: 1). The solvent was allowed to run up to 9cm. Once the 
solvent had reached this point (±25 min), the plates were taken out of the TLC tanks and the 
position of the solvent front marked. They were dried under nitrogen, then placed back into the 
same solvent and run once again in the same direction up to the mark. Following this, the plates 
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were dried under nitrogen, turned 90° and placed in a second TLC tank containing solvent B 
(ethyl acetate). They were run in this second direction up to a height of 6cm. 
The ethyl acetate was evaporated off the plates with nitrogen and the plates were sprayed with Van 
Urk's reagent (lg of paradimethylbenzaldehyde dissolved in 50 ml of 25% HCI followed by the 
addition of 50ml of 95 % ethanol). The plates were then placed in an oven at 60°C for 20 min to 
visualize the spots. 
2.2.1.5.2 Quantitation 
The various spots were clearly visible after their development. The locations of the various 
metabolites together with the directions in which the solvents were run are shown in Figure 2.1. 
These locations have been indentified by previous workers in this laboratory (Daya, 1982; 
Morton, 1982). Only 5-methoxytryptamine did not migrate and remained at the starting spot with 
serotonin. The radioactivity in each of the identified spots was determined by scraping off the 
spot into a scintillation vial containing Iml absolute ethanol. After the ethanol had dissolved the 
scraping, 3ml of scintillation cocktail (Beckman Ready-Solv HPIb®) was added to the vials, and 
they were vortexed on a Rota-mixer Deluxe ® for 30 seconds. Thereafter the vials were placed in 
a Beckman LS 2800 scintillation counter and each vial was counted for a total of 5 min. 
2.2.1.6 Analysis of Data 
The counts per minute (cpm) were converted to disintegrations per minute (dpm) using the H-
Number method of quench monitoring. The scintillation counter determines the amount of quench 
in a given sample using the external 137Cs standard. It then computes the H-Number from 
previously constructed quench curves. 
Blanks were run in exactly the same way except that no tissue was included. Blank values, which 
were very low, were first subtracted from the results before these were finally expressed as dpm of 
product formed! 101L1 of medium! pineal gland. 
Nomenclature for the pineal indoles follows the system suggested for international adoption by 
Smith (1982). A list of the indoles, together with abbreviations is presented in Figure 2.1. 
Data analysis for all studies in this thesis were performed by computer assisted analysis using 
either the BMDp® (Statistical Software, Los Angeles) programme or KWIKSTAT® (Mission 
aML 
• MA 
il 
aMT 
I 
chloroform:methanol:acetlc acid 
(93:7:1) 
aHT 
I HT/MT 
• 
• • • 1st dlrectfon X2 
<:> 
<:> 
0-
2nd direction 
ethyl acetate 
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Figure 2.1: A trace of a 1LC plate, showing the direction in which the solvents were 
run, and the subsequent location of the pineal indole metabolites. 
Nomenclature as to Smith (1982). 
Key: HT/MT Serotonin and 5-methoxytryptamine at the origin 
aHT N-acetylserotonin (5-hydroxy-N-acetyltryptamine) 
HA 5-hydroxyindoleacetic acid 
HL 5-hydroxytryptophol 
aMT melatonin (5-methoxy-N-acetyltryptamine) 
MA 5-methoxyindoleacetic acid 
ML 5-methoxytryptophol 
aML O-acetyl-5-methoxytryptophol 
Technology Software). All statistical treatments carried out are listed in each individual study and 
were chosen after consultation with Radloff, 1988 and Van Schalkwyk, 1988. 
2.2.2 Discussion 
This system has recently been validated by Skene (1985). She was able to confirm that removal of 
aliquots of medium, did in fact present an accurate picture of the indole synthesis within the 
isolated pineal gland, and also that the radioactivity on the TLe plates was present within the area 
of the standard spots. She was able to demonstrate a recovery from the medium of expected 
metabolites in excess of 90 %. Although Morton (1982) does not include acetic acid in solvent A, 
it was found that the acetic acid was essential to good separation of the ML and MA indoles. For 
this reason I have continued to include it in solvent A. Separation of the indole in terms of Rf 
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values changed according to weather conditions. However, the relative positions of the various 
spots always remained the same. 
2.3 
2.3.1 
Experiment 1: THE EFFECT OF ISOPRENALINE STIMULATION 
OF [14Cl-SEROTONIN METABOLISM BY ORGAN CULTURE OF 
RAT PINEAL GLANDS OVER A 24 HOUR PERIOD. 
Introduction 
Although several different systems of organ culture have been documented in [§ 2.1.1], and the 
methods of Klein and Notides (1969) are frequently referred to, only Daya and Fata (1986) have 
described a system which allows the progressive formation of the indole metabolites to be 
monitored over a 24 hour period. If the pineal gland is to be used as a test system, as has so often 
been suggested, then it would be of great value to know i) the relative proportions of metabolites 
at anyone time, and ii) if 24 hours is indeed the ideal time at which to terminate the reaction. 
The t1-agonist, isoprenaline (ISO) is often used to stimulate melatonin synthesis in the rat pineal 
gland (Deguchi and Axelrod, 1972a; Auerbach et al., 1981). This study therefore investigates the 
effect of isoprenaline stimulation on [14C]-serotonin metabolism by organ cultures of rat pineal 
glands over a 24 hour period. 
2.3.2 
2.3.2.1 
Materials and Methods. 
Materials 
l-Isoprenaline-HCI was purchased from the Sigma Chemical Co., USA. All other materials are 
recorded in [§ 2.2.1.1]. 
2.3.2.2 Animals 
Adult male Albino Wistar rats (200 - 250 g b. wt) were used in this study. Their environment has 
been described in [§ 2.2.1.2]. 
2.3.2.3 Methods 
Six pineal glands were rapidly collected and cultured individually in the presence of 0,4 JLCi 
[14C]-serotonin and [10JLM] isoprenaline as described in [§ 2.2.1.4]. A further six pineal glands 
were incubated in the absence of isoprenaline to act as a control group. For each tube containing 
-68-
a pineal, a duplicate tube containing the identical constituents but without any tissue was also 
incubated. At two-hourly intervals, 5JLI aliquots of culture medium were removed from each of 
the tubes and an equivalent volume immediately replenished from its corresponding duplicate 
tube. The 5JLI aliquots were immediately spotted onto TLC plates, the metabolites were separated 
using the TLC methods outlined in [§ 2.2.1.5] and their radioactivity quantitated. 
2.3.2.4 Data analysis and statistics. 
Data are expressed as dpml5JLI medium, with each point representing the mean ± SEM for 6 
glands. Statistical comparisons are made using Students t-test. 
2.3.3 Results 
The production of melatonin (aMT) and its precursor N-acetylserotonin (aHT) rose sharply after 
the first two hours of culture in those pineals stimulated with isoprenaline. The rise continued 
progressively, reaching a peak after 16 h (Figure 2.2). This peak in the levels of aMT and aHT 
was significantly higher than the corresponding levels of aMT (p < 0.001) and aRT (p < 0.001) 
in unstimulated control pineals. The levels of aRT closely followed those of aMT in control 
pineals up to 16 h, whereafter the aMT levels decreased to below those of aHT (p < 0.05). 
On the other hand, aMT levels in the isoprenaline stimulated pineals, were always significantly 
higher than aHT levels, a trend which remained even at 24 h. After 16 h in culture no further 
increases were observed in either stimulated or control pineals. 
Progressive increases in the levels of the other indole metabolites, methoxyindoleacetic acid 
(MA), methoxytryptophol (ML), hydroxyindoleacetic acid (HA) and hydroxytryptophol (HL) , 
occurred for up to 14-16 h, with HA > HL > ML > MA. After this period of culture there 
were no significant differences in the levels of these metabolites (between stimulated and control 
pineals). 
One interesting observation was that during the first few hours of culture, pineal glands stimulated 
with isoprenaline showed an increase (p < 0,05) in hydroxyindole production (Figures 2.3 and 
2.4) with a corresponding decrease (p < 0,05) in methoxyindole production (Figures 2.5 and 
2.6). 
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A 24 h profile of [14C]-serotonin metabolism to 5-hydroxyindoleacetic 
acid (HA) in isoprenaline (ISO) stimulated and control pineal glands 
* (means ± SEM; n = 6; P <: 0.05; Student's t test) 
Figure 2.4: 
Figure 2.5: 
2500 
2000 
:r: 
::> 
Cl 1500 w 
:r: 
.....J 
f;} 1000 , 
:r: 
Il.. 
Cl 
500 
a 
.. HL/CONTROL 
• HL/I SOPREN 
J /t1-tr1 'tTl 1 1 
a 2 4 6 8 10 12 14 16 18 20 22 24 
TI ME (HOURS) 
A 24 h profile of 
hydroxytryptophol(HL) in 
pineal glands (means ± SEl 
100 
80 : ~:~~~:~:~l J 1111 ,I 
:r: 
~ III 
-Cl 60 1 W 1 :r: 
1-)1 .....J 
~ 40 , I 
%: I 
Il.. I Cl 
I 
20 I 
I 
I 
I 
a 
0 2 4 6 8 101214 16 18202224 
TI ME (HOURS) 
-70-
A 24 h profile of [14C]-serotonin metabolism to 5-methoxyindoleacetic 
acid (MA) in isoprenaline (ISO) stimulated and control pineal glands 
* (means ± SEM; n = 6,· P <: 0.05; Student's t test) 
Figure 2.6: 
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A 24 h profile of [14C]-serotonin metabolism to 5-
methoxytryptophol (ML) in isoprenaline (ISO) stimulated and control 
pineal glands (means ± SEM; n = 6; p <:*0.05; Student's t test) 
Discussion 
As shown in Figure 2.2, stimulation with the J1-adrenoceptor agonist isoprenaline causes a marked 
rise in the synthesis of aMT and aHT compared with that seen in the unstimulated control pineal 
glands. These observations support those of other workers (Axelrod et ai., 1969; Deguchi, 1973) 
and confirm that production of the pineal hormone aMT is under J1-adrenergic control. It appears 
that the production of these metabolites in stimulated pineals rises rapidly for the first few hours 
to attain maximum levels after 16 h in culture (Figure 2.2). This sharp rise can be explained by 
the observation that the activity of serotonin N-acetyltransferase (NAT), the enzyme responsible 
for the synthesis of aHT, rises markedly for the first three hours in organ cultures of pineals 
treated with isoprenaline, whereafter it slowly declines (personal observation). 
After 16 h of culture in the presence of ISO, the aMT level is approximately ten-fold greater and 
the aHT level, four-fold greater compared to the unstimulated controls. Interestingly, in the 
control group the aMT level drops to a significantly lower level after 16 h in culture (p < 0.05), 
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whereas in the ISO stimulated group this is not observed and aMT levels are always above those 
of aRT levels. The rate at which aRT is converted to aMT is determined by the activity of the 
enzyme hydroxyindole-O-methyltransferase (HIOMT) (Wurtman et al., 1963). From these 
results, it would appear that HIOMT is stimulated by isoprenaline (Banoo et aI., 1987). Klein and 
Berg, (1970) have previously shown a small increase in HIOMT activity following NA 
stimulation, although much controversy surrounds this point. More recently l3-adrenergic 
receptor stimulation of HIOMT has again been found (Sugden and Klein, 1983a; 1983b). 
It is therefore more likely, because HIOMT is one of the more abundant single proteins in the 
pineal gland (Jackson and Lovenberg, 1971) and because of the high levels of aRT present due to 
the ISO induced stimulation of NAT, that this conversion is occurring as a result of simple mass 
action (Klein and Rowe, 1970; Klein et al., 1970a). 
The marked reduction in the conversion of HL and HA to ML and MA observed during the first 
few hours of culture, in the presence of isoprenaline, is probably due to substrate competition for 
the methylating enzyme. 
2.3.5 Conclusion 
These results confirm that organ culture is both a valid and valuable technique with which to study 
the variation in pineal indole production, when pineal glands are subjected to various 
pharmacological manipulations. They furtp.er show that 16 h profiles would appear to be optimal 
for determining the behaviour of isolated pineal glands in the presence of various drugs (Banoo 
et aI., 1987). 
2.4 
2.4.1 
Experiment 2: THE EFFECT OF ISOPRENALINE. 
NORADRENALINE OR COMBINED ISOPRENALINE AND 
PHENYLEPHRINE STIMULATION OF ORGAN CULTURES OF 
RAT PINEAL GLANDS. 
Introduction 
It was known that noradrenaline released from sympathetic nerves innervating the pineal (Klein 
et ai., 1971) stimulated primarily 131-receptors on pinealocytes, leading to a rapid increase in 
cAMP, followed by an elevation of NAT (Klein et ai., 1981). Later Sugden and Klein (1984) 
identified c¥l-adrenoceptors on the pinealocyte, confirming that NA was probably acting through 
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both al and {31 receptors (Klein et al., 1983). More recently it has been shown that combined 
stimulation of both al and {3 adrenergic receptors increases changes in cAMP and cGMP levels 
(Vanecek et al., 1986) and NAT activity (Klein et aI., 1983) more than those following {3-
adrenergic stimulation alone and that al stimulation by itself proves ineffective. These studies 
used the alpha-adrenergic agonist, phenylephrine. Since these initial studies, protein kinase C 
(Sugden et aI., 1985) as well as Ca2+ fluxes have been implicated in this potentiation (Sugden 
et al., 1986, 1987). 
2.4.1.2 Objective 
As the intention of the current study is to investigate the Ca2+ fluxes following al adrenoceptor 
stimulation in the pineal gland, it set out to examine the possible use of NA in place of the 
combination of ISO and PE to stimulate pineal glands in organ culture. 
2.4.2 
2.4.2.1 
Materials and Methods 
Materials 
I-Isoprenaline-HCl, phenylephrine-HCL and I-noradrenaline bitartrate salt were purchased from 
Sigma Chemical Co., USA. Sources of other materials are described in [§ 2.2.1.1]. 
2.4.2.2 Animals 
Sixteen adult male Wistar rats (210-230 g b. wt) were used for this study. They were housed as 
described in [§ 2.2.1.2]. The rats were sacrificed between 09hOO and 09h30 by neck fracture. 
Their pineal glands were swiftly removed, cleaned and transferred to tubes containing culture 
medium as described in [§ 2.2.1.3]. 
2.4.2.3 Methods 
The glands were incubated in the presence of either ISO [lOJ.tM) or NA [lOj.'M) or the 
combination of PE [lOj.'M) + ISO [10j.'M). These 3 groups were compared with unstimulated 
control glands. 
Table 2.2: Effect of isoprenaline (/SO) [JOp.MJ. noradrenaline (NA){JOJl.MJ or the combination of isoprenaline 
[JOJ1.MJ + phenylephrine (PE)[JOJl.MJ on [14C]-serotonin metabolism by rat pineal glands in organ culture. 
Metabolite Control ISO NA ISO + PE 
MT/HT 106505.25 !. 5439.6 80954.50 !. 1750.4(b) 78813.75 !. 5112.4(b) 91129.50 !. 7630.1 
aHT 1070.55 !. 163.0 3258.30 !. 511.5(b) 3905.50 !. 597.7(b) 2120.53 !. 388.1 
aMT 2136.60 !. 168.6 3447.28 !. 397.1(b) 4442.75 !. 731.1(b) 7080.73 !. 448.4(a) 
HA 19262.50 !. 900.7 34230.40 !. 4895.6 34060.65 !. 7378.8 21966.2 !. 3588.8 
HL 2251.28 !. 313.2 15658.85 !. 2936.4 13740.38 :!: 2039.0(b) 8976.85 !. 1002.7(b) 
MA 219.50 !. 79.8 381.35 !. 102.2 187.52 !. 26.2(d) 312.46 !. 48.8 
ML 261.88 !. 69.4 585.95 !. 113.4 301.45 !. 57.9(d) 502.18 !. 86.3 
NaP 3208.15 !. 199.4 6705.58 !. 426.5(b) 8348.25 :!:. 1288.1(b) 9201.26 !. 467.1 (b)(c) 
lOJl.I aliquots of medium were chromatographed by nc. Results are expressed as dpm/pineal gland (mean ±. SEM;!! = 4 
individually cultured glands per group). Significance is computed using the Neuman-Keuls multiple range test. 
(a) Significantly different from all other groups at p < 0.05 
(b) significantly different from control at p < 0.05 
(c) Significantly different from ISO at p < 0.05 
(d) Significantly different from ISO and PE groups at p < 0.05 
~ 
... 
I 
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The incubation was terminated after a 24 h incubation period. 101-'1 aliquots of medium were 
removed, and spotted onto TLC plates. The radioactive metabolites were separated by two-
dimensional TLC methods, and quantitated using liquid scintillometry as described in [§ 2.2.1.5]. 
The adrenergic agonists were dissolved in culture medium. They were protected from oxidation 
by the addition of ascorbic acid, 0.1mg/ml medium in which they were dissolved (Sugden and 
Klein, 1984). 
2.4.2.4 Data analysis and statistics 
The results are analysed primarily using the two indole metabolites aRT and aMT as biological 
markers of pineal activity. The reasons for this are discussed later in [§ 2.5.2.4]. The results are 
therefore discussed using these values. 
In spite of the earlier findings [§ 2.3.5], that 16 h profiles would appear to be optimal, it was 
decided that in view of the investigative nature of these studies, they all be continued to the 24 h 
time point, thus allowing for easier comparison to be made with reported literature values if 
needed. 
Data are expressed as dpm/ 101-'1 medium. Statistical analysis for multiple groups is best analysed 
using an analysis of variance (ANOV A) test (Modrak, 1983). The nonparametric equivalent test 
is the Kruskal-Wallis H test, and would probably be more appropriate where small groups (n=4) 
are used (Radloff, 1988). The significantly different groups were identified using the post-hoc 
Neuman-Keuls multiple range test. Groups were judged at the p < 0.05 level of significance. 
2.4.3 Results 
The results are presented in Table 2.2 and Figure 2.7 
2.4.4 Discussion 
Glands stimulated with the combination ISO + PE showed the greatest increase in aMT, supporting 
previous literature reports. This potentiation has even been observed in the Syrian hamster pineal 
gland (Santana et ai., 1988a). The observed reduction of the aRT levels in relation to the other 
two agonist groups is probably a result of increased substrate usage by NAT, caused by the higher 
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stimulation taking place in these glands. In the NA group, relative to the other stimulated groups, 
the methoxy products are reduced. 
Previous work done by Weiss (1968) has reported a reduction in HIOMT in the presence of NA 
stimulation. Subsequent data from Brownstein and Heller (1968), were able to confirm these 
findings. 
The ISO+PE group shows a reduction in the hydroxylated indoles (HT and HL) relative to the 
ISO and PE groups. The reasons for this are not apparent from the present work. It could be that 
a possible inhibition of the monoamine oxidase (MAO) responsible for the deamination of HT is 
occurring, or that because of the increased stimulation, the second metabolic pathway for HT is 
taking precedence. These two pathways can be seen in Figure 1.3. 
Figure 2.7 best depicts the aim of this experiment. It clearly shows that when pineal function is 
measured as the sum of the N-acetylated products (NaP), the ISO+ PE group shows the greatest 
metabolic activity. Although the ISO + PE group showed the greatest increase, it was not 
significantly different from the NA group. in terms of the statistical test employed here. 
2635 
dpm/10,.d MEDIUM 
I 
7031 10081 
G Control glands 
Figure 2.7: 
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~ + r NA [lOp.Mj 
o PE [lO".M] + ISO [lO".Ml 
Results from experiment 2, plotted in tenns of a statistical "Box and 
Wisker" plot of the NaP groups (means ± SEM; n = 4; P < : *0.05; 
Neuman-Keuls multiple range test) 
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The results of this study therefore confirm that NA is able to stimulate pineal glands in organ 
culture, in a manner similar to ISO, and also ISO+PE. NA does not show the marked clear 
potentiation, consistent with al and {J combined stimulation, because it has both different intrinsic 
activity and affinity compared to the former agonists. Differences in the effects of these 
compounds under the same conditions, have been observed previously (Vanecek et al., 1985). 
It would however seem justifiable to use ISO and NA for their respective {J and mixed al{J 
. properties in the ensuing studies. Using dispersed pinealocyte preparations, Sugden et al., 1987 
have reported that the basal intracellular Ca2+ concentration (0. 10M) rose almost threefold within 
1 min of exposure to NA, and that this phenomenon could be blocked, using the aI-receptor 
blocker prazosin (Cardinalli and Vacas, 1987). 
2.5 
2.5.1 
2.5.1.1 
Experiment 3: THE EFFECT OF THREE ORGANIC CALCIUM 
CHANNEL BLOCKERS ON [14C]-SEROTONIN METABOLISM BY 
ORGAN CULTURES OF RAT PINEAL GLANDS 
Introduction 
A role for calciwn in the pineal gland? 
Calcium appears to play an important role in the pineal gland. Initially pineal calcium was of 
interest because of the increasing prominence of calcification seen in the gland with increasing 
age, both in man and some mammals (Diehl, 1978; Allen et al., 1981; Welsh, 1984; Krstic 
1985). 
More recently the role of calcium in the adrenergic regulation of the rat pineal gland has come 
under greater scrutiny because of its link with the al-adrenoceptor potentiation of the {J-
adrenoceptor induced increase of cAMP. 
2.5.1.2 A role for calciwn in the regulation of the pineal gland. 
In the rat pineal gland. {J-adrenoceptor stimulation increases cyclic 3' -5' adenosine 
monophosphate (cAMP) by activating adenylyl cyclase. Cyclic-AMP regulates the production of 
the pineal hormone melatonin(aMT), from serotonin, via the rate-limiting enzyme serotonin-N-
acetyltransferase (NAT) (Axelrod, 1974). Alphal-adrenoceptor activation, which alone is without 
effect, has been shown to enhance {J-adrenoceptor stimulation of cAMP. This enhancement has 
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been linked to an increase in the entry of Ca2+ into the pinealocyte (Sugden et aZ., 1986; Sugden 
et ai., 1987). Additional support came from the observations in in vitro glands which show that, 
i) the removal of calcium from the culture medium resulted in the inhibition of NAT and cAMP 
which would normally follow adrenergic stimulation (O'Dea and Zatz, 1976; Zatz and Romero, 
1978), ii) the calcium ionophore A23l87 was able to mimic the effects of ai-adrenergic 
stimulation on the cyclic nucleotides in rat pinealocytes stimulated with isoprenaline (Vanecek 
et ai., 1986), and iii) the potentiation of cAMP was dependent on the activation of a calcium-
regulated phospholipid-dependent enzyme, protein kinase C (Sugden et aZ., 1985). 
2.5.1.3 The use of the pineal gland to study calcium's role 
The rat pineal gland has previously been suggested as being an ideal environment in which to 
study the effects of calcium in cell biology (Meyer and Theron, 1988). In organ culture, the 
gland represents an attractive experimental tool. Various drug manipulations can be examined 
directly, without the complexities of in vivo control (Axelrod, 1974). This is especially useful in 
investigations into the effects of ions, e.g. Ca2+, where the ionic environment can be 
manipulated, and toxic drugs, e.g. EGTA and A23l87. The well-documented metabolic pathway 
through which melatonin is synthesized, with its high-amplitude circadian rhythms of enzymes 
and metabolites (Zatz, 1981), provides a relatively convenient way in which to monitor the gland 
for iatrogenic changes. It was hoped that by using the CCBs as described below, any effects of 
these drugs would be reflected as altered melatonin production. It would be interesting to see if 
the CCBs could inhibit the influx of calcium ions across the cell membrane, a phenomenon 
associated with the ai-receptor enhancement of /3-receptor stimulation in the gland. 
The CCBs have been used in many studies as probes for calcium-dependent processes [§ 2.1]. 
Since pineal Ca2+ levels vary diurnally (Piechowiak and Schnizer, 1976; Theron et aZ., 1988; 
Pizarro et aZ., 1988) in harmony with NAT and aMT, and the synthesis of the latter is dependent 
on ea2+ (Zatz and Romero, 1978), it would seem that aMT could be a useful marker of calcium-
mediated events in the pineal (Meyer and Theron, 1988). It is not known to what extent the 
calcium channel plays a role in the regulation of aMT synthesis, although it has been shown that a 
VOC, opened by K+ induced depolarization and blocked by nifedipine, exists (Sugden, et ai., 
1986). 
2.5.1.4 Objectives 
It was therefore decided to determine the effects of three stucturally diverse CCBs. viz. verapamil, 
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diltiazem and nifedipine, on the conversion of [l4C]-serotonin to its N-acetylated products ([14C]_ 
aMT + [14C]-aHT) using organ cultures of rat pineal glands. 
The effect of these agents was assessed in the presence of i) isoprenaline (ISO), a /3-specific 
agonist known to stimulate melatonin synthesis, but which would not influence the Ca2+ influx 
associated with aI-receptor stimulation in the rat pineal gland, and ii) noradrenaline (NA) , a 
mixed a+/3 agonist which would stimulate both the al and /3 receptors. It was speciously 
hypothesised that this drug protocol would show to what extent the synthesis of aMT was 
dependent on the calcium influx. 
2.5.2 
2.5.2.1 
Materials and Methods 
Materials 
Verapamil-HCl, diltiazem, nifedipine, I-isoprenaline-HCl and I-noradrenaline bitartrate salt were 
purchased from Sigma Chemical Co., USA. Sources of other materials are described in 
[§ 2.2.1.1], 
2.5.2.2 Animals 
Adult male Wistar rats (250-280 g b. wt) were used for this series of experiments. Their 
environment has been discussed in [§ 2.2.1.2]. The rats were sacrificed between 09hOO and 
09h30 by neck fracture. Their pineal glands were swiftly removed, cleaned and transferred to 
tubes containing culture medium for culture as described in [§ 2.2.1.3]. 
2.5.2.3 
2.5.2.3.1 
METHODS 
Experiment A 
The culture medium contained either the organic calcium channel blocker, verapamil [l0JLM], or 
vehicle. The glands were exposed to verapamil or vehicle 30 minutes prior to the addition of the 
adrenergic agonists ISO and NA [lOJLM]. Glands were thus incubated in the presence of 
verapamil and either ISO or NA [lOJLM]. These were compared with control glands incubated 
with vehicle, in the presence of either ISO or NA [lOJLM]. 
The incubation was terminated after a 24 h incubation period. 10JLl aliquots of· medium were 
removed, and spotted onto TLC plates. The radioactive metabolites were separated by two-
dimensional TLC methods, and quantitated using liquid scintillometry as described in [§ 2.2.1.5]. 
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Isoprenaline and noradrenaline were dissolved in culture medium. The adrenergic agonists were 
protected from oxidation by the addition of ascorbic acid, O.lmg/ml medium in which they were 
dissolved (Sugden and Klein, 1984). Verapamil was dissolved in distilled water. It was added to 
the cultures, in a lOILI volume from a freshly prepared stock solution. Control incubations 
therefore contained lOILI distilled water. 
2.5.2.3.2 Experiment B 
. The procedure in Experiment A [§ 2.5.2.3.1] was repeated, but verapamil was replaced by 
diltiazem at the same molar concentration. 
Diltiazem was also dissolved in distilled water, with control incubations receiving the equivalent 
amount of vehicle. 
2.5.2.3.3 Experiment C 
The procedure in Experiment A [§ 2.5.2.3.1] was repeated, but verapamil was replaced by 
nifedipine at the same molar concentration. Because nifedipine was relatively insoluble in water, 
it was first dissolved in 70 % ethanol, before further dilution in distilled water. The final 
concentration of ethanol did not exceed 1 %. Control incubations contained the equivalent amount 
of vehicle. 
In addition, because of nifedipine's sensitivity to light, all solutions of nifedipine were made up in 
dim light and glassware was covered with aluminum foil. Earlier work on the Langendorff 
isolated perfused rat heart preparation had shown that nifedipine solutions made up in this 
manner, produced their characteristic dose-dependent decline in cardiac activity, which was 
reversible on washout (Brown, 1985). 
2.5.2.4 Data analysis and statistics 
When using the pineal as an experimental tool it would seem logical to use the two indole 
metabolites, aHT and aMT, as biological markers of pineal activity. These two metabolites 
represent the products of the two primary enzymes, NAT and HIOMT, in indole metabolic 
pathways. Skene (1985) suggested that an overall gauge of pineal activity could be the sum of the 
N-acetylated product (NaP), i.e. (aRT and aMT). The results are therefore analysed primarily 
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using these values. However, it would not be fair to ignore the other indoles produced, especially 
the hydroxy indoles HA and HL, which are produced in such great quantity. As these two 
hydroxy indoles are further methylated by HIOMT, to MA and ML respectively, any correlations 
evident here could be used as a possible indicator of HIOMT activity. 
Data are expressed as dpml IOJLI medium. As there were only 4 pineal glands per group, 
significance was computed using the Mann-Whitney U test, the nonparametric equivalent of the 
Students t-test. This was suggested by Radloff (1988). 
2.S.3 
2.S.3.1.1 
Results and Discussion 
Results of glands stimulated in the presence of verapamil 
Figure 2.8 shows the values for aHT, aMT and the N-acetylated product (NaP), the latter being 
defined as the sum of [14C]-aHT and [14C]-aMT. Table 2.3 shows all the metabolites separated 
by TLC, with the exception of the starting spot which contains both HT and MT. 
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Figure 2.8: 
ISO NA ISO NA ISO NA 
The effect ofverapamil [lOJLM} [.} on [14C]-serotonin metabolism by 
rat pineal organ cultures, to [14C]-aHT, [14C]-aMT and NaP, in the 
presence of either ISO or NA [lOJLM}, compared to control glands with 
vehicle [11i,in the presence of either ISO or NA [10JLM}. (means ± 
* - . SEM; n = 4; P <: 0.01, 0.025 Mann-Whitney U test 
Table 2.3. 
Metabolite ISO + Vec 
aHT 2979.98 :!:. 320.3 
aMT 4142.51 :!:. 415.9 
HA 48892.60 :!:. 4568.4 
HL 12275.42 :!:. 2003.6 
MA 150.83 :!:. 33.7 
ML 556.32 :!:. 180.8 
NaP 7122.49 :!:. 566.3 
Effect ofverapamil on {J4Cj-serotonin metabolism by rat pineal organ cultures, stimulated with either isoprenaline 
(ISO) {lOp.MJ or noradrenaline (NA) [[JOp.MJ. 
ISO + VER Level of NA + Vec NA + VER Level of 
significance s i gnif i cance 
4583.54 :!:. 924.7 p<0.100 2803.47 :!:. 523.1 5189.34 :!:. 616.3 p<0.025 
6439.64 :!:. 682.7 p<0.025 2954.14 :!:. 533.6 5066.64 :!:. 495.3 p<0.025 
46696.65 :!:. 2287.5 N.S 39209.41 :!:. 4103.3 41560.28 :!:. 4916.4 N.S 
12808.59 :!:. 712.6 N.S 14249.97 :!:. 1991.8 12510.03 :!:. 2069.9 N.S 
224.46 :!:. 68.5 N.S 160.06 :!:. 54.3 172.47 :!:. 17.8 N.S 
456.82 :!:. 116.09 N.S 423.15 :!:. 136.42 266.65 :!:. 50.1 N.S 
11023.18 :!:. 1188.68 p<0.025 5757.62 :!:. 947.7 10255.99 :!:. 1034.2 p<0.025 
1Op.1 aliquots of medium were chromatographed by ]LC. Results are expressed as dpm/pineal gland (mean ± SEM; n = 4 individually cultured glands per group). 
Significance is computed using the non parametric Mann-Whitney Jl. test (2 tails). 
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2.5.3.1.2 Discussion 
Pineal glands stimulated with ISO in the presence of VER, showed an unexpected 54 % increase in 
N-acetylated product (p < 0.01), relative to the control glands which were stimulated with ISO 
only. N-acetylserotonin was raised 53 % and aMT a corresponding 55 %. 
Those glands stimulated with NA in the presence of VER showed an even greater (78 %) increase 
in N-acetylated product (p < 0.025). N-acetylserotonin increased by 85 % relative to its control, 
and aMT by 71 %. 
A further surprise is evident on examining the levels of the remaining metabolites. There is no 
change in the levels of HA and HL in the presence of VER after either ISO or NA stimulation. A 
similar pattern is seen with the MA and ML metabolites. If any trend is apparent, it is that the 
ML metabolites in the presence of VER are slightly decreased. The rate at which aRT is 
converted to aMT is dependent on the activity of HIOMT (Wurtman et ai., 1963). Thus, as 
HIOMT is responsible for the conversion of aRT to aMT as well as HL and HA to ML and MA, 
this suggests some possible variation in the activity of HIOMT. Either that i) HIOMT is 
primarily responsible for the conversion of aRT to aML (i.e. it has a greater affinity for this 
reaction), and the other metabolites are methylated only if there are free catalytic sites available 
and they are at a suitable concentration (Morton, 1982), or ii) there are two species of HIOMT, as 
suggested by Jackson and Lovenberg (1971) and later confirmed by Balemans et ai., (1980). This 
is further supported by Pevet et aI., (1980) who have reported that aMT is produced at night and 
in the middle of the light period by one HIOMT species, while the HIOMT enzyme responsible 
for ML production, is only produced during the day. 
2.5.3.2.1 Results of glands stimulated in the presence of diltiazem 
Figure 2.9 shows the values for aHT, aMT and the N-acetylated products, the latter being defined 
as the sum of [l4C]-aHT and [14C]-aMT. Table 2.4 shows all the metabolites separated by TLC, 
with the exception of the starting spot which contains both HT and MT. 
2.5.3.2.2 Discussion 
Following ISO stimulation of glands in the presence of DIL, aHT levels are raised by 46 % while 
Melatonin levels are decreased by 46 %. The result is that indole metabolism measured as N-
acetylated product shows no significant difference. This finding tends to suggest some effect of 
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* 
ISO NA ISO NA ISO NA 
The effect of diltiazem [lOJLM] [.] on [14C]-serotonin metabolism by 
rat pineal organ cultures, to [14C]-aHT, [14C]-aMT and NaP, in the 
presence of either ISO or NA [lOp.M], compared to control glands with 
vehicle [ },in the presence of either ISO or NA [lOJLM}. 
(means ± SEM; n = 4; P < : *0.05 Mann-Whitney U test 
OIL on HIOMT activity, as HIOMT would normally convert the aHT (which is raised) to aMT. 
The HL level also shows an increase, while ML is slightly decreased. This does seem to suggest 
that some inhibition of HIOMT activity occurs when the glands are stimulated with ISO in the 
presence of OIL. 
After NA stimulation of glands in the presence of DIL, aHT levels are increased by 36%, and 
aMT levels by 59%, resulting in a nett significant (p < 0.05) increase of 48% in N-acetylated 
product. 
The remaining indoles all show increases as well, relative to their controls. The strong correlation 
between aHT and aMT and the increased level of MA and ML suggests an increase in HIOMT 
Table 2.4 
Metabol ite ISO + Vec 
aHT 3008.89 :!: 638.2 
aMT 3297.45 :!: 1521.9 
HA 39230.47 :!: 5010.4 
Hl 15659.09 :!: 2936.5 
MA 381.61 :!: 102.2 
Ml 586.26 !. 113.1 
SUM 6306.35 :!: 1282.1 
Effect of diltiazem on [14C]-serotonin metabolism by rat pineal organ cultures, stimulated with either 
isoprenaline (ISO) [JOflMl or noradrenaline (NA) [JOJLMJ. 
ISO + OIL Level of NA + Vec NA + OIL Level of 
significance significance 
4420.34 :!: 793.6 p<0.10 3682.99 :!: 490.1 5031.72 :!: 609.3 p<0.10 
2256.31 !. 483.3 N.S 4410.85 :!: 701.7 7023.11 !. 1024.1 p<0.10 
32620.34 :!: 6120.5 N.S 34060.31 :!: 4231.8 44468.76 !. 3690.7 N.S 
27660.94 :!: 4510.2 N.S 13739.65 :!: 2038.6 20358.25 :!: 2961.5 p<0.10 
263.18 :!: 128.8 p<0.10 163.32 !. 35.1 276.29 :!: 51.7 p<0.05 
404.89 !. 53.2 N.S 290~74 !. 49.8 477.94 !. 132.8 p<0.10 
6676.65 !. 895.9 N.S 8093.84 :!: 1184.3 12054.84 :!: 1392.7 p<0.05 
JOJLI aliquots of medium were chromatographed by TLC. Results are expressed as dpml pineal gland (mean ± SEM; l! = 4 individually cultured glands per group). 
Significance is computed using the nonparametric Mann-Whitney U test (2 tails). 
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activity. It would therefore seem that HIOMT activity is stimulated by NA in the presence of 
OIL. It could also be that monoamine oxidase activity is somehow influenced by OIL following 
NA stimulation, and that the increase in methoxyindoles is merely a result of mass action (Banoo 
et aI, 1987) following the increased availability of substrate. Monoamine oxidase converts 
serotonin to the unstable 5-hydroxyindole-3-acetaldehyde intermediate, which is rapidly converted 
to HT and HL by aldehyde reductase and dehydrogenase respectively (Lerner and Case, 1960). 
These metabolic pathways are shown in Figure 1.3. 
2.5.3.3.1 Results of glands stimulated in the presence of nifedipine 
Figure 2.10 shows the values for aRT, aMT and the N-acetylated products, the latter being 
defined as the sum of [14C]-aHT and [14C]-aMT. Table 2.5 shows all the metabolites separated 
by TLC, with the exception of the starting spot which contains both HT and MT, and is not 
included. 
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aHT aMT NaP 
** 
ISO NA ISO NA ISO NA 
The effect ofnifedipine {lO/LMj [.j on [14C]-serotonin metabolism by 
rat pineal organ cultures, to [14C]-aHT, [14C]-aMT and NaP, in the 
presence of either ISO or NA [lO/LMj, compared to control glands with 
vehicle [ 1.<1 J,in the presence ?t. either ISO or NA [lO/LMj. 
(means ± SEM; n = 4; P < : *0.05, *0.025 Mann-Whitney U test 
Table 2.5. 
Metabol ite ISO + Vec 
aHT 1784.66 :! 295.4 
aMT 4371.66 :!: 363.7 
HA 34749.33 :! 3192.8 
Hl 7398.38 :! 841.5 
MA 160.67 :! 46.9 
Ml 289.01 :! 96.1 
SUM 6156.31 :! 533.1 
Effect ofnifedipine on fJ4ej-serotonin metabolism by rat pineal organ cultures, stimulated with either isoprenaline 
(/SO) {lOJl.Mj or noradrenaline (NA) {[lOJl.Mj. 
ISO + NIF level of NA + Vec NA + NIF level of 
significance significance 
4517.50 :! 812.8 p<0.025 4841.00 :! 160.8 8110.50 :! 982.1 p<0.025 
8041.25 :! 1251.6 p<0.05 4386.33 :! 596.1 6936.01 :! 489.4 p<0.025 
35400.05 :! 2001.1 N.S 38545.33 :! 2344.6 25706.75 :! 5113.3 p<0.10 
7271.50 :! 576.4 N.S 12508.10 :! 621.67 6832.40 :! 1006.1 p<0.025 
129.75 :! 12.3 N.S 133.31 :! 13.8 69.75 :! 22.7 p<0.10 
159.09 :! 25.60 N.S 187.33 :! 28.22 33.25 :! 5.4 p<0.025 
12558.75 :! 1989.7 p<0.025 9227.38 :! 727.4 15046.51 :! 1348.7 p<0.025 
lOJl.1 aliquots of medium were chromatographed by TLC. Results are expressed as dpml pineal gland (mean ± SEM; n = 4 individually cultured glands per group). 
Significance is computed using the non parametric Mann-Whitney U test (2 tails). 
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2.5.3.3.2 Discussion 
Glands stimulated with ISO in the presence of NIF also show an increase in aHT (150%), aMT 
(83 %) and the N-acetylated product shows a resultant twofold increase (p < 0.025). The 
remaining metabolites show the same trend as that seen with VER and ISO in [§ 3.5.3.1.2], i.e. 
the HA and HL levels do not vary significantly, while the MA and ML levels tend to decrease 
relative to the control levels. This again tends to suggest the view that HIOMT primarily converts 
aHT to aMT, the remaining indoles being methylated if a site becomes available to them. 
After NA stimulation in the presence of NIF an overall increase of 63 % is found in N-acetylated 
product (p < 0.025). N-acetylserotonin increases by 67%, and aMT by 50%. However a 
decrease in other metabolites is found: HA (p < 0.10), HL (p < 0.025), MA (p < 0.10), and 
ML (p < 0.025). The decreased ML and MA levels could be because of reduced substrate 
availability, or they could add further support to the possibility of a difference in HIOMT 
activity. The high levels of hydroxyindoles found in the pineal suggest that there is still sufficient 
substrate available and make the former explanation improbable. 
2.5.4 Conclusion 
In conclusion then, the presence of diltiazem did not alter the ISO-induced increase in N-
acetylated products. This is to be expected since Ca2+ influx in the pineal has been associated 
with the aI-receptor stimulation. However, both verapamil and nifedipine potentiated the effect 
of ISO. It is difficult to speculate at this stage as to why this happens. This phenomenon could be 
associated with the action of VER and NIF at a site other than the calcium channel (Millar and 
Struthers. 1984; Lamers et ai., 1985; Brown et al.. 1989a). Alternatively, Morton (1987) has 
recently shown that high levels of Ca2+ are able to inhibit bovine HIOMT activity. which could 
have some bearing on these results. If the CCBs are reducing Ca2+ entry into the cells by some 
small amount, this could account for less inhibition on HIOMT activity, and hence for the 
increased aMT levels seen. The differences observed with diltiazem, relative to results using 
verapamil and nifedipine. could possibly point to a difference in the respective ability of the CCBs 
to inhibit Ca2+ entry. This however is purely speculative, and should be regarded with care in 
view of the large intra-species variations seen in pineal work. For instance Meyer et ai., (1986) 
have shown that 2 classes of CCB administered in vivo to baboons, produce different effects on 
circulating plasma aMT levels. Three dihydropyridine CCBs of which one was nifedipine, 
reduced aMT levels, while verapamil had no effect. 
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In the presence of NA, all three CCBs were found to potentiate the effect of NA on N-acetylated 
product formation. This was opposite to the original hypothesis that the CCBs would inhibit the 
Ca2+ influx following (Xl stimulation and thus show a decrease in aHT following NA stimulation. 
It would appear that the CCBs are in some way bringing about an increase in NAT levels, 
resulting in an increase in aHT. With the exception of those glands stimulated with ISO in the 
presence of OIL. HIOMT continued to methylate the increased substrate available, and melatonin 
rose accordingly. in tandem with its precursor aHT as could be expected (Axelrod and Weissbach, 
1960; Zatz. 1978). HIOMT activity was however variable with respect to the other 
methoxyindoles. showing a general trend towards decreased ML levels. This suppressed 
production of ML suggests that a second form of HIOMT would appear to be present, and that 
some inhibition of the latter is possibly occurring. Continuing from the work of Morton (1987), 
this second species perhaps displays more sensitivity towards Ca2+ levels. This could possibly 
explain the differences observed between diltiazem and nifedipine, following NA stimulation. In 
the presence of diltiazem, HL, HA, MA, and ML are raised, while in glands in the presence of 
nifedipine, these levels are decrc:ased. Any relationship between the Ca2+ levels and HIOMT 
activity appears to be highly complex, without further complicating factors introduced by the 
CCBs. 
While the levels of the methoxyindoles remain variable and open to different interpretation, the 
salient feature of these results is the increased level of aHT observed. It would seem that the 
CCBs are in some way causing an increase in NAT, the enzyme responsible for the formation of 
aHT (Klein and Weller, 1970). It thus Seems pertinent to examine the effects of these CCBs on 
the level of NAT in isolation. This would clarify if NAT is indeed raised as suggested by the high 
levels of aHT observed. 
3 
3.1 
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CHAPTER 3 
N-ACETYL TRANSFERASE STUDIES 
INTRODUCTION 
Adrenergic stimulation and N-acetyltransferase in the rat pineal gland. 
In the rat pineal gland the release of NA (from the nerve terminals innervating the gland), 
stimulates ,a-receptors, which leads to an elevation of intracellular cAMP. The elevated cAMP 
levels in tum stimulate a series of protein phosphorylations (Morgan et al., 1988) which induce 
the activity of the arylalkylamine N-acetyltransferase (NAT; EC 2.3.1. 87), the rate-limiting 
enzyme in the conversion of serotonin to melatonin (Klein et al., 1981). The mechanism through 
which NA controls cAMP involves both al and ,a-receptors. The presence of aI-receptors - in the 
pineal gland was confirmed by Sugden and Klein (1984). Noradrenaline regulates pinealocyte 
cAMP and cGMP through an unusual synergistic mechanism. While ,a-adrenoceptor stimulation 
increases both cAMP and cGMP, al-adrenoceptor stimulation of the pmeal gland alone produces 
no detectable change in the levels of these two nucleotides (Vanecek et al., 1986). However. aI-
adrenoceptor stimulation amplifies the ,a-response by potentiating the accumulation of cAMP and 
cGMP (Klein et al., 1983; Vanecek et al., 1985; Klein. 1985; Vanecek et al., 1986). 
,a-Adrenergic activity sufficient for the induction of NAT (Klein. 1978; Zatz, 1982) has also been 
shown to be potentiated by arreceptor stimulation (Klein et al., 1983), although the effect is not 
as pronounced as that seen with cAMP levels (Illnerova et al., 1983; Klein, 1985; Illnerova, 
1985). 
Although NAT was originally thought to be similar to liver arylamine N-acetyltransferase 
(EC 2.3.1.5), that enzyme has broad substrate specificity (Voisin et al., 1984). Serotonin N-
acetyltransferase (NAT; EC 2.3.1.87) found in the retina, harderian gland and pineal gland (Pang 
et al .• 1977), has been found to have narrow substrate specificity for arylalkylamines, - aromatic 
compounds with a primary amine on the side-chain - e.g. serotonin (Klein, 1985). This enzyme 
also differs from liver arylamine N-acetyltransferase in that it is under ,a-adrenergic control via 
cAMP (Klein and Weller, 1973; Chan and Ebadi, 1980), and it exhibits a circadian rhythm with 
its levels rising during the scotophase of the light:dark cycle. 
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3.1.2 The use of NAT as an indicator of pineal activity 
Before the advent of the very sensitive radioimmunoassays for melatonin the most common indices 
of pineal function and especially of melatonin production, were the activities of NAT (Klein and 
Weller, 1970) and HIOMT (Wurtmann et al., 1963). Of the two, NAT had been shown to best 
correlate with melatonin production (Panke et al., 1978; Wilkinson et al., 1977; Morton, 1982). 
This lead to the popular belief that NAT was the rate-limiting enzyme in the formation of 
melatonin (Klein and Weller, 1970, 1973). Some evidence has accumulated which shows that 
NAT activity does not always mirror the production of its product, melatonin. For example, King 
et al., (1984) have shown that HT may also playa role. Rats subjected to various forms of stress 
have also shown varied NAT vs aMT results (Seggie et al., 1985; Vollrath and Welker, 1988), 
which could however stem from investigating the wrong end parameter. When examining the 
effect of stress on a rat, and the response of the pineal gland to this stress, the production of 
melatonin itself would probably be the best indicator; the pineal appears to modulate the body's 
response to stress via a mechanism involving the release of melatonin. In support of this, 
Tannenbaum et al., (1988) working with rats exposed to cold stress, demonstrated results showing 
decreased NAT levels in the presence of raised aMT levels. Khan et al., (1990) have 
demonstrated that ulcers induced by cold-stress are reduced in the presence of melatonin, while 
Morton et al., (1989) has shown that the CCB nifedipine is able to inhibit the release of 
melatonin, when rats are stressed by forced swimming. 
On the other hand, NAT would still appear to be a sensitive biochemical parameter when 
examining the effects of agents on the pineal gland. 
3.1.3 Objective 
In terms of the previous chapter's results, it would seem useful to evaluate the effect of the CCBs 
on NAT activity. As the activity of this enzyme is modulated by an adrenergic cAMP 
mechanism, any effects of the CCBs on the levels of cAMP should manifest themselves at this 
level. The theory of the NAT assay is discussed below [§ 3.1.4] while the full protocol is 
outlined in [§ 3.2]. 
3.1.4 Theory of the Assay 
The principle involves the N-acetylation by endogenous pineal NAT of a substrate, tryptamine-
HCI, using [3H]-acetyl coenzyme A as the acetyl donor. Under the conditions of the assay, NAT 
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is able to utilize tryptamine far more efficiently than the endogenous HT. The radiolabelled 
product, [3H]-N-acetyl tryptamine, is extracted into an organic solvent and the radioactivity is 
evaluated by routine liquid scintillometric techniques. 
3.2 
3.2.1 
3.2.1.1 
NAT ASSAY TECHNIQUE 
Materials and Methods 
Chemicals, drugs and reagents 
[3H]-Acetyl-coenzyme A (2S0JLCi/ml : specific activity 4.3 Ci/mmol) was purchased from 
Amersham Laboratories, England. Tryptamine-HCI was purchased from the Sigma Chemical 
Co., USA. All reagents used were of analytical grade, from commercial sources. 
3.2.1.2 Animals 
Female Albino Wistar rats were used throughout the NAT studies as NAT, unlike HIOMT, has 
been shown not to be influenced by the various stages of the estrous cycle (Cardinali and Vacas, 
1978). Illemova (197S) showed NAT in rats to be insensitive to oestradiol treatment. 
The rats (2oo-2S0 g b. wt) were housed four per cage in the environment previously described in 
[§ 2.2.1.2]. They were sacrificed between 09hoo and 09h30 by neck fracture, at the same time as 
those rats used in the organ culture studies. This was done to avoid possible interference with (3-
receptor sensitivity changes. It is well known that the increase in NAT activity following 
adrenergic stimulation is dependent on the time of day (Romero and Axelrod, 1974). The (3-
receptors show down-regulation after the full stimulation of the night, a rhythm in receptor 
density which is well-documented (Reiter et ai., 1985; Gonzalez-Brito et al., 1988; Santana et al., 
1988b). 
3.2.1.3 Pineal glands 
Following decapitation of the rats the pineal glands were exposed as described in [§ 2.2.1.3]. 
They were immediately removed, placed on a cold stainless steel spatula, and dissected free of the 
pineal stalk and any adhering tissue. They were transferred to sterile homogenation tubes, kept on 
ice, which contained 70JLl cold O.OSmM phosphate buffer (pH 6.S). 
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3.2.1.4 Assay of N-acetyltransferase 
The assay used is a modification of that originally described by Deguchi and Axelrod (1972). Rat 
pineal glands were individually placed in thick-walled, 2ml, glass tubes (pyrex® 10 x 75mm, 
thick walled, no rim) containing 70J.Ll of cold 0.05M phosphate buffer (pH 6.5) and kept on ice. 
Pineal glands were homogenised by 6-8 full rotations of a glass homogenation rod. Fifty 
microlitres of homogenate was removed and transferred to a corresponding culture tube (Kimble ® 
10mm x 75mm). To this, 10J.Ll of a IOmM stock solution of tryptamine was added, followed by 
lOJ.Ll of [3H]-acetyl coenzyme A. The tubes were sealed and incubated on a waterbath at 37°C for 
10 min. The final reaction volume of 70J.LI thus contained 1.4mM tryptamine and 29.1 pM 
[3H]-acetyl-CoA. The reaction was terminated by the addition of 5ooJ.L1 ice-cold 0.2M borate 
buffer (PH 10.0). 
The contents of each tube was transferred to a 15ml glass stoppered tube containing 3ml 
toluene:isoamyl alcohol (97:3). Extraction of the radioactive product of the reaction into the 
organic solvent was aided by vortexing the tubes for 1 min on a Rota-Mixer Deluxe®. The 
resulting emulsion was broken by centrifuging the tubes at 3500 rpm on a Hettich ® physiological 
centrifuge for 10 min. Two millilitre aliquots of the organic phase were aspirated into 
scintillation vials containing 3ml cocktail (Beckman Ready-Solv HPIb®). The vials were shaken 
for 20 min, allowed to stand for a further 20 min and then placed in a Beckmann LS 2800 
scintillation counter, where the radioactivity in each was quantitated. 
3.2.1.5 Data analysis and statistics 
Blanks were run in the same way, except that they contained buffer in place of homogenate. The 
cpm were converted to dpm as described in [§ 2.2.1.6]. Blank values were first subtracted from 
the assay values before expressing the results as picomoles of [3H]-N-acetyl tryptamine formed per 
gland per hour (Deguchi and Axelrod, 1972). 
Statistical significance was computed using, where appropriate, the nonparametric Mann-Whitney 
U or Kruskal-Wallis H tests. Post hoc analysis using the Neuman-Keuls multiple range test for 
comparison of significance among the means at the p < 0.05 level (Zar, 1974) was performed. 
3.3 
3.3.1 
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Experiment 1: DETERMINATION OF THE LARGE DIURNAL 
VARIATION IN NAT ACTIVITY IN RAT PINEAL GLANDS 
Introduction 
A circadian rhythm in N-acetyltransferase with a large variation in amplitude is known to exist 
(Klein and Weller, 1970). The data presented by Iuvone and Besharse, (1986) indicate that the 
increase in NAT requires extracellular Ca2+ in the micromolar range and that calcium influx 
through a VOC is involved. This large and well-documented rhythm, during which there is a 15 
to 30 fold increase in N-acetyltransferase activity, allows an easy assessment of the assay's 
integrity to be made. This study therefore set out to determine the levels of N-acetyltransferase in 
rats' pineal glands at 09hOO and 23hOO, in an elementary validation of the technique. 
3.3.2 
3.3.2.1 
Materials and Methods. 
Materials 
All materials used are described in [§ 3.2.1.1]. 
3.3.2.2 Animals 
Adult female Albino Wistar (which are suitable for use in the NAT assay [§ 3.2.1.2]) rats (250 -
280 g b.wt) were used in this study. Their environment is described in [§ 2.2.1.2]. 
3.3.2.3 Methods 
Four rats were sacrificed at 09hOO by neck fracture. Their pineals were rapidly removed 
[§ 2.2.1.3.] and transferred to glass homogenation tubes and assayed as described in [§ 3.2.1.4]. 
A further 4 rats were sacrificed at 23hOO. This was performed in the dark using protected red 
lighting of very low intensity to avoid the precipitous drop known to occur in NAT levels when 
light exposure occurs at night (Vollrath and Hueson, 1988). The pineal glands were assayed in 
the normal manner. 
3.3.2.4 Data analysis and statistics. 
Data are expressed as pmol of N-acetyltranferase activity/ pineal gland/ h, with each point 
representing the mean ± SEM for 4 glands. Statistical comparisons are made using the 
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nonparametric Mann-Whitney U test. 
3.3.3 Results 
The results are presented below in Table 3.1 
TABLE 3.1: The diurnal change occurring in NAT activity in the rat pineal gland 
Time N-Acetyltransferase activity 
(pmol/ pineal/ h) 
9hOO 0.88 ± 0.15 
p < 0.001 
23hOO 35.6 ± 3.41 
(mean ± SEM; n = 4 glands per group; Mann-Whitney U test) 
3.3.4 Discussion 
The results confirm those of previous workers (Deguchi and Axelrod, 1972). The large diurnal 
variation in NAT activity is seen, showing the assay to be functional. 
3.4 
3.4.1 
3.4.1.1 
Experiment 2: CUMULATIVE DOSE RESPONSE 
RELATIONSHIPS FOUND FOLLOWING ISOPRENALINE AND 
NORADRENALINE STIMULATION OF NAT ACTIVITY IN RAT 
PINEAL GLANDS 
Materials and Methods 
Materials 
I-Isoprenaline-HCI and noradrenaline bitartrate was purchased from the Sigma Chemical Co., 
USA. All other items are described in [§ 3.2.1.1]. 
3.4.1.2 Animals 
Adult female Albino Wistar rats (180 - 220 g b. wt) were used in this study. Their environment is 
described in [§ 2.2.1.2]. 
3.4.1.3 
3.4.1.3.1 
METHODS 
Experiment A 
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Rats were sacrificed between 09hOO and 09h30. Their pineal glands were removed [§ 2.2.1.3] 
and transferred to sterile culture vessels consisting of the bottom part of Z ml amber glass 
ampoules that had been cut ca lOmm from the base. These vessels contained BGJb culture 
medium (Fitton-Jackson modification) at the required volume. Four pineal glands were 
transferred to each vessel. The required volume of ISO, previously dissolved in culture medium, 
was added, resulting in a fmal incubation volume of ZOOJLl. The final concentration of agonist in 
each of the five culture vessels was then OJLM (basal level), O.3JLM, IJLM, 3JLM, and lOJLM. 
These culture vessels were placed in the bottom of 30cc Poly-Top® glass vials and the atmosphere 
therein was saturated with carbogen (5%COZ:95%OZ)' before the to.p was firmly sealed. The 
vials were placed in a Forma Scientific® incubator, and incubated in the dark at 3rC for 3 h. 
After the 3 h, the incubation was terminated by removing the glands from the vessels and placing 
them in individual Iml glass homogenation tubes. They were assayed by the usual technique 
[§ 3.2.1.4]. 
3.4.1.3.2 Experiment B 
The procedure in Experiment A [§ 3.4.1.3.1] was repeated, but NA replaced ISO at the same 
concentrations. 
3.4.1.4 Data analysis and statistics. 
Data are expressed as pmol N-acetyltranferase activity! pineal gland! h, with each point 
representing the mean ± SEM for 4 glands. Statistical comparisons are made using the 
nonparametric Kruskal-Wallis H test for multiple groups. Post-hoc analysis to identify the 
significantly different group means was performed using the Neuman-Keuls multiple range test at 
the p < 0.05 level. 
3.4.2 Results 
The results are presented in Figures 3.1a and 3.1h 
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Figures 3.1a and 3.1b: Cumulative dose response relationships found following 
3.4.3 
isoprenaline (/SO){LeJtl and noradrenaline (NA)[Rightl stimulation of 
NAT activity in rat pineal glands (mean ± SEM; n = 4; p <:* 0.05; 
Neuman-Keuls multiple range test) 
Discussion 
Significant stimulation of NAT was only evident at concentrations of [3JLM] and [lOJLM]. NA 
showed less stimulation of NAT than ISO had done. This follows the trend first seen in Chapter 2 
[§ 2.2.4], where NA showed smaller stimulation of aMT than ISO did. This provides further 
evidence of intrinsic activity - and/or affinity differences between the two agonists. The results 
also confirm the findings of other investigators, that [lOJLM] appears to provide optimal 
stimulation of NAT (Klein et ai., 1983; Vanecek et al., 1985), and thus it seems justifiable to use 
a concentration of [lOJLM] in the succeeding studies to investigate the role of the CCBs in NAT 
stimulation. 
3.5 
3.5.1 
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Experiment 3: ISOPRENALINE AND NORADRENALINE 
STIMULATION OF NAT IN THE PRESENCE OF PROPRANOLOL 
AND PRAZOSIN 
Introduction 
As discussed in [§ 3.1], NAT has been shown to increase following adrenergic stimulation. 
Concurrent al and {3 stimulation has been shown to produce a greater increase in NAT than does 
{3-receptor stimulation alone. This enhancement has been associated with an influx of Ca2+ ions 
. following the acreceptor stimulation. NAT activation is however critically dependent on the 
activation of adenylyl cyclase (Klein et aI., 1970; Klein et al., 1978) leading to increased cAMP 
levels. These are controlled by {3-receptor stimulation. 
3.5.1.1 Objective 
This experiment investigates the role of the respective {3 and al receptors in the adrenergic 
stimulation of NAT. 
3.5.2 
3.5.2.1 
Materials and methods 
Materials 
dl-Propranolol-HCI was purchased from Sigma Chemical Co., USA. Prazosin-HCI was donated 
by Pfizer, Johannesburg, S.A. Sources of all other materials have been described [§ 3.2.1]. 
3.5.2.2 Animals 
Adult female Albino Wistar rats (280 - 320 g b.wt) were used in this study. Their living 
environment has been described [§ 2.2.1.2]. 
3.5.2.3 
3.5.2.3.1 
METHODS 
Experiment A 
Rats were sacrificed between 09hOO and 09h30. Their pineal glands were removed as described in 
[§ 2.2.1.3] and transferred to 4 sterile culture vessels containing BGJb culture medium (Fitton-
Jackson modification) at the required volume. Four pineal glands were transferred to each vessel. 
Prazosin was dispersed in 501'1 of absolute ethanol! mg prazosin before diluting it to volume in 
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distilled water (Yuwiler, 1987). The vehicle control contained an equivalent volume of ethanol. 
Propranolol was dissolved in culture medium. 
After a 10 min pre-incubation period with glands in the presence of either vehicle, propranolol or 
prazosin, ISO[10JLM] was added. The 4 vessels thus contained in a final incubation volume of 
200JLI, the following combinations of drugs, at the listed concentrations: 
i) 
ii) 
iii) 
iv) 
Column 1 
Control 
[lOJLM] ISO 
[lOJLM] ISO 
[lOJLM] ISO 
Column 2 
+ vehicle (unstimulated control), 
+ vehicle, 
+ [lOJLM] propranolol, 
+ [lOJLM]prazosin. 
The vessels were then placed in glass vials as described in [§ 3.4.1.3], incubated for 3 h and 
assayed by the usual technique [§ 3.2.1.4]. 
3.5.2.3.2 Experiment B 
The procedure in Experiment A [§ 3.5.2.3.1] was repeated, but NA replaced ISO at the same 
concentrations. 
3.5.2.4 Data analysis and statistics 
Data are expressed as pmol N-acetyltranferase activity/ pineal gland/ h, with each point 
representing the mean ± SEM. Statistical comparisons are made using the nonparametric 
Kruskal-Wallis H test for multiple groups. Post-hoc analysis to identify the significantly different 
group means was performed using the Neuman-Keuls multiple range test at the p < 0.05 level. 
3.5.3 
3.5.3.1.1 
Results and Discussion 
Glands stimulated with ISO in the presence of blockers. 
The results for those glands stimulated with ISO in the presence of propranolol and prazosin are 
presented in Figure 3.2. 
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* 
BASAL ISO ISO + PROP ISO + PRAZ 
Effects of vehicle, isoprenaline and isoprenaline plus adrenergic 
blockers on NAT activity in rat pineal glands (mean ± SEM; n = 4; 
P <:* 0.05 Neuman-Keuls multiple range test) 
Discussion 
ISO produced an increase in NAT as expected. This increase was however totally abolished in the 
presence of propranolol, the ,8-adrenoceptor blocker. This is in accordance with previous results 
(Deguchi and Axelrod, 1972b; Parfitt et al., 1976) and confirms that NAT is dependent on ,8-
adrenoceptor stimulation. Prazosin, on the other hand, had no apparent effect on ISO stimulation 
of NAT. This is to be expected as prazosin is a pure (X1-adrenoceptor blocker (Cavero and Roach, 
1977; Cambridge et ai., 1977), and ISO at a [lOILM], should be acting primarily on ,8 adrenergic 
receptors. 
3.5.3.2.1 Glands stimulated with NA in the presence of blockers. 
The results for those glands stimulated with NA in the presence of propranolol and prazosin are 
presented in Figure 3.3. 
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* 
* 
BASAL NA NA + PROP NA + PRAZ 
Effects of vehicle, noradrenaline and noradrenaline plus adrenergic 
blockers on NAT activity in rat pineal glands (mean ± SEM; n = 4,· 
P < * 0.05; Neuman-Keuls multiple range test) 
Discussion 
NA produced an increase in NAT activity as expected. It was not as large as that seen with ISO, 
confirming the results seen in the dose response experiments [§ 3.4.2]. Propranolol again 
produced a complete abolition of NAT activity, confirming the dependence of the latter on {3-
adrenoceptor stimulation. prazosin however was able to bring about a significant (p < 0.05) 
reduction in NAT activity, but far less acute than that found with propranolol. This is to be 
expected as NA should be acting through both {3 and ai-receptors (Vanececk et al., 1986), and 
blocking the latter should still allow the {3-receptors to remain functional as demonstrated 
[§ 3.4.3.1.2]. Similar findings were reported by Klein et aI., (1983). 
3.5.4 Conclusion 
These results therefore demonstrate that NAT is stimulated through both al and {3 receptors, with 
the latter being an absolute requirement for NAT activity, and the al component acting to 
potentiate this effect. 
3.6 
3.6.1 
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Experiment 4: THE EFFECT OF CALCIUM MANIPULATIONS 
ON NAT ACTIVITY IN RAT PINEAL GLANDS 
Introduction 
Calcium ion fluxes have been implicated in the potentiation subsequent to combined OtJ/{3 
adrenoceptor stimulation in the rat pineal gland. This is discussed in [§ 3.1]. 
3.6.1.1 Objective 
This investigation examines the role of calcium in the adrenergic receptor control of NAT, by 
using several experimental manipulations which vary the concentration of calcium within the 
culture vessels. Ethyleneglycol-bis({3-aminoethylether)-N ,N ,N' ,N' -tetraacetic acid (EGTA) is a 
selective chelating agent with high selectivity for Ca2+ (Miller, 1984). Calcium ionophore 
AnJS7 strongly increases the permeability of the plasma membrane to bivalent cations, by 
combining with Ca2+ and transporting it through the membrane (Pressman, 1976). It can thus be 
used to mimic the Ca2+ influx that occurs with the Oti-receptor stimulation following ISO 
stimulation (by by-passing the Ca2+ gating mechanism). This is similar to the way in which 
dibutyryl cAMP has been used to mimic {3-adrenoceptor stimulation in the pineal gland, and hence 
to increase NAT (Deguchi and Axelrod, 1972; Klein et ai., 1970). 
3.6.2 
3.6.2.1 
Materials and methods 
Materials 
Ethyleneglycol-bis({3-aminoethylether)-N ,N ,N' ,N' -tetraacetic acid was purchased from Sigma 
Chemical Co., USA. AnIS7 was purchased from Boehringer Mannheim, West Germany. 
Dimethyl sulphoxide (DMSO) was of analytical grade from commercial sources, and the sources 
of the other materials are recorded in [§ 3.2.1.1]. 
3.6.2.2 Animals 
Adult female Albino Wistar rats (280 - 320 g b.wt) were used in this study. Their environment 
has been described in [§ 2.2.1.2]. 
3.6.2.3 
3.6.2.3.1 
METHODS 
Experiment A 
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Rats were sacrificed between 09hOO and 09h30. Their pineal glands were removed [§ 2.2.1.3], 
and transferred to sterile culture vessels containing BGJb (Fitton-Jackson modification) culture 
medium at the required volume. Four pineal glands were transferred to each vessel. Stock 
solutions of A23187 [0. 1M] were made up in DMSO and serially diluted in culture medium, while 
EGT A was dissolved in distilled water. These agents were added to the vessels in the required 
volumes. The unstimulated control received an equivalent amount of vehicle. The adrenergic 
agonist ISO was then added. The 7 vessels thus contained in a final incubation volume of 200ILI, 
the following combinations of drugs, at the listed concentrations: 
i) 
ii) 
iii) 
iv) 
v) 
vi) 
vii) 
Column 1 
Control 
[lOILM] ISO 
[lOILM] ISO 
[lOILM] ISO 
[lOILM] ISO 
[ OILM] agonist 
[lILM] ISO 
Column 2 
+ vehicle (unstimulated control), 
+ vehicle, 
+ [3.3mM]CaC12 , 
+ [3. 3mM ]EGTA, 
+ [3.3mM]EGTA + [3.3mM]CaC12 , 
+ [lOILM ]A23187, 
+ [lOILM ]A23187 
The vessels were then placed in glass vials as described in [§ 3.4.1.3], incubated for 3 hours and 
assayed by the usual technique [§ 3.2.1.4]. 
Prior to this experiment, the concentration of Ca2+ in the culture medium was determined to be 
2.38 ± 0.03mM Ca2+ using a Varian AA 1275 Atomic Absorption Spectrophotometer®, in a 
flame of acetylene/nitrous oxide. 
A concentration of 3.3mM EGTA is commonly reported in the literature (Sugden et ai., 1986, 
1987), and is thus deemed sufficient to chelate the Ca2+ present in the incubation medium. 
3.6.2.3.2 Experiment B 
The procedure followed in Experiment A [§ 3.6.2.3.1] was repeated, but NA replaced ISO. 
Two groups were not included. These were NA + CaCl2 and A23187 alone. They were not tested 
as they did not show any unexpected results in [§ 3.6.3]. The 5 vessels thus contained the 
following combinations of drugs, at the listed concentrations in a fmal incubation volume of 
200ILI: 
... 
3.6.2.4 
i) 
ii) 
iii) 
iv) 
v) 
Column 1 
Control 
[10J.LM1NA 
[ 10J.LM1NA 
[10J.LM1NA 
[1J.LM1NA 
Column 2 
+ vehicle (unstimulated control), 
+ vehicle, 
+ [3. 3mM 1 EGTA, 
+ [3.3mM1EGTA + [3.3mM1Cac12, 
+ [lOJ.LM lA23187 
Data analysis and statistics 
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. Data was analysed as in [§ 3.5.2.4]. 
3.6.3 
3.6.3.1.1 
Results and Discussion 
Results of glands stimulated with ISO 
The results are presented in Figure 3.4 
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BASAL ISO ISO ISO ISO A23187 ISO 
CA'J.+ EGTA EGTA A23187 
CA'%.· 
Effects of vehicle. A231!!7. isoprenaline alld i.wprenaline plus calcium 
manipulating agents 01/ NAT activity in rat pineal glwuls (mean ± 
SEM; n = 4; P <: * 0.05 Neuman-Keuls multiple ran!;e te.H). 
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3.6.3.1.2 Discussion 
Glands stimulated with ISO showed an increase in NAT as can be expected. The addition of 
Ca2+ to the culture medium of glands already stimulated with ISO did not bring about any 
significant change in the level of NAT. This suggests that the Ca2+ must somehow be introduced 
into the cells for its effect to be seen. On the other hand, removal of calcium from the culture 
medium, with the calcium chelating agent EGTA, totally abolished NAT activity. This finding 
has been demonstrated before (Zatz and Romero, 1978; Wilkinson, 1978). Addition of [3.3mM] 
calcium to the medium containing EGTA, was able to restore NAT activity to a level that was not 
. statistically different from that containing ISO alone. 
The calcium ionophore A23187 was unable to stimulate NAT by itself, but when added to the 
vessel containing ISO [l",M], it was able to potentiate NAT activity to a level similar to that seen 
with [10",M] ISO. This is in agreement with other reports showing a role for calcium in the 
adrenergic regulation of this gland [§ 2.5.1.2]. These results also show that an influx of calcium 
coupled to ,B-receptor stimulation can produce a synergistic effect. 
3.6.3.2.1 Results of glands stimulated with NA 
The results are presented in Figure 3.5. 
3.6.3.2.2 Discussion 
These results are similar to those seen with ISO stimulation. EGT A totally abolished the 
stimulation of NAT, while the addition of calcium to the medium containing EGTA was able to 
restore NAT activity. This confirms the dependence of NAT on calcium. Addition of A23187 to 
glands stimulated with [1",M] NA brought about an even larger stimulation of NAT than that seen 
with ISO [l",M] + A23187 [lO",M]. It is possible that increased calcium in the cell due to the 
ionophore, when it accompanies al-adrenergic stimulation, leads to a greater enhancement of 
NAT activity. 
3.6.4 Conclusion 
These results then confirm that NAT activity is indeed sensitive to manipulations of Ca2+ levels. 
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BASAL NA NA + EGTA NA + EGTA +CA1.· NA + A23187 
Effects of vehicle, noradrenaline and noradrenaline plus calcium 
manipulating agents on NAT activity in rat pineal glands (mean ± 
SEM; n = 4;p < * 0.05 Neuman-Keuls multiple range test) 
Experiment 5: THE EFFECT OF THREE ORGANIC CALCIUM 
CHANNEL BLOCKERS ON NAT ACTIVITY IN RAT PINEAL 
GLANDS. 
Introduction 
Calcium ion fluxes have been implicated in the potentiation subsequent to combined cx1/{3 
adrenoceptor stimulation in the rat pineal gland. A VOC is reportedly present on the pinealocyte 
membrane. In Chapter 2 [§ 2.5] an attempt was made to investigate these fluxes. by using the 
CCBs to probe them. Instead of the CCBs inhibiting the Ca2+ entry into the pinealocyte. and 
thus inhibiting the enhancement dicussed in [§ 2.5.1.2], a paradoxical increase in aMT 
production was found (Brown et aI.. 1989). N-acetylserotonin. the metabolic precursor to aMT, 
was also found to be raised. N-acetyltransferase is the enzyme responsible for the conversion of 
serotonin to N-acetylserotonin. Raised levels of NAT would add credibility to the findings of 
Chapter 2 and possibly suggest interference at the level of cAMP, the nucleotide on which NAT 
activation is dependent. This dependance was shown by the abolition of NAT activity in the 
presence of the {3-adrenergic blocker propranolol [§ 3.5.3]. 
-107-
3.7.1.1 Objective 
It was therefore decided to investigate the effects of the three stucturally diverse CCBs, verapamil, 
diltiazem and nifedipine, on the conversion of tryptamine to its N-acetylated product using the 
assay protocol described in [§ 3.2] and adapted to in vitro studies [§ 3.4.1.3]. This would serve 
as an indicator of NAT activity in the pineal glands. 
3.7.2 
'3.7.2.1 
Materials and methods 
Materials 
Verapamil-HCI, diltiazem, nifedipine, I-isoprenaline-HCI and I-noradrenaline were purchased from 
the Sigma Chemical Co., USA. Sources of all other materials have been recorded in [§ 3.2.1.1]. 
3.7.2.2 Animals 
Adult female Albino Wistar rats (190 - 220 g b. wt) were used in this study. Their environment 
has been described in [§ 2.2.1.2]. 
3.7.2.3 
3.7.2.3.1 
METHODS 
Experiment A 
Rats were sacrificed between 09hoo and 09h30 by neck fracture. Their pineal glands were 
removed [§ 2.2.1.3] and transferred to sterile culture vessels containing BGJb culture medium 
(Fitton-Jackson modification) at the required volume. Four pineal glands were transferred to each 
vessel. 
The culture medium contained either the CCB verapamil [lO/LM] or vehicle. The glands were 
exposed to verapamil or vehicle 30 min prior to the addition of the adrenergic agonists ISO and 
NA [IO/LM]. Glands were thus incubated in the presence of verapamil and either ISO or NA 
[lO/LM]. These were compared with control glands incubated with vehicle, in the presence of 
either ISO or NA [lO/LM]. The total incubation volume was 2oo/L1. A fourth vessel contained no 
adrenergic agonist. This served to determine basal levels of NAT, and also acted as a system 
standard control in the series of experiments. The vessels were then placed in glass vials as 
described in [§ 3.4.1.3], and incubated as before. The reaction was terminated after a 3 h 
incubation period. The glands were assayed individually by the usual technique [§ 3.2.1.4]. 
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protected from oxidation by the addition of ascorbic acid medium in which they were dissolved 
(Sugden and Klein, 1984). Verapamil was dissolved in distilled water. It was added to the 
cultures, in a IOILI volume from a freshly prepared stock solution. Control incubations therefore 
contained lO1L1 distilled water. 
3.7.2.3.2 Experiment B 
The procedure in Experiment A [§ 3.7.2.3.1] was repeated, but verapamil was replaced by 
diltiazem at the same molar concentration. 
Diltiazem was also dissolved in distilled water, with control incubations receiving the equivalent 
amount of vehicle. 
3.7.2.3.3 Experiment C 
The procedure in Experiment A [§ 3.7.2.3.1] was repeated, but verapamil was replaced by 
nifedipine at the same molar concentration. Because nifedipine was relatively insoluble in water, 
it was first dissolved in 70% ethanol, before further dilution in distilled water. Final 
concentration of ethanol did not exceed 1 %. Control incubations contained the equivalent amount 
of vehicle. In addition, because of nifedipine's sensitivity to light, [§ 2.5.2.3.3] all solutions of 
nifedipine were made up freshly just prior to use and kept in glassware protected from light. 
3.7.2.4 Data analysis and statistics 
Data were analysed as described in [§ 3.5.2.4], however a nonparametric Mann-Whitney U test 
was used to determine significance between each agonist/vehicle control and its corresponding 
agonist/CCB combination. 
3.7.3 
3.7.3.1.1 
Results and Discussion 
Results of glands stimulated in the presence of verapamil 
The results of those experiments in which glands are stimulated with ISO and NA in the presence 
of verapamil are presented in Table 3.2 and Figure 3.6 
TABLE 3.2: 
TREATMENT 
Basal 
ISO + vehicle 
ISO + CCB 
NA + vehicle 
NA + CCB 
p < : ( a) 
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N-acetyltransferase activity per rat pineal gland in the presence of 
vehicle or CCB, when stimulated with either isoprenaline (ISO) 
[1Op.MJ or noradrenaline (NA) [1Op.MJ. (mean ± SEM; n =4 
glands per group) 
N-acetyltryptamine formed (pmol/ hr/ pineal gland) 
Verapamil Diltiazem Nifedipine 
0.83 ± 0.17* 0.78 ± 0.46* 0.79 ± 0.08* 
2.38 ± 0.53 3.19 ± 0.86 3.06 ± 0.25 
3.44 ± 0.18 1.62 ± 0.35(b) 2.87 ± 0.15 
2.09 ± 0.13 1.86 ± 0.27 2.16 ± 0.08 
3.04 ± 0.33(a) 2.66 ± 0.16 3.45 ± 0.95(a) 
0.025, (5 ) 0.95 , (Mann-Whitney U test) compared 
to respective vehicle control. 
* Significantly different from respective stimulated groups 
(Kruskal Wallis H testp<0.005). 
3.7.3.1.2 Discussion 
The results differ slightly from those observed in the parallel experiment in the organ culture 
studies [§ 3.5.2.3.1]. There is no difference between NAT activity in those glands stimulated 
with ISO, and those stimulated with ISO in the presence of verapamil. The organ culture studies 
showed an increase in aHT in the parallel experiment. The results from studies on glands 
stimulated with NA in the presence of verapamil are in agreement with the organ culture study. 
showing the paradoxical increase in the level of NAT. 
3.7.3.2.1 Results of glands stimulated in the presence of diltiazem 
The results of those experiments in which glands are stimulated with ISO and NA in the presence 
of diltiazem are presented in Table 3.2 and Figure 3.7. 
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** 
BASAL ISO ISO + VER NA NA + VER 
The effect of verapamil (VER) on N -acetyltransferase activity per rat 
pineal gland in the presence of either ISO or NA [lOp,M], compared to 
control glands with vehicle, in the presence of either ISO or NA [JOp,M] 
(mean ± SEM; n=4 glands per group; p <: *0.05;Mann-Whitney U test) 
5r--------.-------------------,------------------~ 
>- 4 ~ 
~.t: 
u--as '0 (l)c 
fI).!! 3 ~C) 
(1)-
_as 
fI) (I) 
C C 
as .-
... 0. 
:= -- 2 »
_0 
(I) E go. 
I 
Z 
1 
Figure 3.7: 
BASAL ISO ISO + OIL NA NA + OIL 
The effect of diltiazem (DIL) on N-acetyltransferase activity per rat 
pineal gland in the presence of either ISO or NA [lOp,M], compared to 
control glands with vehicle, in the presence of either ISO or NA 
* ** {lOp,MJ. (mean ± SEM; n=4 glands per group; p < : 0.05; 0.025 
Mann-Whitney U test) 
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3.7.3.2.2 Discussion 
The paradoxical increase following NA stimulation in the presence of diltiazem is still observed, 
but in contrast, those glands stimulated with ISO in the presence of diltiazem show a significant 
decrease in NAT levels. This supports the findings of a decrease in aMT observed in this group 
in the organ culture studies [§2.5.3.1.1), although those did not show a decrease in aHT. This 
could imply that the NAT assay is a more sensitive parameter, or it could be that the organ culture 
study returned a false high in aHT levels, as this substrate was not being converted to aMT, 
because of an inhibition of HlOMT activity [§ 2.5.3.1.2). To further complicate this matter, the 
recent data of Walker and Aloyo, (1988) shows an increase in the secretion of HT from the pineal 
following NA stimulation. This theoretically would reduce the substrate available to NAT in 
organ culture. 
3.7.3.3.1 Results of glands stimulated in the presence of nifedipine 
The results of those experiments in which glands are stimulated with ISO and NA in the presence 
of nifedipine are presented in Table 3.2 and Figure 3.8. 
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Figure 3.8: The effect of nifedipine (NIF) on N-acetyltransferase activity per rat 
pineal gland in the presence of either ISO or NA {/Op.MJ. compared to 
control glands with vehicle, in the presence of either ISO or NA {/Op.MJ 
(mean ± SEM; n=4 glands per group; p < *0.05; Mann-Whitney U test) 
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3.7.3.3.2 Discussion 
A similar trend is seen here, to that observed with the verapamil group [§ 3.7.3.1.2]. Glands 
stimulated with ISO are not significantly different from those stimulated with ISO in the presence 
of nifedipine. Those glands stimulated with NA in the presence of nifedipine again show the 
paradoxical increase in NAT as they did in aMT previously [§ 3.5.3.2.2]. 
3.7.4 Conclusion 
. In summary then, the following trend emerges: all glands stimulated with NA in the presence of 
anyone of the CCBs showed an increase in NAT activity. Glands stimulated with ISO showed no 
significant differences in NAT activity in the presence of verapamil and nifedipine, but did show a 
decrease in the presence of diltiazem. Once again diltiazem shows a difference when compared 
with the other two CCBs [§ 2.5.4]. 
It would thus seem that the CCBs are in some way influencing cAMP levels and interfering with 
the metabolic cascade simplistically represented as: 
t cAMP-- t NAT-- t aRT-- t aMT 
Although purely speculative at this stage, the following mechanism may provide a plausible 
explanation for the observed phenomenon: 
Following adrenergic stimulation in the pineal gland, the intracellular concentration of cAMP 
rises, coupled to a corresponding increase in its regulator cAMP-phosphodiesterase (PDE) 
(Oleshansky and Neff, 1975). The cellular flux of ea2+, by way of its interaction with the 
ubiquitous intracellular protein calmodulin (CaM), plays a crucial role in regulating PDE activity 
(Cheung, 1982). 
Ca2+ must first bind to CaM in its inactive state. This causes a conformational change in the 
latter, resulting in the exposure of a hydrophobic surface (La Porte et aI., 1980) and the formation 
of the active conformer (CaM-Ca2+). This in tum binds to PDE producing the active holoenzyme 
Ca2+-CaM-PDE (Klee et aI., 1980). More specifically the CCBs have been shown to bind to the 
exposed hydrophobic surface of CaM-Ca2+, preventing the active conformer, CaM-Ca2+ binding 
PDE (Johnson and Wittenauer, 1983; Lamers et aI., 1985). This proposed mechanism is shown 
diagrammatically in Figure 3.9. Both the CaM-sensitive and CaM-insensitive forms of cAMP-
+ 
Figure 3.9: 
+ 
ACTIVATED 
PHOSPHODIESTERASE 
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A diagrammatic representation of the activation of calmodulin by Ca2 + , the 
conformational change which occurs, resulting in the active conformer, 
to which either the CCB binds (thereby preventing PDE binding) or the 
enzyme to be activated binds e.g PDE resulting in the active holoenzyme 
(adaptedfrom Weiss and Levin, 1978). 
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PDE have been shown to be inhibited at the micromolar concentrations used in this study (Epstein 
et al., 1982). 
If this is the case then cAMP levels could be expected to remain high, with correspondingly 
higher levels of NAT, leading to an increased acetylation of HT, and ultimately to higher 
concentrations of aMT. Some credence would be lent to this hypothesis if increased cAMP levels 
were demonstrable in the presence of the CCBs. 
4.1 
4.1.1 
CHAPTER 4 
CYCLIC-AMP STUDIES 
INTRODUCTION 
A role for calcium in cyclic-AMP regulation? 
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Sutherland and RaIl (1958) were the first to demonstrate the existence and function of a cyclic 
nucleotide: cyclic 3' ,5' -adenosine monophosphate (cAMP). They showed the accumulation of 
cAMP in liver tissue, following adrenaline stimulation. Sutherland and his co-workers were able 
to demonstrate that cAMP was formed via a membrane-bound adenylyl cyclase, while its 
destruction occured via an enzyme -cyclic-AMP phosphodiesterase (cAMP-PDE)- present in the 
cytosol. This work has been reviewed in Sutherland et aI., (1968). By 1968 they were able to 
advance the second messenger concept. 
Stated simplistically this concept embodies a first messenger, an external stimulus specific for a 
particular cell type, interacting with the membrane-bound adenylyl cyclase. This interaction 
initiates a flow of information into the cell and induces that cell to generate increased cAMP 
levels. The generated cAMP then acts internally as the so-called second messenger, performing a 
variety of specific functions (Sutherland et aI., 1968). Kuo and Greengard (1969) extended this 
concept to include the stimulation of second messenger dependent protein kinases. 
Second messengers are now understood to include not only cAMP, but also cGMP and Ca2+, all 
of which playa prominent role in the regulation of protein phosphorylations (Rasmussen, 1981). 
They are discussed in [§ 1.6]. 
It was investigations into the control of cAMP in brain tissue that implicated calcium as a 
controller of several intracellular events. In 1970 Cheung linked Ca2+ levels to the control of 
cAMP-PDE. Teo et al., (1973) found that Ca2+ acts via some protein, to influence cAMP-PDE. 
They named the protein responsible for this control, calcium dependent regulator (CDR), in the 
light of both its high affinity for Ca2+, and the need for Ca2 + to be present for its activity. In 
1980, Cheung renamed it calmodulin, a name, derived from its function as a calcium modulating 
protein. Calmodulin (CaM) is discussed in [§ 1.10.2]. 
The duality of Ca2 + and cAMP in the control of so many control functions within the universal 
',. 
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system of stimulus response coupling led to adoption of the term "synarchic control". This is 
based on an analogy to the ancient Greek Arcons: Heralds of special status sent out in twos, each 
carrying part of a message and syn meaning together (Rasmussen, 1981). The analogy between the 
arcons and the dual messengers, cAMP and calcium, is easily perceivable. An analysis of second 
messenger function in a variety of cells shows that calcium mediates many of the cellular 
responses, while cAMP acts to modulate the action of calcium (Berridge, 1984). 
4.1.2 Synarchic control in the pineal gland. 
In the rat pineal gland NA stimulates cAMP, cGMP and Ca2+ through al and {31 receptors 
(Cardinali and Vacas, 1987). The characterization of these receptors has been discussed in 
[§ 1.5.2]. 
{3-Adrenergic stimulation of pinealocyte cAMP is known to involve Ns (Minneman and Iverson, 
1976; Vanecek et al., 1986), the stimulatory GTP-binding regulatory protein which couples 
receptor occupation to the activation of adenylyl cyclase (Hurley et al., 1984). Cyclic-GMP is 
probably regulated by the a subunit of a related GTP binding protein, Gsa (Sugden and 
Klein, 1987). ai-Adrenergic stimulation potentiates (3 adrenoceptor stimulation by a variety of 
complex mechanisms. For example, an increase in intracellular Ca2+ levels is associated with, or 
may even be essential to, i) the activity of pineal phospholipase C (Smith and Hauser, 1981), ii) 
the activity of phospholipase A2 (Ho and Klein: 1987), and iii) the translocation of protein kinase 
C (Sugden et al., 1985). In the rat pineal gland, the al blocker prazosin is able to inhibit this 
effect, while the a2 blocker yohimbine shows no effect, confirming that in this system, NA is 
acting via al and {3 receptors (Ho et al., 1988). 
The activity of NAT is regulated via an adrenergically mediated stimulation of adenylyl cyclase 
(Klein and Berg, 1970; Klein et aI., 1978). (3-Adrenoceptor stimulation increases cAMP, in the 
rat pineal gland, by activating adenylyl cyclase. Cyclic-AMP levels are critical in the production 
of the pineal hormone melatonin(aMT) from serotonin, via the rate-limiting enzyme 
N-acetyltransferase (NAT) (Axelrod, 1974). al-Adrenoceptor activation, which alone is without 
effect, has been shown to enhance {3-adrenoceptor stimulation of cAMP. This enhancement has 
been linked to an increased influx of Ca2+ into the pinealocyte (Sugden et ai., 1986). 
Furthermore, treatments which result in increased cAMP levels have been shown to increase NAT 
levels (Klein and Berg, 1970; Klein et ai., 1970). A similar result could be expected if cAMP-
POE (the enzyme responsible for the termination of cAMP activity) were to be inhibited. 
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4.1.3 Objectives 
It was therefore proposed to investigate the effect of the these three CCBs on rat pineal cAMP 
levels, to ascertain if the latter were indeed raised, as suggested by the high levels of NAT found 
in Chapter 3. To enable such a study to be made, a suitable cAMP assay had to be selected from 
the many methods currently available for this purpose. 
4.1.4 Methods for the detemtination of cyclic-AMP 
Although several very sensitive radioimmunoassays for the determination of cAMP are available, 
their cost was prohibitive. Since the action of cAMP in all tissues involves its binding to some 
type of protein (Oye, 1973), several techniques have been devised which make use of a natural 
binding protein coupled to a radioisotope type of dilution assay, thereby giving greater sensitivity. 
The methods of Gilman (1970) and Brown et al., (1971) are two well known examples of these 
so-called saturation binding assays. While Gilman's method requires the onerous isolation of a 
protein from bovine muscle, that of Brown et al., (1971), makes use of a crude protein, easily 
extracted from bovine adrenal tissue, to bind cAMP. A brief outline of this latter method follows 
[§ 4.1.5] 
4.1.5 Swnmary of the assay 
The assay is based on the competition between unlabelled cAMP and a fixed quantity of the 
tritium labelled compound for binding to a protein which has a high specificity and affinity for 
cAMP. The amount of [3H]-cAMP bound to this protein is inversely related to the amount of 
cAMP present in the assay sample. The amount of unlabelled cAMP in the sample is calculated 
by measurement of the protein-bound radioactivity. Separation of the protein-bound cAMP from 
the unbound nucleotide is achieved by centrifugation. The supernatant (which contains the 
protein-bound complex) is added to scintillation cocktail and its activity determined by liquid 
scintillometry. The concentration of unlabelled cAMP in the sample is then determined from a 
linear standard curve. The method used for the isolation of this cAMP binding protein and its 
subsequent use to investigate the effect of the CCB on pineal gland cAMP levels is described 
hereafter [§ 4.2]. 
4.2 
4.2.1 
4.2.1.1 
CYCLIC-AMP DETERMINATION TECHNIQUE 
Materials and Methods 
Chemicals, drugs and reagents 
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[8..3H]Adenosine 3' ,5' -cyclic phosphate, ammonium salt (1.0 mCi/ml : specific activity 26.1 
Ci/mmol) was purchased from Amersham, England, and the activated charcoal from Merck, 
Germany. i-Isoprenaline-HCI, noradrenaline bitartrate, phosphodiesterase (EC 3.1.4.17, specific 
activity ca 0.31 U/mg), cyclic-AMP, theophylline and bovine serum albumin were obtained from 
Sigma Chemical Co., USA. The chemicals used in buffers were of analytical grade from 
commercial sources. 
4.2.1.2 Animals 
Male Wistar rats (220-250 g b. wt) were housed four per cage in a temperature controlled room 
under a fixed lighting cycle of LD 12: 12 (lights on 06hOO) with food and water ad libitum. The 
rats were sacrificed between 09hOO and 09h30. This maintained uniformity with the previous 
studies [§ 3.2.1.2]. 
Male rats were chosen for the cAMP studies because they tended to be less anxious, when 
handled, than the female rats. It was therefore felt that their cAMP levels would more accurately 
reflect the drug treatment, rather than exogenous stress influences. Skene (1985) has reported 
higher basal cAMP levels in female rats, which she ascribed to their more anxious nature. As each 
rat acts as its own control [§ 4.2.1.6] any variance in basal levels should be removed. 
4.2.1.3 Pineal glands 
The pineal glands for assay were rapidly removed and bisected under a dissecting microscope on a 
cold glass sheet. The pineal hemisections were then transfered to prewarmed (37°C) BGJb culture 
medium (Fitton-Jackson modification). 
4.2.1.4 
4.2.1.4.1 
Assay of cAMP in rat pineal glands 
Collection and preparation of binding protein 
Bovine adrenals were dissected out as soon as possible after slaughter and transported from the 
abbatoir on ice. The cortices were separated from the medullas, finely chopped and homogenised 
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(Ultra-Turrax®) in 1.5 volumes of ice-cold buffer (O.25M sucrose, 50mM Tris-HCl buffer, pH 
7.4, 25mM potassium chloride, 5mM magnesium chloride). The homogenate was spun (Hettich 
Universal 2S ®) at 2000g for 5 minutes and the supernatant respun at 5000g for 15 minutes. 
Aliquots of the supernatant were stored in 1 ml Eppendorfr@ tubes at -20°C. The stored protein 
remained stable for the duration of this study. 
4.2.1.4.2 Dilution 
For each cAMP assay [§ 4.2.1.5.1], an aliquot of binding protein was thawed and diluted with an 
appropriate volume of cyclic-AMP buffer (50",M Tris-HCl buffer, pH 7.4, 8",M theophylline, 
6",M mercapto-ethanol). As the concentration of isolated binding protein varied from batch to 
batch, it was essential to first determine the appropriate dilution of stock protein that would be 
suitable for a particular batch. Serial dilutions of binding protein in buffer were assayed for 
radioactivity, by following the zero dose column in Table 4.1 and adding increasing dilutions of 
stock protein. 
A typical protein dilution curve obtained (cpm vs dilution used) is shown in Figure 4.1. It shows 
that a 1:3 dilution with buffer provides both sufficient binding (80%) and radioactive counts. 
This dilution factor was thus used in all subsequent cAMP assays with this batch of stock protein. 
Most other batches used in this laboratory required a similar dilution factor. 
4.2.1.5.1 Cvclic AMP Assay 
Cyclic AMP levels were measured in duplicate pineal homogenate samples by the saturation 
binding method of Brown et al. (1971). A simplified scheme adapted to pineal work is presented 
in Table 4.1. 
The pineal hemisections were pre-incubated at 3rC for 10 min. One half was then transferred to 
fresh, prewarmed incubation medium containing [20",M] isoprenaline, the other half to control 
incubation medium containing vehicle. Both preparations were incubated for another 10 min at 
37°C. The halves were then removed and homogenised separately in 110 ",1 ice-cold cAMP 
buffer. Duplicate (50 ",l) aliquots of the tissue suspension were transferred to reaction tubes. 
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Figure 4.1: A typical protein dilution curve obtained in these experiments 
Briefly each reaction tube contained 50 ",1 of sample or known amounts (0 - 8 pmol) of cAMP 
standard; 50 ",1 of [3H] cAMP (8 nCi), cAMP buffer and 100 ",1 of a 1:3 dilution of binding 
protein. The final incubation volume was 350 ",1. The incubation tubes were placed on ice and 
stored at 4°C. After 100 min, 100 ",I of a 10% w/v suspension of charcoal in buffer containing 
2 % w/v bovine serum albumin, was added to each tube and the tubes were briefly vortexed on a 
Rota-Mixer Deluxe®. After centrifugation (14000g for 15 minutes at 4°C), a 100 ",1 aliquot of 
the supernatant was added to 3ml Ready Solv HP/B® (Beckmann). The vials were shaken 
(Griffin Flask Shaker®) for 10 min and then counted for radioactivity in a Beckmann LS 2800 
liquid scintillation counter at an efficiency of 60 % to 69 %. 
4.2.1.5.2 Quantitation 
A calibration curve was set up for each assay. Calibration curves were plotted using the data 
obtained from the standard amounts of cAMP added to the tubes as outlined in Table 4.1 
columns 2 through 8. The amounts of unknown cAMP in samples were determined by reference 
to such curves. 
In order to linearize the standard curves a slightly different plotting procedure was used from that 
employed by Brown et ai., (1971). The terms used are derived from the resultant mean cpm as 
follows: 
Co = mean cpm zero standard - mean cpm blank 
Cx = mean cpm standard - mean cpm blank' or for the samples, mean cpm sample - mean cpm blank 
-121-
TABLE 4.1: Protocol usedfor the determination of cyclic AMP using the method of 
Brown et al., (1971). Quantities are in microlitre. 
BLANK o DOSE 0,25 0,5 1,0 2,0 4,0 8,0 
ILL Buffer 250 150 150 150 150 150 150 150 
ILL Std (1:10) 12,5 25 50 
ILL Std (as is) 10 20 40 
Dist Water 50 50 37,5 25 40 30 10 
3H-cAMP 50 50 50 50 50 50 50 50 
Homogenate for assay 
Mix Mix 
ILL Diluted Protein 100 100 100 100 100 100 100 
Mix gently Mix gently to avoid frothing 
Incubate in cold room at 4°C for 100 minutes 
Charcoal 100 100 100 100 100 100 100 100 
Vortex Vortex Briefly 
Centrifuge at 15 OOOg for 15 min using p~ecooled rotor 
Carefully remove 100 ILL Supernatant and add to 3 ml cocktai l, and count radioactivity 
The ratio CO/Cx (ordinate) was calculated from the standard data, and plotted against the 
corresponding concentration (pmol/tube) of cAMP (abscissa). 
An example of such a calibration curve is shown in Fagure 4.2 
4.2.1.6 Data analysis and statistics. 
SAMPLE 
150 
50 
50 
100 
100 
VetuJani et al., (1976) expressed the cAMP response to isoprenaline administration as the 
difference in cAMP levels between two halves of tissue preparation, one half being exposed to 
isoprenaline and the other half serving as the control. The advantages of using this technique are 
many. Since each animal acted as its own control, animal, environmental and experimental 
variables could be controlled. Thus, the reported effect of decapitation on cAMP levels (Weiss 
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and Strada, 1972) would not affect the results. The possible effects of the oestrous cycle on 
adenylyl cyclase activity (Weiss and Crayton, 1970), would also be avoided. 
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Figure 4.2: A typical cAMP calibration curve obtained in these experiments 
This technique was adapted for use in the experiments with the CCBs [§ 4.4.0], as it allowed one 
half of a pineal to be incubated in the presence of an agonist and vehicle, while the corresponding 
half was incubated in the presence of agonist and CCB. 
4.2.1.6.1 Statistical Analysis 
Cyclic AMP levels - the mean of duplicate determinations - were determined from the cAMP 
standard curve and expressed as pmol! pineal ± SEM. For each drug group, the the cAMP levels 
in those glands stimulated with agonist and CCB were compared with those in control glands 
stimulated with agonist, but incubated in the presence of vehicle. The significance was evaluated 
using Student's paired t-test (2-tailed). 
Pairing data for statistical analysis normalizes the data to its own control, thereby adjusting for 
any variations in basal activity. Warnick et al., (1988) are one group of researchers using this 
method in their analysis. 
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4.2.1.7 Results and discussion 
Although initial pilot studies had shown that [lOJLM] isoprenaline stimulation for 5 or 10 min was 
not able to stimulate cAMP in pineal gland hemisections, further investigation revealed that 
pineal gland hemisections incubated with [20JLM] isoprenaline for 10 min, did show stimulation of 
cAMP well above basal levels. 
The integrity of the assay was further validated as described in [§ 4.2.1.8]. 
4.2.1.8 Validation of results 
Three approaches were used to test the validity of the system. 
i) A stock solution of PDE 0.31 U/mg was made up. One unit should hydrolyse IJLM of 3', 5'-
cAMP to 5'-AMP per min at pH7.5 at 30°C. Aliquots of increasing concentrations of PDE were 
added to some tubes, and these were incubated for 30 min. This ensured a quantitative hydrolysis 
of the cAMP present. Results obtained from this procedure could be used to test the sensitivity of 
the system. 
ii) After addition of tracer quantities of [3H]-cAMP, BSA-coated activated charcoal was added to 
the tubes. Assay of the supernatant showed all tracer had been removed. 
iii) Known quantities of standard cAMP were added to tubes containing zero added cAMP. These 
were placed among the normal assay tubes, and the results from these were tested to see that they 
agreed with the calibration curve. 
4.2.1.9 Discussion 
The results obtained confirm that this assay is suitable for the determination of cAMP in pineal 
hemisections. However, one additional test remained: to test the assumption that splitting the 
pineal gland would indeed produce equal halves. 
4.3 
4.3.1 
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Experiment 1. PROTEIN DETERMINATION IN CORRESPONDING 
HALVES OF PINEAL GLANDS. 
Introduction 
To vindicate the use one half of the pineal gland as the control, while the other half was 
stimulated with agonist in the presence of an CCB, it was important to check that equal amounts 
of protein were present in each of the halves. 
Two methods are commonly used for the determination of protein in biological samples. 
Bradford (1976) makes use of a dye-binding method, while Lowry and his workers, use a slightly 
more complex method. As the dye (Coomassie Brilliant Blue G-250) was not available in this 
laboratory, but the reagents required for the second method were available, it was decided to use 
the method of Lowry et ai., (1951). A simple protocol for this method using bovine serum 
albumin as standard is outlined in Table 4.2. 
4.3.2 
4.3.2.2 
Materials and Methods. 
Materials 
All reagents used were of analytical grade from commercial sources. 
4.3.2.1 Animals 
Six adult female Wistar rats were used for this experiment. As the objective was to quantify the 
relative amounts of protein in each hemisection and not to assay cAMP levels, female rats could 
be used here, to conserve male rats for use in subsequent assays. 
4.3.2.2 Pineal glands 
Pineal glands were rapidly removed, placed on a cold glass sheet, and bisected under a dissecting 
microscope. The pairs of halves were kept together to ensure that the correct pairs were 
transferred to corresponding homogenization tubes (Pyrex ®, thick wall, no rim lOx 75mm tubes). 
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4.3.2.3 Methods 
Each hemisection was placed in a 2 ml glass homogenization tube, and homogenised in looJLl of 
cAMP buffer. A further 900JLl of buffer was added to the tubes. Due care was taken to ensure 
that the homogenate was adequately mixed with this buffer. Duplicate looJLl aliquots of 
homogenate were assayed following the procedure outlined in Table 4.2. 
Briefly 2ml of reagent C (2 % N~C03 in O.IN NaOH; 0.5 % CuS04.5H20) in 1 % sodium tartrate 
(50: 1) was added to 400 JLl of Tris-HCI buffer (50mM,pH8.0) containing known amounts of 
bovine serum albumin (BSA) as standard or 100 JLl pineal homogenate. This solution was 
vortexed for 1 min and then allowed to stand for 15 min at room temperature (21-23°C). To each 
tube, 200JLl of a 1: 1 dilution of Folin-Ciocalteau phenol reagent was added and the tube 
immediately vortexed. After 30 mins at room temperature, the absorbance of the samples was 
measured at 750 nm using a spectrophotometer (Bausch & Lomb Spectronic Model 1001 ®). 
4.3.2.4 Data analysis and statistics. 
A calibration curve had to be set up for each assay. Calibration curves were plotted using the data 
obtained from the standard amounts of BSA added to the tubes as outlined in Table 4.2 rows 1 
and 2. The amounts of unknown protein in samples were determined by reference to such curves. 
An example of such a calibration curve is shown in Figure 4.3. 
For each group, the significance of the difference in protein levels between the two halves was 
determined. The significance was evaluated using Student's paired I-test (2-tailed). 
4.3.3 Results 
The mean protein content (JLg ± SD) in the first half of glands was 78.4 ± 10JLg, while that 
of the corresponding halves was 82.5 ± 8JLg. 
These results show that there is no significant difference (p < 0.445) between the halves if 
due care is taken, when splitting the halves under a dissecting microscope. 
4.3.4 Discussion 
It would thus seem that provided due care is taken when splitting the pineal glands into two 
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TABLE 4.2: Schemefor the determination of protein (Lowry et aI., 1951). 
SAMPLES (/Lg) 
REAGENTS BLANK SAMPLE (mls) 2.5 5.0 1.0 2.0 4.0 
STANDARD (0.1 mg/ml) 0.025 0.05 0.1 
STANDARD (1 mg/ml) 0.02 0.04 
SAMPLE 0.1 
BUFFER * 0.4 0.315 0.35 0.3 0.38 0.36 0.3 
REAGENT C ** 2.0 2.0 2.0 2.0 2.0 2.0 2.0 
STAND: 15 min at room temperature 
REAGENT E *** 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
STAND: 30 min at room temperature 
READ at 150nm. 
* Tris'HCl buffer (50mM, pH 8.0) containing 3mM MgCl 2 • 
** 2% Na2C03 in 0.1 N NaOH: 0.5% CuS04.5H20 in 1% sodium tartrate (50:1). 
*** Diluted Folin'Ciocalteu phenol reagent (1:1). 
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Figure 4.3: A typical protein calibration curve obtained in these experiments 
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halves, it would be justifiable to split a pineal and use one half as a control of the other half. This 
would then enable the determination of the effect of the CCB on pineal cAMP levels in the same 
gland, by using one half as a control (agonist in the presence of vehicle) while the other half was 
stimulated with agonist in the presence of CCB. 
4.4 
4.4.1 
Experiment 2: THE EFFECT OF THREE ORGANIC CALCIUM 
CHANNEL BLOCKERS ON CYCLIC-AMP LEVELS IN RAT 
PINEAL GLANDS 
Introduction 
The findings in Chapter 3 [§ 3.7.4] suggest that the increased NAT levels seen are as a result of 
raised cAMP levels. 
It is well known that adrenergic agonists will elevate cAMP, however the same effect may be 
brought about by an inhibition of cAMP-phosphodiesterase (cAMP-PDE). A few recent reports 
have suggested that the organic calcium channel blockers might well be able to inhibit cAMP-PDE 
by binding to calmodulin (CaM), a protein itself requiring activation by Ca2+ before it will 
activate cAMP-PDE (Lamers et ai., 1985; Johnson and Mills, 1986). 
4.4.1.1 Objective 
To ascertain whether this might account for the potentiation previously observed, the effect of the 
three CCBs on rat pineal cAMP levels was investigated, using the same drug paradigm used in 
Chapter 3 [§ 3.7], i.e. isoprenaline (ISO) was used for its {3 stimulating properties while NA was 
used for its dual a/{3 properties. It was hoped that by keeping to the original experimental design, 
it would be possible to pursue the original hypothesis, and to see if the CCB would alter the Ca2+ 
influx following al/{3 stimulation. At the same time an explanation of the paradoxically increased 
stimulation previously observed might be found. 
4.4.2 
4.4.2.1 
Materials and Methods 
Materials 
Verapamil-HCI, diltiazem, nifedipine, i-isoprenaline-HCI and I-noradrenaline-bitartrate were 
purchased from the Sigma Chemical Co., USA. Sources of all other materials have been recorded 
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in [§ 4.2.1.1]. 
4.4.2.2 Animals 
Male Wistar rats (230-260 g b. wt) were used in this study. Their living environment has been 
described [§ 2.2.1.2.]. 
4.4.2.3 
4.4.2.3.1 
METHODS 
Experiment A 
The rats were killed by neck fracture between 09hOO and 09h30. This maintained uniformity with 
previous studies [§ 3.2.1.2]. 
Their pineal glands were rapidly removed, placed on a cold glass sheet and bisected with a scalpel 
blade under a dissecting microscope. The two halves were transfered into separate wells 
(Falcon ® 18x6 rows) containing 50 JLI of BGJb incubating medium (Fitton-Jackson modification) 
and pre-incubated at 37°C for 5 min. 
One half was then transferred to fresh, prewarmed incubation medium containing verapamil 
[10JLM], the other half to control incubation medium containing vehicle. Both preparations were 
incubated for a further 10 min at 37°C, whereafter they were stimulated with either NA[lOJLM] or 
ISO [20JLM] for 10 min. 
The halves were then removed and homogenised separately in HOJLI cyclic AMP buffer (50JLM 
Tris-HCI buffer, pH 7.4, 8JLM theophylline, 6JLM mercaptoethanol). Duplicate 50 JLI aliquots of 
the tissue suspension were assayed for cAMP by the saturation binding method of 
Brown et al. ,(1971) [§ 4.2.1.5.11. 
4.4.2.3.2 Experiment B 
The procedure in Experiment A [§ 4.4.2.3.11 was repeated, but verapamil was replaced by 
diltiazem at the same molar concentration. 
Diltiazem was also dissolved in distilled water, with control incubations receiving the equivalent 
amount of vehicle. 
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4.4.2.3.3 Experiment C 
The procedure in Experiment A [§ 4.4.2.3.1] was repeated, but verapamil was replaced by 
nifedipine at the same molar concentration. Because nifedipine was relatively insoluble in water, 
it was first dissolved in 70% ethanol, before further dilution in distilled water. Final 
concentration of ethanol did not exceed 1 %. Control incubations contained the equivalent amount 
of vehicle. All solutions of nifedipine were made up freshly just prior to use and kept in 
glassware protected from direct light [§ 2.5.2.3.3]. 
4.4.2.4 Data analysis and statistics 
Cyclic-AMP levels were determined from the cAMP standard curve and expressed as pmol/ pineal 
± SEM. For each drug group, the significance of the difference between the cyclic AMP levels 
stimulated with agonist in the presence of vehicle (control), and those glands stimulated with 
agonist in the presence of CCB was evaluated using Students paired t-test (2-tailed). 
Nifedipine was partly dissolved in ethanol and the other CCBs were dissolved in distilled water as 
described. This, coupled to the fact that experiments with each CCB were performed on different 
days, necessitated the use of separate control groups. A nonparametric Kruskal Wallis H test was 
performed to ensure that the control groups were not significantly different. 
4.4.3 
4.4.3.1.1 
Results and Discussion 
Results of glands stimulated in the presence of verapamil 
The results of those experiments in which glands are stimulated with ISO and NA in the presence 
of verapamil are presented in Table 4.3 and Figure 4.4. 
4.4.3.1.2 Discussion 
The results differ slightly from those observed in the parallel experiment in the organ culture 
studies [§ 2.5.3.1.2], but are in agreement with those fmding in the NAT study [§ 3.7.3.1.2]. 
There is no significant difference between cAMP levels in those glands stimulated with ISO, and 
those stimulated with ISO in the presence of verapamil. The organ culture studies showed an 
increase in aHT in the parallel experiment. 
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The results from those glands stimulated with NA in the presence of verapamil are in agreement 
with those from the organ culture study, i.e. an increase (p < 0.025) in cAMP levels is seen 
which could account for the increased level of NAT found previously. 
TABLE 4.3: Cyclic-AMP formed per rat pineal gland in the presence of vehicle or CCB, when 
stimulated with either isoprenaline (ISO) [20p.Mj or noradrenaline (NA) 
[lOp.Mj. (mean ± SEM; n = 4 glands per group) 
cAMP formed (prool/ 10 mini pineal gland) 
Treatment Verapamil Diltiazem Nifedipine 
ISO + vehicle 1.98 ± 0.13 2.12 ± 0.22 1. 75 ± 0.22 
ISO + CCB 1.61 ± 0.22 1.20 ± 0.24** 1.99 ± 0.15 
NA + vehicle 3.53 ± 0.38 3.17 ± 0.28 4.71 ± 0.27 
NA + CCB 6.76 ± 0.55** 7.28 ± 1. 81 ** 7.44 ± 1.22* 
In comparison with respective vehicle control, p < : *0.05; **0.025 (Student's paired t-test) 
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** 
ISO ISO+VER NA NA+VER 
Cyclic-AMP formed per rat pineal gland in the presence of vehicle or 
verapamil (VER), when stimulated with either isoprenaline (ISO) 
[20p.Mj or noradrenaline (NA) [lOp.Mj (mean ± SEM; n = 4 glands 
per group; p < :**0.025 w.r.t NA -vehicle control-: Student's paired t 
test) 
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4.4.3.2.1 Results of glands stimulated in the presence of diltiazem 
The results of those experiments in which glands are stimulated with ISO and NA in the presence 
of diltiazem are presented in Table 4.3 and Figure 4.5. 
4.4.3.2.2 Discussion 
The paradoxical increase (p < 0.025) following NA stimulation in the presence of diltiazem is 
again observed, but in contrast, those glands stimulated with ISO in the presence of diltiazem 
show a significant decrease (p < 0.025) in NAT levels. This supports the findings of a decrease 
in aMT observed in this group in the organ culture studies [§2.5.3.2.1J, as well as the decrease 
found in the NAT study [§ 3.7.3.2.2J. 
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4.4.3.3.1 
ISO 
** 
ISO+OIL NA NA+OIL 
Cyclic-AMP formed per rat pineal gland in the presence of vehicle or 
diltiazem (DJL), when stimulated with either isoprenaline (ISO) [20p.M] 
or noradrenaline (NA) [10p.M] (mean ± SEM; n = 4 glands per group 
p < :**0.025 w.r.t respective vehicle control: Student's paired t test) 
Results of glands stimulated in the presence of nifedipine 
The results of those experiments in which glands are stimulated with ISO and NA in the 
-132-
presence of nifedipine are presented in Table 4.3 and Figure 4.6. 
4.4.3.3.2 Discussion 
A similar trend of cAMP production in glands is seen here, to that observed with the verapamil 
group [§ 4.4.3.1.1). Results from glands stimulated with ISO are not significantly different from 
those of glands stimulated with ISO in the presence of nifedipine, while those glands stimulated 
with NA in the presence of nifedipine again show a paradoxical increase (p < 0.05) in cAMP. 
The fmding for this group are consonant with the previous NAT [§ 3.7.3.3.2) and organ culture 
studies [§ 2.5.3.3.2) for the same group. 
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4.4.4 
* 
ISO ISO+NIF NA NA+NIF 
Cyclic-AMP formed per rat pineal gland in the presence of vehicle or 
nifedipine, when stimulated with either isoprenaline (/SO) {20pM] or 
noradrenaline (NA) {JOpM] (mean ± SEM; n = 4 glands per group 
p < :**0.05 w.r.t NA -vehicle control-: Student's paired t test) 
Conclusion 
In summary then. the results from the cAMP studies on the CCB show the following: 
The control groups did not differ signiticantly over the three test days. 
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The presence of nifedipine and verapamil did not alter the ISO induced increase in cAMP . This is 
to be expected since Ca2+ influx in the pineal has been associated with ai-receptor stimulation. 
Diltiazem, however, inhibited the effect of ISO on cAMP, showing a statistically significant 
(p < 0.025) decrease in cAMP levels. 
So once again diltiazem differs from the other two CCBs [§ 2.5.4], [§ 3.7.3.2]. Why this 
happens is speculative, and difficult to define. For instance, although the CCBs as a group share 
. several common properties such as antagonising Ca2+ entry, there exists certain distinct 
fundamental in vitro differences amongst these drugs. It could be due to differences in receptor 
occupation. Alternately, data probably not relating to channel function suggest that all these 
agents bind to a greater or lesser degree to CaM, and yet another of the studied discrepancies is 
that because of allosteric interaction, verapamil-like agents inhibit nitrendipine binding in several 
tissues whereas diltiazem facilitates its binding at these sites (Johnson, 1984). Whatever the 
reason, the difference persists. 
In those pineal glands stimulated with NA, all three CCBs were found to potentiate the effect of 
NA on cAMP formation: verapamil (p < 0.025), diltiazem (p < 0.025) and nifedipine (p < 0.05). 
In Chapter 3 [§ 3.7.4] it was suggested that that the CCBs might in some way influence cAMP 
levels and interfere with the metabolic cascade simplistically represented as: 
t cAMP= t NAT = t alIT = t aMT 
Intracellular levels of cAMP reflect a balance between adenylyl cyclase and cAMP 
phosphodiesterase activities. 
Shenolikar, (1988) suggests that when cell regulation is initially being studied, the main focus of 
attention is usually directed at the level of adenylyl cyclase, because this initiates a cascade of 
events facilitated by the intracellular second messengers and mediated in many cases by protein 
kinases. 
It could be that adenylyl cyclase is being influenced by the use of NA in this test system, because 
the paradoxical increase in stimulation always occurs following NA stimulation of pineal glands 
incubated in the presence of CCB. 
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There are two basic types of a-adrenergic receptor. The first type (al) is located postsynaptically. 
Activation of these is associated with changes in cell Ca2+ fluxes, which are believed to be 
responsible for the physiological responses to aI-receptor stimulation, and are the focus of this 
work. 
The second type (a2) is located both pre- and postsynaptically. Activation of presynaptic a2 
receptors results in an inhibition of NA release from the adrenergic nerve endings. while 
activation of the postsynaptic a2 receptors results in a decrease in cAMP via an inhibition of 
adenylyl cyclase (Exton. 1981). 
NA is relatively non selective between al and a2 receptors - its selectivity on a particular tissue is 
determined by the relative densities of al and a2 receptors available (Exton, 1981). As such, it 
has been shown to inhibit cAMP levels in chick pineal glands which have postsynaptic a2-
receptors (Nayler et aI., 1982). The CCB have been found to bind to the al and a2 receptors 
present on rat pineal, cardiac and brain tissue (Glossmann and Hornung, 1980). If they bound to 
the al receptors in the rat pineal gland one would expect an inhibition of NA stimulation. Were 
they to bind to the inhibitory a2 receptor, an increase in cAMP levels could be expected, as NA 
would not be able to exert its inhibitory influence via these a2 receptors. Two lines of evidence 
argue against the operation of either of these mechanisms in the rat pineal gland. Firstly, an 
abundance of al receptors is present (Ho et aI., 1988), yet the CCBs do not appear to have bound 
to these. Verapamil, the most potent al blocker should have demonstrated this (Glossmann and 
Hornung, 1980), yet instead the potentiation is seen (Brown et aI., 1989a, 1989b). Secondly, the 
lack of effect of yohimbine on NA stimulation of cAMP (Ho et aI.. 1988), suggests that a2 
receptors do not playa significant role in NA stimulation in the rat pineal gland, via their reported 
inhibitory role on adenylyl cyclase (Exton, 1981), as the concentration at which the CCBs act on 
a2 receptors is higher than that at which they would influence al receptors (Glossmann and 
Hornung, 1980). 
As the adenylyl cyclase does not seem to hold the answer, it would seem justifiable to examine the 
role of cAMP-PDE, the counterpoise, in the control of cAMP levels. 
The heterogeneous group of compounds classified as Ca2+-entry-blockers, Ca2 + channel blockers 
or even calcium channel antagonists which share the common pharmacological property of 
inhibiting ea2+ entry, has been reported to inhibit several calcium-dependant processes, including 
the activation of cAMP-PDE (Epstein et ai., 1982; Lamers et aI., 1985; Johnson and Mills. 
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1986). 
Thus while the compounds as a group share several common properties such as antagonising Ca2 + 
entry, there exists certain distinct fundamental in vitro differences amongst these drugs, e.g. data 
probably not relating to channel function suggest that all these agents bind to a greater or lesser 
degree to CAM. The studies of Johnson and Mills, (1983) provided the first evidence that CaM 
was indeed an allosteric protein with regard to its drug protein binding sites. With regard to 
allosteric interaction, one of the best studied discrepancies is that verapamil-like agents inhibit the 
nifedipine analogue nitrendipine in several tissues whereas diltiazem facilitates its binding at these 
sites (Johnson, 1984). 
Other non-channel in vitro differences are reported. Verapamil and diltizem but not nifedipine 
have the ability to interfere with CaM activation of the Ca2 + -pump and ATPase. The failure of 
nifedipine to do this is in agreement with the studies of Lamers et aZ., (1985) who found the same 
discrepancy when working with soluble dog brain CaM-activated-PDE. 
The differences observed with diltiazem, relative to results using verapamil and nifedipine in the 
present study, could possibly point to a difference in the respective ability of the CCBs to inhibit 
Ca2+ entry. This however is purely speculative, and should be regarded with care in view of the 
large intra-species variations seen in pineal work. For instance Meyer et aZ., (1986) have shown 
that two classes of CCB administered in vivo to baboons, produced different effects on circulating 
plasma aMT levels. Nifedipine reduced aMT levels in the plasma, while verapamil did not. On 
the other hand, Morton et aZ., (1989) shows data where verapamil prevents a decrease in aMT (in 
rats forced to swim), while nifedipine is less effective. 
5 
5.1 
CHAPTER 5 
cAMP-PHOSPHODIESTERASE STUDIES 
INTRODUCTION 
Regulatory role of cAMP-PDE 
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Since cyclic nucleotides play important regulatory roles in many biological functions (Robison 
et al., 1968), it is reasonable to assume that their intracellular concentrations are delicately 
controlled (Teo et al., 1973). 
In any informational system, the quenching of the signal and its generation must be considered 
equal. The hydrolytic cleavage of the cyclic nucleotides to their corresponding 5'-nucleotides is 
catalysed by one or more types of phosphodiesterase, and is the only well-established mechanism 
through which the biological actions of these nucleotides is terminated. 
5.1.2 Nomenclature / Classification 
In eucaryotic systems at least three types of PDE activities have been demonstrated: 
i) a Ca2+ -activator (calmodulin) dependent form hydrolysing both cAMP and cGMP 
ii) a cAMP specific or 'low-Km' cAMP-PDE, (Reviewed in Hardman and Wells, 1975), and 
iii) a form in which cGMP levels activate the hydrolysis of cAMP (Terasaki and Appleman, 
1975; Gain and Appleman, 1978). 
The characterisation of the regulatory properties of cAMP-PDE is fundamental to the delineation 
of how cAMP effects are controlled. 
The PDE's were characterized by Strada and Thompson (1984) according to their substrate 
preference and regulatory properties as follows: 
Type I: Calmodulin-sensitive cyclic nucleotide PDE. This enzyme hydrolyses both cAMP and 
cGMP, and its activity is enhanced by Ca2+ and calmodulin. 
Type II: cGMP-sensitive cyclic nucleotide PDE. This enzyme also hydrolyses both cAMP and 
cGMP, but its cAMP hydrolytic activity is enhanced by cGMP. 
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Type III: Rhodopsin-sensitive cGMP-POE. 
Type IV: Cyclic AMP-POE. This enzyme is relatively specific for cAMP and has been referred 
to as the "low-Km" or high-affinity cAMP-POE. 
Literature however does not seem to adhere to the above but follows the more commonly used 
format whereby the POE's are named in the order of their elution from a chromatographic 
column. Thus Types I, II and IV are more commonly designated PDE I, PDE II and PDE III 
. respectively. 
5.1.3 History 
The history of phosphodiesterase is interesting. Sutherland and RaIl (1958) were the first to 
demonstrate the presence of POE. In 1967, Butcher and Sutherland were able to partially purify 
the enzyme from bovine heart. The next important event was when Kakiuchi and Yamazaki 
(1970), were able to show that rat brain POE could be inhibited by EGT A. 
After passing the enzyme through an anion exchange column in order to purify it and enable better 
characterisation, Cheung (1970) noted a precipitous drop in activity, relative to his starting 
product. This he found was due to dissociation of an activator protein from the enzyme. In 
independent studies Kakiuchi et al., (1970) also demonstrated the presence of an activator. 
Teo and Wang, (1973) were able to show that the activation of POE was dependent on the 
presence of both the activator and Ca2+. This activator protein has since been named calmodulin 
(Cheung, 1980). 
Calmodulin (CaM) has been fully discussed [§ 1.10.2]. As shown above, its role was first 
demonstrated in investigations with PDE. Since then, this Ca2+ -dependent protein regulator has 
been shown to play a role in the function of ca 30 physiological processes. As such, it has been 
termed "a universal receptor of the Ca2+ signal" in cells (Klee et aI., 1980). Whenever the free 
Ca2+ concentration in a cell changes, the concentration of the different Ca2+ -CaM complexes 
varies, thus modulating the target enzymes that determine the cell's response. As part of its 
activation mechanism, hydrophobic domains on CaM are exposed during the conformational 
change occuring when Ca2+ first binds to it. It is these exposed domains which are recognised by 
the target enzymes and for which the CaM antagonists compete, preventing the interaction of CaM 
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with its target protein. 
A growing volume of evidence indicates that many diverse classes of drugs can in fact modify the 
activity of CaM. Inasmuch as CaM can influence a wide variety of cellular events, modification 
of its activity by drugs might well have profound pharmacological implications. One of the 
several forms of POE is activated by CaM and this activation can be inhibited by the 
phenothiazine group of antipsychotic drugs (Weiss et aZ., 1974). More recently other drugs 
including the CCBs have been found to inhibit CaM activation of POE. 
5.1.4 Objectives 
The purpose of this study was therefore to develop a suitable cAMP-POE assay, and to use this to 
ascertain if the raised cAMP levels in the previous chapter could be correlated to any inhibition of 
cAMP-POE levels. 
5.1.5 Methods for the detennination of cAMP-PDE 
Several methods of measuring POE activity are presently available. Because separation of the 
cyclic nucleotide from its corresponding nucleoside is generally easier than from the 
monophosphate, most assays incorporate the principle introduced by Butcher and Sutherland 
(1962). This is a two-step process in which cAMP is first hydrolysed by the cAMP-POE present, 
then a 5' -nucleotidase from snake venom is used to convert the adenosine 5' -monophosphate, to 
adenosine. The inorganic phosphate formed is then measured chemically. 
The method, although simple, is relatively insensitive (Lynch and Cheung, 1975), and so the 
more widely-used and sensitive methods employ isotopically labelled cyclic nucleotides. The 
separation of radioactive substrate from the hydrolysed radioactive product is generally achieved 
by means of batch- or column anion-exchange resins (Thompson and Appleman, 1971; Lynch and 
Cheung, 1975; Gulyassy and Farrad, 1976), paper chromatography (Nakai and Brooker, 1975 ), 
or precipitation (LeOonne and Coffee, 1979). 
The batch method of Thompson and Appleman (1971) is popular because of its simplicity and 
economy of time. The method makes use of anionic exbange resin which presumably binds the 
unreacted cAMP (which carries a negative charge) but not the adenosine (which has no nett 
charge). However Lynch and Cheung (1975) have shown that this method may underestimate the 
true cAMP-POE activity, as the resin may sometimes not bind all the unreacted substrate. They 
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feel that column methods under certain circumstances may produce the same error. 
The method of LeDonne and Coffee, (1979) which employs a precipitation (PPT) technique, has 
been used in this laboratory, but as the filter apparatus was being fully utilized in a binding study, 
it was decided to use the thin-layer chromatography (TLC) method of Neuman (1983) because 
both the plates and solvents were readily available. This method and a validation thereof is 
described below [§ 5.2] 
5.1.6 Swnmary of the assay 
In this method cAMP and tritiated cAMP (tracer) are used as substrate. Pineal tissue homogenate 
is then added. The phosphodiesterase present in the homogenate hydrolyses the cAMP substrate. 
The reaction is then terminated by the addition of trichloroacetic acid. An aliquot of the reaction 
mixture is spotted onto a TLC plate and the 5' -AMP formed from the hydrolysis of cAMP is 
separated by TLC. The [3H]-5' -AMP is then quantitated, to be used as an indicator of PDE 
activity. 
5.2 
5.2.1 
5.2.1.1 
CYCLIC-AMP POE DETERMINATION TECHNIQUE 
Materials and Methods 
Chemicals, drugs and reagents 
[8-3H]Adenosine 3',5' -cyclic phosphate, ammonium salt (1.0 mCi/ml : specific activity 26.1 
Ci/mmol) was purchased from Amersham, England. Phosphodiesterase (EC 3.1. 4.17, specific 
activity ca 0.31 U/mg), Adenosine 3',5' -cyclic phosphate and Adenosine 5' -monophosphate 
were obtained from Boehringer Mannheim, West Germany. TLC plates (Alugram® Sil G/UV254 
0.025 x 20 x 20 cm) were from Macherey-Nagel, West Germany. The solvents used for TLC, 
and chemicals used in buffers were of analytical grade from commercial sources. 
5.2.1.2 Animals 
Male Albino Wistar rats (200-240 g b. wt) were housed four per cage in a temperature controlled 
room under a fixed lighting cycle of LD 12: 12 (lights on 06hOO) with food and water ad libitum. 
The rats were sacrificed by neck fracture between 09hOO and 09h30 (to maintain uniformity with 
the previous studies [§ 4.2.1.2]) 
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Male rats were chosen for all the cAMP-PDE studies for the same reasons outlined in the cAMP 
studies [§ 4.2.1.2]. 
5.2.1.3 Pineal glands 
Pineal glands for cAMP-PDE determinations were swiftly removed as before [§ 2.2.1.4] and 
placed in culture vessels containing 200 1'1 BGJb culture medium. Four pineal glands were 
transferred to each vessel. 
·5.2.1.4 
5.2.1.4.1 
Assay of cAMP-POE in rat pineal glands 
Introduction 
Oleshansky and Neff, (1975) reported that the amount of PDE activity in the pineal gland changes 
as a function of adrenergic stimulation. Treatment of animals with ISO results in a 50% increase 
in the activity of the low-Km PDE enzyme. 
Since increased cAMP levels are known to induce cAMP-PDE, and stimulation of the former is 
relatively easy in the pineal gland, it was decided to use this as a test of the integrity of Neuman's 
cAMP-PDE assay, modified to suit pineal work. 
5.2.1.4.2 CAMP-PDE assay 
Four pineal glands were exposed to vehicle (control glands) while the remaining four glands were 
stimulated with the adrenergic agonist ISO. The culture medium in the one culture vessel thus 
contained ISO[10JLM] while the other culture vessel contained the control pineal glands in the 
presence of vehicle alone. 
After a 3 h incubation period at 37°C, the pineals were removed from the vessels and each pineal 
gland was transferred to its own homogenisation tube, for the determination of cAMP-PDE 
activity as described below. 
The pineal glands were individually homogenised in 1001'1 of buffer (40JLM Tris-HCl, pH 8, 5JLM 
MgC12). A 101'1 aliquot of pineal homogenate was removed and transferred to a reaction tube. It 
was incubated at 37°C with IJLM cAMP, 3 x 105 cpm [3H]-cAMP and buffer (final volume 50 JLl). 
The reaction was stopped after 30 min by the addition of 301'1 of 10% trichloroacetic acid (TCA), 
and the [3H]-5' -AMP formed was separated from the [3H]-cAMP remaining, on thin layer 
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chromatography (TLC) plates, using a solvent system containing isopropyl alcohol, 25 % water of 
NH40H and water (7:1:2). 
5.2.1.4.3 Thin-layer chromatography 
Duplicate 101L1 aliquots of each sample were spotted 15 mm from the bottom of the plates, and in 
the center of 15 mm wide channels inscribed on the silica gel TLC plates. The mobility of cAMP 
and 5' -AMP was monitored routinely by spotting 101L1 aliquots of standard solutions containing 
0.2mg/ml authentic cAMP or 5' -AMP, dissolved in distilled water, in adjacent channels at one 
. end of the plate. Following development of the plates (± 2 h), the plates were dried under a 
stream of nitrogen, then placed in an oven at 60°C (10 min) to remove any remaining moisture. 
5.2.1.5 Quantitation 
Visualization of these markers was accomplished under short wave ultraviolet light. The 
radioactivity in the identified spots was determined by scraping off the spot into a scintillation 
vial containing 400ILI O.OIM KOH (Beckman Information Brochure). 
After the KOH had solubilized the scraping, 3ml of scintillation cocktail (Beckman Ready-Solv 
HPIb®) was added to the vials. They were then shaken on a Griffith Flask Shaker® for 20 min. 
Thereafter the vials were placed in a Beckman LS 2800 scintillation counter and each vial was 
counted for a total of 5 min. 
5.2.1.6 Data analysis and statistics 
The counts per minute (cpm) were converted to disintegrations per minute (dpm) using the H-
Number method of quench monitoring as discussed previously [§ 2.2.1.6]. The mean of the 
duplicate determinations was used as the dpm result for each sample. 
Blanks were run in exactly the same way except that TeA was added to the tubes before tissue or 
PDE was included. Thompson et ai., (1974) described several factors which could influence 
blank values. They suggest that the method of terminating the reaction by boiling for 2 min could 
possibly increase blanks in tritium-based assays, apparently due to formation of tritiated water. 
Wells and Hardman (1977) suggest that the construction of appropriate blanks is best achieved by 
the addition of the "stopping mixture" prior to the addition of tissue or PDE. They report that 
this should equal blank values obtained if boiled PDE were added at the beginning of the 
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incubation. 
Blank values, which were very low, were first subtracted from the results before these were 
finally expressed as nmol cAMP hydrolysed/ 30 mini pineal gland. 
5.2.1.6.1 Statistical analysis 
Cyclic-AMP POE levels (the mean of duplicate determinations) for the assay are expressed as 
nmol cAMP hydrolysed/ 30 min /pineal gland. The significance of the difference between those 
. glands stimulated with ISO and the control glands was evaluated using the nonparametric Mann-
Whitney U test because of the small group sizes. 
5.2.1. 7 Results and Discussion 
The relative R.!values for the cAMP and 5'-AMP were 0.16 and 0.61 respectively. These R.! 
values are comparable with those reported in the literature for a similar method (Goldberg et al., 
1969). 
The results (nmol ± SEM) show a significant difference (p < 0.001) in cAMP-POE levels 
between glands stimulated with ISO (1.29 ± 0.12) and the control glands (0.56 ± 0.03). This 
confirms reports that POE levels are raised following ISO stimulation, and also shows that the 
assay is able to quantitatively assess this difference. 
Although the results show a difference in POE activity following ISO stimulation, it was stilI 
deemed necessary to ensure that i) the radioactivity being applied to the TLC plates was in fact 
being recovered, and ii) that the assay results were comparable with a different technique. This 
would safeguard against false values through possible underestimation of cAMP-POE activity, if 
for instance radioactivity were to be adsorbed onto the silica gel. 
5.2.1.8 Validation of results 
Two methods were used to validate the assay: i) the recovery of chromatographed rH]-cAMP was 
assessed, and ii) this assay was compared with that of LeOonne and Coffee (1979), by using a 
standard solution of POE. 
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5.2.1.8.1 Recovery of chromatographed [3H]-cAMP 
In order to assess the recovery of cAMP from silica gel TLC plates in the assay system, sample 
tubes were made up containing the equivalent amounts of reaction mixture that they would have 
contained under assay conditions. The TCA was added first to inactivate any PDE in the pineal 
tissue homogenate used. 
Aliquots (101-'1) were then removed from these sample tubes and applied to TLC plates, either 
before or after development, or directly to scintillation vials. The quantitation and counting 
. procedures were then followed as described above [§ 5.2.1.61. The results of this study are 
presented in Table 5.1. 
TABLE 5.1: Recovery of f3 H)-cAMP from silica gel 1LC plates. Blanks were made 
up and aliquots from these were spotted either before or after 
development of 1LC plates, or directly to scintillation vials. The 
selected regions as described were quantitated by the method of 
Neuman (1983). 
Procedure and/or region quantitated 
Spotted, developed, quantitated: 
Starting spot after development 
5'--AMP region after development 
cAMP region after development 
Developed, spotted, quantitated (starting spot) 
Added direct to scintillation vial 
cpm 
8 
21 
9 
44 
52 
48 
%recovery 
56105 86.6 
60890 
58395 
90.8 
92.0 
60761 93.8 
57939 
58783 
64no 
67052 
63445 
86.4 
92.7 
The efficiency of the recovery of chromatographed [3H]-cAMP from the silica plates is shown in 
Table 5.1 to range from 86.4% to 93.8%. These results are comparable with previously reported 
results in a similar system (Goldberg et ai., 1969). 
The radioactivity remaining at the origin or at the 5'-AMP region was negligible in the TCA 
-144-
blanks, with the major radioactivity being recovered at the [3H]-cAMP region. 
5.2.1.8.2 Comparison of a standard phosphodiesterase by two methods 
Once the recovery had been tested, it remained to verify that the assay results would be an 
accurate reflection of cAMP-POE activity. To test this a standard solution was made up 
containing 1mg/ ml POE. Aliquots (51£1 and 101£1) of this solution were then added to assay tubes 
in place of homogenate, and assayed either by the TLC method of Neuman, (1983) or by the 
precipitation (PPT) method of LeDonne and Coffee (1979). The latter technique was chosen as a 
. method of comparison, because it too determines the amount of 5'- AMP formed, and does not 
proceed on to the nucleotidase step. The results are presented in Table 5.2. 
TABLE 5.2: 
Aliquot 
Comparison of a Standard phosphodiesterase solution as 
detennined by a TLC procedure and a PPT procedure 
(Values are cpm recovered as hydrolysed cAMP) 
Assay method 
TLC PPT 
3455 (100) 43287 (96) 51£1 
3501 (100) 45519 (100) 
3605 (100) 46144 (98) 
7348 (100) 102063 (106) 101£1 
8152 (100) 108421 (102) 
7809 (100) 100736 (99) 
The activity of a standard solution of cAMP-PDE was assayed by the TLC procedure 
described or by a precipitaion (PPT) procedure. The numbers in parentheses are 
the percentage of the corresponding cpm by the TLC procedure, which is taken as 
100. 
5.2.1.8.3 Discussion 
Although the results may look vastly different at first glance, this is because the TLC method 
quantitates only a 101£1 aliquot of reaction mixture, while the second method utilizes the entire 
volume of reaction mixture. The relative amounts of cAMP hydrolysed do in fact correlate. 
The results obtained with the TLC assay compare favourably with those of the PPT assay and 
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therefore this technique is shown to be valid. 
Using this technique, it would be possible to determine the levels of cAMP-POE in the pineal 
gland in the presence of the CCB, under the same test conditions employed in the previous 
studies. 
5.3 
5.3.1 
Experiment 1: THE EFFECT OF THREE ORGANIC CALCIUM 
CHANNEL BLOCKERS ON CYCLIC-AMP PDE LEVELS IN RAT 
PINEAL GLANDS 
Introduction 
The findings in Chapter 4 [§ 4.4.4] show that cAMP levels are indeed raised in those groups of 
glands where the paradoxical increase in NAT activity was noted [§ 3.7.4]. 
It is often inferred that the relative rates of formation and degradation of the cyclic nucleotides 
determine the steady-state levels of these compounds. For this reason, the concept delineated by 
Robison et al. (1971), that inhibition of cAMP-POE activity should potentiate the effect of a 
hormone acting via cAMP, has often been used in attempts to demonstrate cAMP involvement in 
a hormone response (Wells and Kramer, 1981). A corollary of this is that the demonstration of 
cAMP potentiation in the presence of the hormone is due to cAMP-POE inhibition. 
In these studies the potentiation of cAMP following stimulation with NA in the presence of the 
CCB is very clear. It therefore seems valid to assay the level of cAMP-POE in the pineal glands 
under the same conditions in which the raised levels of cAMP are found. 
5.3.1.1 CAMP-PDE in the pineal gland 
The POE forms have been reviewed by Wells and Hardman (1977). They pointed out the 
difficulty of summarising the results, both because of the extreme diversity of methods in use and 
the heterogenicity of tissues. 
Kinetically, the POE forms of many tissues have been shown to have two activities with 
characteristic low- and high-Km values for cAMP. The pineal is no exception. Oleshansky and 
Neff (1975) found the Michaelis constants (Km) of the two pineal forms to be ca 2JLM and 37JLM 
for the low- and high- forms respectively. They also reported that the level of low-Km POE 
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increased significantly following ISO stimulation while that of the higher form showed only a 
small increase. Vacas et al., (1984) were able to show that the low-Km also increased following 
combined (Xl and {3 stimulation. Epplen et al., (1982) have reported similar Km values in the 
pineal. 
Minneman and Iversen (1976) have demonstrated a diurnal rythym (which parallels that of NAT) 
in both pineal cAMP-PDE and cGMP-PDE activities, with peak levels raised by some 160% three 
hours into the dark period (w.r.t. the equivalent time in the light photoperiod) . 
. More recently Chons et al., (1988) making use of a histochemical technique, have demonstrated 
the presence of cAMP-PDE along the plasma membrane of pinealocytes. The same location was 
evident when cGMP was used as substrate. This is an important finding because it suggests that 
the same PDE isozyme may be hydrolysing both forms of cyclic nucleotide in the pineal. The 
low-Km form, by definition, should only hydrolyse cAMP. On the other hand PDE I, a 
calmodulin-activated form of PDE, exhibits no such substrate preference; instead it hydrolyses 
both cyclic nucleotides. 
In the light of the findings of Chons et aI., (1988), the possibility that the CCB might be 
influencing the activation of PDE present in the pineal becomes more feasible. Pineal cAMP-
PDE levels were therefore assayed using the same drug paradigm as in the cAMP studies, to 
ascertain if there was a relationship between the increased cAMP levels found in the previous 
chapter [§ 4.4.4] and the levels of cAMP-PDE. 
5.3.2 
5.3.2.1 
Materials and methods 
Materials 
Verapamil-HCI, diltiazem, nifedipine, l-isoprenaline-HCI and I-noradrenaline bitartrate were 
purchased from the Sigma Chemical Co., USA. Sources of all other materials have been recorded 
in [§ 5.2.1.1]. 
5.3.2.2 Animals 
Male Albino Wi star rats (230-260 g b. wt) were used in this study. Their living environment has 
been described [§ 2.2.1.2.]. 
5.3.2.3 
5.3.2.3.1 
METHODS 
Experiment A 
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The rats were killed by neck fracture between 09hOO and 09h30. This was at the same time as in 
the other studies, thus maintaining uniformity with those studies, and also avoiding any variation 
in basal cAMP-POE levels which might be evident in view of the reported diurnal variation 
(Minneman and Iversen, 1976). 
Their pineal glands were swiftly removed as before [§ 2.2.1.4] and placed in culture vessels 
. containing 200 J.tl BGJb culture medium. Four pineal glands were transferred to each of four 
vessels. 
The pineal glands were exposed to verapamil 20 min prior to the addition of the adrenergic 
agonists, NA and ISO. The culture medium for each group thus contained either ISO or NA 
(lOI'M), in the presence of either vehicle, or verapamil (lO~). 
After a 3 h incubation period at 37°C, the pineals were removed from the vessels and each 
transferred to its own homogenisation tube containing 1001'1 "cAMP-POE buffer". The cAMP-
POE activity was then assayed as described above [§ 5.2.1.4]. 
5.3.2.3.2 Experiment B 
The procedure in Experiment A [§ 5.3.2.3.1] was repeated, but verapamil was replaced by 
diltiazem at the same molar concentration. 
Oiltiazem was also dissolved in distilled water, with control incubations receiving the equivalent 
amount of vehicle. 
5.3.2.3.3 Experiment C 
The procedure in Experiment A [§ 5.3.2.3.1] was repeated, but verapamil was replaced by 
nifedipine at the same molar concentration. 
Nifedipine was dissolved as described previously [§ 4.3.2.3.3] 
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5.3.2.4 Data analysis and statistics 
Cyclic-AMP PDE levels were assessed as described [§ 5.2.1.4J and are expressed as DIDol cAMP 
hydrolysed/ 30 mini pineal gland ± SEM. For each group, the significance of the difference in 
cAMP-PDE levels between glands stimulated with agonist in the presence of CCB and the control 
glands was evaluated using the nonparametric Mann-Whitney U test (because of the small group 
sizes). 
Nifedipine was partly dissolved in ethanol and the other CCBs were dissolved in distilled water as 
. described previously [§ 4.4.2.3.31. This, coupled to the fact that experiments with each CCB 
were performed on different days, necessitated the use of separate control groups. A Kruskal 
Wallis H test (nonparametric version of the ANOVA) was performed to ensure that the control 
groups were not significantly different. 
5.3.3 
5.3.3.1.1 
Results and Discussion 
Results of glands stimulated in the presence of verapamil 
The results of those experiments in which glands are stimulated with ISO and NA in the presence 
of verapamil are presented in Table 5.3 and Figure 5.1. 
5.3.3.1.2 Discussion 
The results are in agreement with the findings of the NAT [§ 3.7.3.1.21 and cAMP studies 
[§ 4.3.3.1.2]. 
There is no significant difference between cAMP-PDE levels in glands stimulated with ISO 
(control), and those stimulated with ISO in the presence of verapamil. While the organ culture 
studies showed an increase in aHT in the parallel experiment, the NAT and cAMP studies have 
shown no difference, and therefore one is not expected here either. 
Glands stimulated with NA in the presence of verapamil show a significant decrease (p < 0.025) in 
cAMP-PDE levels. This decrease could account for the increased levels of NAT and cAMP found 
previousl y . 
TABLE 5.3: 
Treatment 
ISO + vehicle 
ISO + CCB 
NA + vehicle 
NA + CCB 
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Cyclic-AMP-phosphodiesterase activity per rat pineal gland in the 
presence of vehicle or CCB, when stimulated with either isoprenaline 
(ISO) [lOpM] or noradrenaline (NA) [JOpM) (mean ± SEM; n = 4 
glands per group) 
cAMP hydrolysed (nmoll 30 mini pineal gland) 
Verapamil Diltiazem Nifedipine 
1.12 ± 0.20 1.22 ± 0.10 1.42 ± 0.15 
1,24 ± 0.28 1.81 ± 0.10* 1.59 ± 0.30 
2.68 ± 0.28 2.69 ± 0.16 2.77 ± 0.13 
1.59 ± 0.15** 1.92 ± 0.06 1.99 ± 0.25 
In comparison with respective vehicle control,p < :*0.05; **0.025 (Mann-Whitney U test). 
5.3.3.2.1 Results of glands stimulated in the presence of diltiazem 
The results of experiments in which glands are stimulated with ISO and NA in the presence of 
diltiazem are presented in Table 5.3 and Figure 5.2. 
5.3.3.2.2 Discussion 
A decrease, which although not significant, may well be real, is observed in glands stimulated 
with NA in the presence of diltiazem. In contrast, glands stimulated with ISO in the presence of 
diltiazem show a significant increase (p < 0.05) in cAMP-POE levels consistent with the decreased 
cAMP level found in the previous chapter. This supports the findings of a decrease in aMT 
observed in this group in the organ culture studies [§2.5.2.2.21. as well as the decrease found in 
the NAT study [§ 3.7.3.2.21. 
5.3.3.3.1 Results of glands stimulated in the presence of nifedipine 
The results of experiments in which glands are stimulated with ISO and NA in the presence of 
nifedipine are presented in Table 5.3 and Figure 5.3. 
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ISO+VER NA NA+VER 
Cyclic-AMP-phosphodiesterase activity per rat pineal gland in the 
presence of vehicle or verapamil, when stimulated with either 
isoprenaline (ISO) [JOpM] or noradrenaline (NA) [JOpM] (mean ± 
SEM; n = 4 glands per group; p < :**0.025 Mann-Whitney U test) 
ISO ISO+OIL NA NA+OIL 
Cyclic-AMP-phosphodiesterase actlVlty per rat pineal gland in the 
presence of vehicle or diltiazem, when stimulated with either 
isoprenaline (ISO) [JOpM] or noradrenaline (NA) [JOpM] (mean ± 
SEM; n = 4 glands per group; p < :*0.05 Mann-Whitney U test) 
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5.3.3.3.2 Discussion 
Again the findings for this group parallel those of the verapamil group [§ 5.3.3.1.1]. Glands 
stimulated with ISO are not significantly different from those stimulated with ISO in the presence 
of nifedipine, while glands stimulated with NA in the presence of nifedipine also show a decrease 
in cAMP-PDE. Athough this decrease does not reach significance (p < 0.10), the finding for this 
group are consonant with the previous NAT [§ 3.7.3.3.2] and organ culture studies [§ 2.5.3.3] 
for the same group. The trend toward a decrease in cAMP-PDE levels would support the raised 
cAMP levels observed in the previous chapter [§ 4.4.3.3.2]. 
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Figure 5.3: Cyclic-AMP-phosphodiesterase actlVlty per rat pineal gland in the 
presence of vehicle or nifedipine, when stimulated with either 
isoprenaline (ISO) [JOpM] or noradrenaline (NA) [lOpM] 
(mean ± SEM; n = 4 glands per group;) 
5.3.4 Conclusion 
In summary then, the results from the cAMP and cAMP-PDE studies on the CCB show the 
following: 
The cAMP-PDE levels of the control groups do not differ significantly over the three test days. 
The presence of nifedipine and verapamil did not alter the ISO induced increase in cAMP or 
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cAMP-POE. Oiltiazem, however, inhibited the effect of ISO on cAMP, showing a statistically 
significant (p <0.025) decrease in cAMP levels, and produced a corresponding increase 
(p < 0.05) in cAMP-POE. 
Oiltiazem again shows a difference when compared with the other two CCBs [§ 2.5.4], 
[§ 3.7.3.2] and [§ 4.4.3.2.2]. 
Pineal glands stimulated with NA in the presence of the CCB showed that all three CCBs 
potentiated the effect ofNA on cAMP formation; verapamil (p < 0.025), diltiazem (p<0.025) and 
. nifedipine (p <0.05). The findings of this study support the above. They show a significant 
decrease (p < 0.025) in the verapamil group, with the remaining two CCBs following a similar 
trend, but not reaching significance. 
Oespite the difficulty of interpretation, a consistent pattern does emerge from this study. It 
suggests that the CCBs could be influencing cAMP -via an inhibition of cAMP-POE- in the 
metabolic cascade represented as: 
.cAMP~ .NAT ~.aHT ~ .aMT 
ePDE~ 
5'-AMP 
5.3.4.1 Implications of this study 
The implications of this study gain importance when viewed in the light of the existing 
literature: 
The phosphodiesterase forms have been reviewed by Wells and Hardman (1977). One of the 
major forms (PDE l) found in many tissues (i.e. brain, heart, smooth muscles) can be activated by 
CaM. This form has a greater maximal velocity (Vmax) and a higher Michaelis constant (Km) for 
cyclic cAMP than for cGMP. Hence it is often described as the "high-Km" POE. The effect of 
CaM is to increase its Vmax on cAMP, and to a lesser extent on cGMP (Stoclet, 1981). The role 
of this enzyme, which is soluble, is not clear at present. 
According to a theoretical analysis based on the assumption that adenylyl cyclase and low-Km 
POE would be bound to the plasma membrane whereas high-Km POE would be cytosolic, the 
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high-Km enzyme would be ineffective in regulating the cAMP concentration near the membrane, 
but would be effective in regulating the cyclic nucleotide level further inside the cell. A 
consequence of this would be the generation of a concentration gradient of cAMP from the plasma 
membrane to the interior of the cell (Fell, 1980). 
If this hypothesis is true, the effect of activation of the high-Km POE (cytoplasmic POE) by CaM 
might be to oppose an increase in cAMP concentration inside the cell, without preventing a local 
mcrease in cAMP concentration at the membrane (where adenylyl cyclase is stimulated and 
calcium simultaneously released under the influence of NA and other hormones and 
. neuromediators). 
Association between adenylyl cyclase stimulation and elevation in intracellular Ca2 + level has 
been described in the pineal [§ 1.11.1]. 
5.3.4.2. Role of Ca2+ and calmodulin 
Ca2+ is needed for the activation of CaM to its active conformer [§ 1.10.2]. Although the 
concentration of CaM in cells is generally high, so too are estimates of total CaM-binding 
proteins. However, because there may be nonuniform distribution within the cellular 
compartments, any inferences about local CaM concentrations are difficult to make (Nehmad 
et al., 1982; Saitoh and Schwartz, 1983). Most models therefore involve the implicit assumption, 
that free CaM is present in a limiting amount (Kranias et aI., 1980), and that the influx of Ca2+ 
or its intracellular concentration becomes the critical factor in the modulation and activation of 
these Ca2+ -dependent processes (Manalan and Klee, 1984). 
The activities of both adenylyl cyclase and POE may be viewed as being regulated by the cellular 
flux of Ca2+. According to this scheme, the influx of Ca2+ through the plasma membrane (or the 
release of membrane-bound Ca2+) in response to stimuli, activates adenylyl cyclase which results 
in an increase of intracellular cAMP. Ca2+ thus made available in the cytoplasmic space 
stimulates the soluble cytoplasmic POE, which then returns the elevated intracellular levels of 
cAMP to its prestimulated level. The sequential stimulation of adenylyl cyclase and POE could 
thus allow momentary elevation of cellular cAMP in response to NA or a hormone (Cheung et aI., 
1975). 
Of further interest is that the cytoplasmic POE also catalyses the hydrolysis of cGMP: in fact, at 
micromolar concentrations of substrates the rate of cGMP hydrolysis is greater than that of cAMP 
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(Kakiuchi et al., 1973; Lin et aI., 1974). The influx of Ca2+, therefore, could result in an 
increase of cAMP and a concommitant decrease of cGMP (Brostrom et al., 1975). This is of 
interest in the pineal gland, in the light of its reported see-saw signal processing [§ 1.6.3]. 
The membrane enzyme is thought to maintain cAMP levels under steady state conditions, whereas 
the cytoplasmic enzyme becomes critical when the cell is confronted with an upsurge of cAMP. If 
activation of this cytoplasmic enzyme were to be inhibited, it would leave the cell in a state of 
pertubation. 
'5.4.3.3 Possible role in pineal function 
Pineal PDE is characterized by having both a high- and a low-Km' The low-Km PDE, that is 
relatively specific for cAMP-PDE is generally considered (with little evidence to support the 
supposition) to be the relevant enzyme (Wells and Kramer, 1981). In support of this, these 
authors point to their earlier work (Wells et al., 1975a) showing that the enzyme is inhibited 
in vitro by relatively low concentrations of cGMP. 
A further bone of contention is the use of low substrate concentrations [lJLM] when measurements 
are attempted on the amount of low-Km PDE. This practise is based on the assumption that 
enzymes with a high-Km will not catalyse the hydrolysis of low concentrations of substrate. Wells 
and Hardman (1976) feel that this assumption is incorrect, and that changes in the kinetic 
parameters of either the high- or low-Km fractions will be detected in assays with low cAMP 
substrate, and could be interpreted incorrectly as changes in only the low-Km enzyme. The data 
of Wells et al., (1975b) lend support to this by showing that as is true of most tissue, where both 
PDE I and the low-Km are present together, they will contribute equally to the hydrolysis of 
[lJLM] cAMP. Simmons and Hartzell, (1988) presented data which adds further support to the 
above. 
5.4.3.4 Implications for low-Km PDE in the pineal 
The results of Oleshansky and Neff (1975), as well as the results of the present study are based 
on low cAMP substrate levels, because that would assay the low-Km PDE enzyme reportedly 
present in the pineal. 
In terms of the arguments presented above, the data collected could just as well represent data 
from an isozyme other than the low-Km one. Oleshansky and Neff (1975) after kinetic analysis do 
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in fact see a significant increase in the V max for their low-Km enzyme, and also a small but 
significant increase in its Km. 
This is a characteristic of calmodulin activation of PDE 1. 
Of further interest in this argument is the recent data of Chons et al., (1988). Using a 
histochemical technique they were able show the presence of cAMP-POE activity along the 
cytoplasmic membrane of pinealocytes. However the same localization was evident when cGMP 
was used, which suggests that the POE enzyme present in the pinealocyte may hydrolyze both 
nucleotides. 
The hydrolysis of both nucleotides by the same enzyme is also a characteristic of PDE l. Either 
way it disputes the assumption that the low-Km POE is the dominant enzyme in the pineal. 
It should be mentioned that other calmodulin-sensitive POE forms with equal affinity for both 
cAMP and cGMP, have been described in some tissues (Ilien et ai., 1978). 
The findings of the present study show a distinct trend of POE inhibition in the presence of the 
CCBs. The latter group of drugs are reported to inhibit the calmodulin-activated form of POE. 
Figure 3.9 showed a diagrammatic representation of the mechanism whereby the CCBs bind to, 
and inhibit the activation of cAMP-POE by CaM. As the CCBs are not specific inhibitors of 
calmodulin, but inhibit it because of their structural arrangement, it was decided to investigate this 
interesting concept further. by using CaM-inhibitors which were far more specific in their mode 
of action. 
6 
6.1 
CHAPTER 6 
CALCIUM-CALMODULIN SYSTEM STUDIES 
Introduction 
Calcium-calmodulin System Manipulations. 
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Calcium has long been known to be important for the maintenance or control of diverse cellular 
functions. This led Rasmussen to suggest that, like the cyclic nucleotides, ea2+ be afforded 
. "second messenger" status (Rasmussen, 1970). However its intracellular mechanisms of action 
have only recently become understood (Norman et ai., 1987). One such mechanism works 
through the class of Ca2+ binding proteins which can directly activate intracellular enzymes. 
Calmodulin (CaM) is the most abundant of these enzymes. In terms of second messenger function 
it has been suggested that CaM, acting as a receptor of Ca2+, serves an analogous role toward 
Ca2 +, as does protein kinase towards cAMP (Klee and Haiech, 1980). An extention of this 
would be the naming of the collaboratory system involving Ca2+ and CaM in the activation of 
many enzyme systems, the calcium-calmodulin system (CCS). 
Sutherland et ai., (1968) have proposed that the potentiation of a hormonally stimulated cellular 
response by inhibition of PDE should be one of the criteria for proving that a response is mediated 
by an intracellular increase in cAMP. Minneman, (1977) has shown that small alterations in 
cAMP PDE activity could have marked effects on pineal cellular cAMP levels. In the previous 
chapter not only has an increase in cAMP been observed, but PDE has also been shown to be 
inhibited in the presence of the CCBs. Interaction with CaM may explain some of the effects of 
Ca2 + -antagonists which cannot be related to Ca2 + -entry blockade only, since CaM mediates many 
intracellular effects of Ca2+. Norman et ai., (1983) have shown that some calcium entry blockers 
inhibit CaM-dependent PDE. This, coupled to the findings of the previous chapter, suggests the 
possibility of a CaM-sensitive PDE in the pineal gland. 
6.1.1 Calmodulin-stimulated PDE's. 
CaM-stimulated PDE's have been indentified in a wide variety of tissue from both vertebrate and 
invertebrate species (for reviews see Beavo et ai., 1982; Klee and Vanalan, 1982). Further 
evidence of the ubiquity of this enzyme is provided by Manalan and Klee, (1984). Because of the 
several forms of PDE present in most tissues, the physiological role of the CaM-stimulated 
enzyme is difficult to assess. In the rat, chronic ,a-adrenergic stimulation results in an initial 
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increase in cAMP but that then declines despite the continued presence of ,8-adrenergic agonist. 
The observed decrease can be inhibited by Ca2+ depletion (using EGTA) or by PDE inhibition 
(alkylated xanthines). An association between the decrease in cAMP content and the translocation 
of CaM to the membrane compartment has been suggested (Claybreger et al., 1981; Stoclet, 
1981). 
Similarly, CaM levels have been shown to rise intracellularly in the presence of agents that mimic, 
or conditions that increase stress, i.e. that cause an increase in cAMP levels (Wells and Hardman, 
1977 and references therein). 
Several mammalian tissues have been shown to contain high concentrations of CaM (Hidaka et al., 
1979 and references therein). The pineal gland is no exception, the presence of CaM having been 
demonstrated by Zhou et al., (1985). 
6.1.2 Objective 
As the CCBs are not PDE inhibitors by design, but appear to be doing so as a result of their 
spatial arrangement, at least in the view of present literature, it was decided to use more specific 
"tools" to elucidate these findings. It was hoped that the judicious use of such tools to 
manipulate the CCS, would allow the mimicking of the present results, thus adding support to 
those findings. 
6.1.3 Selectivity of action? 
Johnson and Wittenauer, (1983) made use of a dansylated CaM to characterise the interaction of 
hydrophobic ligands with CaM and CaM-antagonists. 
The current understanding of a mode of action favours a primary action of the CCB, particularly 
the dibydropyridines, on a VOC with additional secondary sites of action within the cell. The 
CaM and CaM -regulated enzymatic systems represent one such secondary site of action. 
Thus, in addition to being Ca2+ -antagonists as defined by Fleckenstein (1977), it should be 
recognised that they are also "CaM antagonists" and could alter many CaM-mediated effects. The 
binding of these hydrophobic ligands exhibits some specificity when binding the hydrophobic 
domains on CaM and competing with the binding of CaM -activated proteins. 
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However, the CCBs verapamil, diltiazem and nifedipine do not bind to CaM with enough affinity 
to be considered "powerful CaM antagonists", a term used by Asano et al., (1982). 
Trifluperazine (TFP) was deemed to be a specific CaM antagonist since it not only bound CaM 
with reasonable affinity (equilibrium constant Kd ca lILM), but it also has the classical structure of 
a CaM inhibitor as proposed by Weiss et ai., (1982). 
In general, the phenothiazine group of neuroleptics (and the CCBs) have the structural features 
previously identified as important for binding to CaM (Prozialek and Weiss, 1982): a hydrophobic 
ring system with a flexible side chain containing an amino group which should be positively 
. charged at physiological pH. 
6.1.3.1 The use of the phenothiazines as CaM inhibitors 
The first CaM inhibitors then, were the phenothiazines (Weiss et ai., 1982). Because TFP was 
thought to be the classical inhibitor many older experimental approaches used this drug as sole 
indicator of CaM activity. This approach was however fraught with problems. 
Admittedly the phenothiazines bound CaM only in the presence of Ca2+, and they did show 
"selectivity". However, the result of this assumption was that phenothiazine inhibition of a 
phenomenon was equated with that phenomenon being a CaM -dependent one. It is now clear that 
the phenothiazines are not that highly selective, as they interact not only with CaM, but also with 
al and DA receptors as well as PK-C. 
They have also been shown to have membrane stabilising effects, a result of which would be 
decreased Ca2+ flux through the membranes. This in itself would be sufficient to produce an 
effect independent of CaM (Landry et ai., 1981). Alternatively it might be argued that membrane 
stabilisation is due to CaM inhibition. Phospholipase A2, an enzyme responsible for hydrolysing 
membrane phospholipids and thus increasing membrane permeability (Hirata and Axelrod, 1980) 
is also CaM-dependent (Wong and Cheung, 1979). 
Blackmore et ai., (1981) have shown that TFP and chlorpromazine can bind to al receptors (in 
the rat liver) and that experimental results thus obtained are a result of al inhibition and not CaM 
inhibition. To circumvent this problem, one experimental approach would be the use of agents 
that can elicit the same response as al agonists active via Ca2+ -dependent manner but which do 
not interact directly with the a} receptor to produce the Ca2+ influx. An example of one such 
agent is A23lS7. Accordingly, one should not use phenothiazine agents alone, when investigating 
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the effects of Ca2 + fluxes and <:Yl -receptor stimulation. 
As the aim of this exercise was to enable manipulations of the CCS which would give a better 
representation of PDE activity in the pineal gland, and thus clarify the results obtained with the 
CCBs, it was important to get an agent which was not only more specific than the CCBs, but 
which would also have few infelicitous effects. 
6.2 
6.2.1 
Experiment 1: THE EFFECT OF CCS MANIPULATIONS ON [l4C]-
SEROTONIN METABOLISM BY ORGAN CULTURES OF RAT PINEAL 
GLANDS 
Introduction 
To enable specific manipulations of the CCS, the following agents were chosen for their reportedly 
selective modes of action. It was hoped that results thus obtained would verify the earlier findings 
and strengthen them. 
6.2.1.1 CaM inhibition 
Of particular interest then is the antimicotic agent, calmidazolium (1-[bis(p-chlorophenyl)methyl]-3-
[2, 4-dichloro-j3-(2, 4-dichlorobenzylox y)phenethyl] imidazolinium chloride) more convenientl y 
referred to by its code number R24571, a highly specific CaM antagonist. 
Van Belle, (l98Ia,b) shows that R24571 inhibits the activation of brain PDE by CaM with a 500 
times greater potency than TFP. Unlike the other agents (phenothiazines) it has no affinity for 
dopamine receptors at concentrations that completely inhibit CaM-regulated functions. R24571 is 
therefore proposed as a useful experimental tool. 
6.2.1.2 Calcium depletion 
Ethyleneglycol-bis(j3-aminoethylether)-N ,N ,N' ,N' -tetraacetic acid (EGT A) is a selective chelating 
agent with high selectivity for Ca2+ (Miller, 1984). EGTA is widely used in biochemistry and 
physiology to buffer Ca2+ ions. It has a stability constant such that Ca2+ can be buffered in the 
micromolar range near neutral pH, as is often required to mimic physiological concentrations. It has 
poor cellular penetration and therefore binds predominantly the external Ca2+(present in the medium) 
with a molar ratio of I: 1 (Bennet, 1979). 
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EGT A therefore provides a useful means of depleting extracellular Ca2+ . 
6.2.1.3 CaM-sensitive PDE inhibition 
Agents used widely for their ability to inhibit PDE activity are the alkylated xanthines [caffeine, 
theophylline and 1 methyl-3-isobutyl-xanthine]. Progressive modification of the methyl xanthines 
(known inhibitors of cyclic nucleotides) led to the flavonoids, a group of compounds with 
antiallergic properties. 
Various other pharmacological effects have also been attributed to the flavonoids. Of these, the 
finding that they inhibited cAMP hydrolysis by PDE is one of the most interesting (Graziani 
Chayoth, 1977). Ruckstuhl and Landry (1981) have reported that some flavonoids are more 
selective for cGMP. 
Bergstrand et al., (1976) studied the antiallergic drug 2-o-propoxyphenyl-8-azapurin-6-one 
propane (M&B 22948) an inhibitor of cGMP and found that it has high selectivity for cGMP. 
Miot et al., (1983) have shown that in the dog thyroid gland, a CaM-sensitive PDE is activated by 
a rise in [Ca2+]j. This becomes the dominant catalytic isozyme and M&B 22948 is able to 
inhibit the response. 
M&B 22948 should thus inhibit the CaM-sensitive cGMP component of PDE (Wells and Kramer, 
1981), were it present in the pineal gland. 
6.2.1.4 Ca2 + Ionophore 
The most currently active area of ionophore interest arises from the ability of a carboxylic 
antibiotic to transport the key biological control ion, Ca2+ , across biological membranes. 
A23187 is a unique ionophore tool because it is predominantly selective for divalent over 
monovalent ions. (Pressman, 1976 and references therein). It is thus capable of stimulating 
various Ca2+-dependent biological reactions without disturbing pre-existing balances of Na+ and 
K+. 
Since the ionophore appears to introduce calcium rapidly into the cell under mild experimental 
conditions. this reaction might be used as an effective experimental tool to study the response 
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pathways of Ca2+ -dependent effects. As in the case with the synthetic butyryl derivatives of 
3' ,5' -cAMP which penetrate the cell and activate certain biological systems, the ionophore may 
serve as an experimental by-pass in some hormonal receptors. Sellinger, (1974) has made 
effective use of this ion bearer in a parallel system, to elucidate the role of Ca2+ influx following 
ex I-adrenergic stimulation in the rat parotid gland. 
Thus with a suitable armamentarium at hand, the modes of action of these agents could be used to 
manipulate the CCS in such a way as to mimic the effect of the CCBs on the conversion of [14C]-
serot~nin to its N-acetylated products (NaP = ([14C]-aMT + [14C]-aHT) in organ cultures of rat 
pineal glands. 
6.2.2 
6.2.2.1 
Materials and methods 
Materials 
Ethyleneglycol-bis(l1-aminoethylether)-N ,N ,N' ,N' -tetraacetic acid (97 % purity) was purchased 
from Sigma Chemical Co., USA. A23187 and R 24571 were purchased from Boehringer 
Mannheim, West Germany. M&B 22948 was a gift from May & Baker Ltd, Port Elizabeth, 
S.A.. Dimethyl sulphoxide (DMSO) was of analytical grade from commercial sources, and the 
sources of the other drugs and materials have been recorded [§ 2.2.1.1]. 
6.2.2.2 Animals 
Adult male Albino Wistar rats (180 - 220 g b.wt) were used in this organ culture study for the 
reasons previously outlined [§ 2.2.1.2]. Their environment has been described in the same 
section. 
6.2.2.3 
6.2.2.3.1 
MEmODS 
Experiment A 
Rats were sacrificed between 09hOO and 09h30. Their pineal glands were removed [§ 2.2.1.3], 
and each transferred to a separate sterile culture tube containing BGJb (Fitton-Jackson 
modification) culture medium at the required volume. 
Tubes were arranged in groups of four. The agents listed below in column two were then added 
to the culture medium, whereafter the glands were incubated for 30 min. After this 30 min 
period, the adrenergic agonist ISO was added at the concentrations listed in column one. 
". 
-162-
The groups of tubes thus contained in a final incubation volume of 50J.LI, the following 
combinations of drugs, at the listed concentrations: 
Column 1 Column 2 
i) [10J.LM] ISO + vehicle (Control) 
ii) [10J.LM] ISO + [ 3 • 3mM ] EGTA 
iii) [lJ.LM] ISO + [10J.LM]A23187 
iv) [10J.LM] ISO + [10J.LM]M&B 22948 
iv) [10J.LM] ISO + [1J.LM]R 24571 
The incubation was terminated after a 24 h incubation period. lOJ.LI aliquots of medium were 
removed, and spotted onto TLC plates. The radioactive metabolites were separated by two-
dimensional TLC methods, and quantitated using liquid scintillometry as described in [§ 2.2.1.5]. 
Results from all groups of glands were then compared with control glands incubated with vehicle, 
in the presence of ISO [lOJ.LM]. 
Stock solutions [0. 1M] of A23187! R 24571 and M&B 22948 were made up in DMSO and serially 
diluted in culture medium, while EGTA was dissolved in distilled water. These agents were 
added to the vessels in the required volumes. ISO and NA were dissolved in culture medium. 
The unstimulated control received an equivalent amount of vehicle. 
DMSO (1 %) solvent in control experiments produced no change in the aHT, aMT or N-acetylated 
product levels. 
6.2.2.3.2 Experiment B 
The procedure in Experiment A [§ 2.5.2.3.1] was repeated, but NA replaced ISO at the same 
molar concentrations. 
The groups of tubes thus contained in a final incubation volume of 50J.LI, the following 
combinations of drugs, at the listed concentrations: 
Column 1 Column 2 
i) [lOJ.LM ]NA + vehicle (Control) 
ii) [10J.LM]NA + [ 3 • 3mM ] EGTA 
iii) [ IJ.LM]NA + [10J.LM]A23187 
iv) [lOJ.LM]NA + [lOJ.LM]M&B 22948 
iv) [ lOJ.LM]NA + [lJ.LM]R 24571 
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The incubation was terminated after a 24 h incubation period. IOJLI aliquots of medium were 
removed, and spotted onto TLC plates. The radioactive metabolites were separated by two-
dimensional TLC methods, and quantitated using liquid scintillometry as described in [§ 2.2.1.5]. 
Results from all groups of glands were then compared with control glands incubated with vehicle, 
in the presence of NA [10JLM]. 
Agents were dissolved as described above [§ 6.2.2.3.1) . 
. 6.2.2.4 Data analysis and statistics. 
Data are expressed as dpm I IOJLI medium, with each point representing the mean ± SEM of each 
group of four glands. 
In keeping with the earlier convention, the results of this organ culture study were assessed using 
primarily the aRT and aMT metabolites as markers. N-acetylated product (NaP) was used as a 
gauge of overall pineal activity. 
Statistical analysis for multiple groups is best analysed using an analysis of variance (ANOV A) 
test (Modrak, 1983). The Kruskal-Wallis H test is the nonparametric equivalent test. The 
significantly different groups were identified using the post-hoc Neuman-Keuls multiple range 
test. Groups were judged at the p < 0.05 level of significance. 
6.2.3 
6.2.3.1.1 
Results and Discussion 
Results of glands stimulated with ISO 
The results are presented in Table 6.1 and Figure 6.1. 
6.2.3.1.2 Discussion 
Glands stimulated with ISO showed an increase in aHT, aMT and N-acetylated product, similar to 
that seen in the initial studies [§ Chapter 2]. The addition of Ca2 + to the culture medium of 
glands already stimulated with ISO was not attempted since initial pilot studies showed no effect 
here. The earlier NAT studies had also shown no effect here. This is in contrast to the findings 
of Morton, (1987) who shows an inhibitory role for Ca2+. 
Table 6.1: The effect of CCS manipulations 011 f14Cl-serotonin metabolism in rat pineal glands. 
GROUP Metabol i te GROUP Metabol ite 
aHT aMT NaP aHT aMT NaP 
ISO[10~MJ + Vehicle Control 2850 1: 185 3044 1: 162 5894 1: 301 NA + Vehicle 3481 1: 200 3283 1: 555 6764 1: 750 
ISO[10~MJ + [3.3mMJEGTA 1150 1: 221(a) 2044 1: 121 3194 1: 270(a) NA + EGTA 2029 1: 227(a) 2530 1: 163 4559 1: 411 
ISO[1~MJ + [10~MJA23187 1809 1: 112(a) 4000 1: 276 5810 1: 200 NA + A23187 3065 1: 363 3448 1: 126 6513 1: 247 
ISO[1~MJ + [10~MJM&B 22948 2687 1: 280 3695 .:t 444 6382 1: 307 NA + M&B 22928 3275 1: 503 7782 1: 371(b) 110571: 631(b) 
I SO [1~MJ + [1~MJR24571 2908 1: 283 3460 .:t 206 6368 1: 401 NA + R 24571 4311 1: 265 6422 1: 265(b) 10734 1: 525(b) 
JO~1 aliquots of medium were chromatographed by nc. Results are expressed as dpml pineal gland (mean ± SEM; n = 4 individually cultured glands per group). 
Significance is computed usillg the Neumall-Keuls multiple range test; p < 0.05 w.r.t respective vehicle control. 
(a) significantly decreased w.r.t vehicle control 
(b) significantly increased w.r.t vehicle control INeuman-Keuls mUltiple range test; p < 0.05 
I 
.-
~ 
I 
0 
0 
0 
.... 
x 
:! 
:::) 
C 
w 
:! 
~ 
.... 
--E 
c.. 
" 
8r-------~--------~--------;_----------------~ 
6 
4 
2 
o 
ISO 
I. 
ISO + EGTA ISO + A23187 ISO 
+ 
MB 22498 
ISO 
+ 
24571 
-165-
Figure 6.1: The effect of CCS manipulations on f14C]-serotonin metabolism 
(f~~\W = aHT, f'(J///A] = aMT, fa] = NaP) in rat pineal glands 
stimulated with ISO (mean ± SEM; n = 4 glands per group; p < *0.05 
w.r.t vehicle control: Neuman-Keuls multiple range test) 
This suggests that the Ca2+ must somehow be introduced into the cells for its effect to be seen. 
On the other hand, removal of Ca2+ from the culture medium, with the calcium chelating agent 
EGTA, resulted in a decrease in aRT, aMT and N-acetylated product. This finding is predictable 
from the NAT studies [§ Chapter 3] and has been demonstrated before (Zatz and Romero, 1978; 
Wilkinson, 1978). 
The Ca2+ ionophore A23187 was unable to cause any significant effects by itself in the NAT 
studies, and showed a small significant decrease here in aRT levels in the presence of [lILM] ISO. 
lt potentiated [lILM] ISO stimulated levels of aMT and N-acetylated product, to levels similar to 
those found in glands stimulated with [lOILM] ISO. This shows that the ionophore is able to 
mimic the potentiation shown to occur in glands following combined al- and {3-adrenergic 
stimulation. 
This is in agreement with other reports showing a role for Ca2+ influx in the adrenergic 
regulation of this gland [§ 2.5.1.2]. The results with EGTA show that there is a requirement for 
Ca2+ even in the presence of {3-adrenoceptor stimulation. 
There does not seem to be any significant effect on either aHT, aMT or N-acetylated product in 
the presence ofM&B 22948 or R 24571. This is similar to earlier fmdings which measured NAT, 
cAMP and PDE levels in glands stimulated with ISO in the presence of verapamil or nifedipine. 
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6.2.3.2.1 Results of glands stimulated with NA 
The results are presented in Table 6.1 and Figure 6.2. 
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Figure 6.2: 
6.2.3.2.2 
NA 
If 
NA + EGTA NA + A23187 NA + MB 22948 NA + R24571 
The effect of CCS manipulations on r14C]-serotonin metabolism 
([rJ!!!Ji = aHT, r~\\\\'IJ = aMT, r-J = NaP) in rat pineal glands , 
stimulated with NA (mean ± SEM,' n = 4 glands per group; 
p < *0.05 decreased w.r.t vehicle control; p < ** 0.05 increased 
w.r.t. vehicle control: Neuman-Keuls multiple range test) 
Discussion 
These results are similar to those observed following NA stimulation in the presence of CCB. 
EGTA abolished the stimulation of NA. with the N-acetylated product being significantly 
decreased. 
The combination of A23187[10J.l.M] and [lJ.l.M] NA shows a synergistic effect similar to that seen 
with NA [lOJ.l.M]. The dose response experiments [§ 3.4.3] found that [IJ.1.M] NA produced only 
a small. non-significant increase in NAT activity. 
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Although aHT does not seem to be increased to any extent, it could be the result of simple 
substrate elimination, i.e. it is being used up to produce the peaks in N-acetylated product seen in 
the presence of A23IS7, M&B 22948 and R 24571 and also the peak in aMT seen in the presence 
of the latter two agents. 
These findings clearly support the earlier hypothesis that a CaM-mediated effect (the inhibition of 
CaM-sensitive PDE) could be responsible for the results found. 
6.2.4 Conclusion 
These studies highlight the critical nature of Ca2+ levels in the control of the CCS. 
It has been shown that Ca2+ is necessary for the adrenergic function of the pineal gland. This 
necessity is far greater in the case of aI-receptor stimulation where it would seem more systems 
are reliant on the Ca2+ influx. One example is the potentiation seen following al - and {3-
receptor stimulation which occurs via a Ca2 + -dependent protein kinase. 
If the concentration of [Ca2+]j is so critical, then any deviation would make less of it available, 
and the system more sensitive to what is available. If this hypothesis is extended further to 
include a fixed quantity of CaM available for Ca2+ to bind to and activate (Manalan and Klee, 
1984) the following situation is possible: assuming that the CCBs are blocking some of the VOC 
available, then less Ca2+ can enter the cell. (This is also assuming that the CCBs are binding 
some to CaM present in the cell). This situation would have equal consequences in 1SO- or NA-
stimulated cells, provided there was no difference in the Ca2+ utilization of the stimulated cells. 
As stated above, aI-receptor stimulation is accompanied by a greater requirement for Ca2+, thus 
the NA system would be more sensitive to the CCBs, were they to bind to CaM. This would 
allow less CaM to be available for the activation of cAMP-PDE, and the potentiation due to PDE 
inhibition, found thus far, would be possible. 
It however remains to be seen if NAT activity and PDE activity can be shown to be altered using 
these CCS manipulations. 
6.2.5 Objective 
The next investigation examines the role of calcium and the CCS in the adrenergic receptor 
control of NAT and PDE, by using several experimental manipulations which vary not only the 
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concentration of Ca2+ within the culture vessels, but which also manipulate the CCS's activation 
of the CaM-sensitive POE. 
6.3 
6.3.1 
Experiment 2: THE EFFECT OF CCS MANIPULATIONS ON NAT 
AND cAMP-POE ACTIVITY IN RAT PINEAL GLANDS 
Introduction 
. In a number of tissues there appears to be an interaction between cAMP and calcium in their 
regulation of the effects of hormones (Zatz and Romero, 1978). Oata indicate that at least part of 
the action of intracellular calcium is indirect and that it affects induction at a step beyond cAMP 
because the latter still rises after 10 min when stimulated with butyryl derivatives of cAMP. 
The rise in NAT occurring at night is well documented. The data presented by Iuvone and 
Besharse (1986), indicate that the increase in NAT requires extracellular calcium in the 
micromolar range and that calcium influx through a VOC is involved. Antagonists of VOCs 
including nifedipine and methoxyverapamil (0600) were found to be effective inhibitors of the 
dark-dependent increase in NAT activity. TFP at 100JLM also effectively inhibits this increase. 
However data concerning the CCBs are not always in agreement e.g. Meyer et ai., (1986) have 
shown that two classes of CCB administered in vivo to baboons, produce different effects on 
circulating plasma aMT levels at night. Three dihydropyridine CCBs, one of which was 
nifedipine, reduced aMT levels. Verapamil had no effect. 
In order to clarify the results found in the preceding chapters, and maybe to elucidate the mixed 
findings in the literature, it was hoped that NAT and POE levels could be determined in the same 
glands, while the CCS was manipulated with the test drugs. 
Quite by chance it appeared that this would be possible if the glands were homogenised in the 
NAT buffer but not the POE buffer. Steinlechner et ai., (1984) have shown that NAT is sensitive 
to pH and is irreversibly blocked by pH higher than 6.9, while POE is not that critical of pH 
(pH's of 7 to 8 are commonly reported in POE assays in the literature). In addition, the 
phosphate present in the NAT phosphate buffer would have a beneficial effect on the POE assay. 
It has been shown to help prevent the further hydrolysis of 5' -AMP by 5' -nucleotidase, under 
assay conditions (Goldberg et ai., 1969). 
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Pilot studies confirmed that in pineal glands stimulated with [lOILM] ISO or (lILM] ISO and 
[3mM] aminophylline, an increase in both NAT and PDE activity was observed, and that the 
effect of the lower dose of ISO was potentiated by the aminophylline. Oleshansky and Neff, 
(1975) have reported similar results. 
6.3.2 
6.3.2.1 
Materials and Methods. 
Materials 
Sources of all drugs, materials and chemicals have been recorded in previous chapters. 
6.3.2.2 Animals 
Adult male Albino Wistar rats (200 - 250 g b. wt) were used in this study. Their environment has 
been described in [§ 2.2.1.2]. 
6.3.2.3 
6.3.2.3.1 
METHODS 
Experiment A 
Rats were sacrificed between 09hOO and 09h30. Their pineal glands were removed [§ 2.2.1.3], 
and transferred to sterile culture vessels containing BGJb (Fitton-Jackson modification) culture 
medium at the required volume. Four pineal glands were transferred to each vessel. 
Stock solutions [0. 1M] of A23187, M&B 22948 and R 24571 were made up in DMSO and serially 
diluted in culture medium, while EGT A was dissolved in distilled water. These agents were 
added to the vessels in the volumes required to achieve the concentrations listed below for each 
group for glands. 
The unstimulated control received an equivalent amount of vehicle. The adrenergic agonists ISO 
(at the concentration indicated below) and NA[lOILM] were added after a 20 min preincubation 
with the test agents. 
The eight vessels thus contained in a final incubation volume of 2001L1, the following 
combinations of drugs, at the listed concentrations: 
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Column 1 Column 2 
i) [ OILM] agonist + vehicle (Basal) 
ii) [lOILM] ISO + vehicle 
iii) [lILM] ISO + [lOILM] A231S7 
iv) [ lOILM]NA + [ 3 • 3mM ] EGTA 
v) [ OILM] agonist + [lILM] R 24571 
vi) [ lOILM]NA + [lILM] R 24571 
vii) [ lOILM]NA + [lOILM] M&B 22948 
viii) [ lOILM]NA + vehicle 
. The vessels were then placed in glass vials as described in [§ 3.4.1.3], incubated for 3 hours at 
37°C, whereafter the pineal glands were removed from the culture medium, and each transferred 
to its own homogenisation tube, containing 80ILI of cold O.05M phosphate buffer (PH 6.5) and 
kept on ice. Pineal glands were homogenised by 6-8 full rotations of a glass homogenation rod. 
Fifty microlitres of homogenate was removed and transferred to a corresponding culture tube for 
the determination of N-acetyltransferase activity as described [§ 3.2.1.4]. 
6.3.2.3.2 Experiment B 
A further 8ILI aliquot was removed from each homogenisation tube used above [§ 6.3.2.3.11. 
These aliquots were transferred to reaction tubes and assayed for cAMP-PDE activity as described 
previously [§ 5.2.1.4.21. 
6.3.2.4 Data analysis and statistics. 
Data from the NAT assay are expressed as pmol of N-acetyltranferase activity! pineal gland! h, 
while data resulting from the determination of cAMP-PDE levels (the mean of duplicate 
determinations) are expressed as nmol cAMP hydrolysedl30 min! pineal gland. 
Each bar represents the mean ± SEM of 4 glands. 
Statistical comparisons are made using the nonparametric Kruskal Wallis H test. Significantly 
different groups were identified using the Keuls-Neuman multiple range test at the (p < 0.05) 
level. 
6.3.3 
6.3.3.1.1 
Results and Discussion 
Results of glands assayed for NAT and cAMP-PDE activity 
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The results are presented in Figure 6.3. 
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pineal /h 
[01 + VEH 
[lOIISO + VEH 
[11 ISO + A23187 
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[10]NA + R24571 
[10]NA + M&S 22948 
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Figure 6.3: Levels of N-acetyltransferase (pmol)[I"j and cAMP-PDE (nmol)[IHi:T;!;;j 
activity determined in the same pineal glands stimulated with either ISO or 
NA in the presence of CCS manipulations as indicated (mean ± SEM; n = 4 
glands per group; P < *0.05 increased w.r.t. vehicle control; P < ** 0.05 
decreased w.r.t. vehicle control: Neuman-Keuls multiple range test) 
6.3.4 Discussion 
The results from both experiments will be discussed together to facilitate their interpretation. 
Those glands stimulated with ISO [lOJLM] show the expected increase in NAT, as well as a 
concomitant increase in cAMP-PDE, as would be expected from earlier findings [§ Chapter 5]. 
[IJLM] ISO + [lOJLM] A23187 show the predictable synergistic results, seen earlier in the organ 
culture experiment above [§ 6.2.2.2.1]. Coupled to this, the cAMP-PDE levels for this group 
have also risen in parallel. The reasons for the increase in PDE following adrenergic stimulation 
have been discussed in Chapter 5. 
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NA [lOJLM] + EGTA [3.3mM] shows an inhibition of the NA activation of NAT, and cAMP-
PDE also does not rise above basal levels. The fact that the latter does not rise could be ascribed 
to two facts: i)cAMP-PDE is coupled to increases in adrenergic activity, and ii) a possible Ca2+-
sensitive mechanism may be at work i.e. Ca2+ is needed for the activation of cAMP-PDE. Levin 
and Weiss, (1976) have presented data showing two groups of Ca2+-CaM-sensitive PDE 
inhibitors to exist. The first group (EGT A type) prevents the Ca2 + -dependent activation of PD E 
by binding the Ca2+, while the second group of inhibitors (as exemplified by the phenothiazine 
group of compounds) bind to CaM itself and prevent activation thereof. 
R 24571 by itself produces no effect, either on NAT or cAMP-PDE. This is to be expected from 
the previous experiment, where it appeared that basal activity was not influenced by this CaM 
inhibitor. Epstein et al., (1982) have shown that the calcium antagonists are all two to five fold 
more potent against the CaM-sensitive PDEs in their activated state than in their resting basal 
state. From these findings it would appear that the activated state would be analogous to the 
situation during which the Ca2+ influx is occurring. 
In support of this, in the presence of NA, a potentiation with R 24571 is seen which is greater 
than either IS0[10JLM] or NA[10JLM] alone. Of even greater interest is the fact that cAMP-PDE 
has not risen in a parallel manner, as would be expected following normal adrenergic activation. 
This suggests that some form of PDE inhibition is probably occuring. 
This is by far the best proof the a CaM-dependent mechanism is at work in the potentiation 
following NA stimulation in the presence of the CCBs. 
The CaM-sensitive PDE inhibitor causes a rise in NAT activity. The PDE activity for this group 
shows a rise greater than that with R 24571, but less than that found, when a reference 
competitive PDE inhibitor (aminophylline) was used in pilot studies. 
Pure competitive inhibition resulted in large increases in available PDE. In this assay system; this 
is as a result of levels of PDE rising due to adrenergic triggering, but being inhibited from acting 
by the aminophylline in the culture medium. Thus the cAMP continues to rise (within the pineal 
gland) and continues to trigger an increase in its terminator (PDE) which is then detected in the 
assay system. 
The finding implies that some mechanism, other than pure competitive inhibition IS active. 
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Although purely speculative, it could be that M&B 22948 is inhibiting the cGMP-PDE component 
of PDE I, and in so doing is making less cAMP-PDE available (partial inhibition). This would 
account for the increased NAT levels found. Alternately, it could also be that the CaM-sensitive 
cGMP-PDE is being inhibited. It would not have been possible to determine this in the present 
system, but the result would be that cGMP rises. Kabovetz et ai., (1979) have shown that the 8-
azapurine-6-one (M&B 22948) can selectively increase cGMP levels. The role of cGMP in the 
pineal gland is unclear, but it is well known that in many tissues, cGMP can inhibit cAMP-PDE 
activity . 
. Work from Sugden and Klein (1987), suggests that the regulation of cGMP levels in the pineal 
gland involves an Ns-like GTP-binding regulatory protein. This is of interest because it is the 
first indication that cGMP is regulated by such a GTP-binding protein in nonretinal tissue. 
Continuing on from this, is the possibility that a cGMP-PDE may be involved in regulating pineal 
cGMP, as is the case in the retina. Support for this comes from the finding that the mammalian 
retina and pineal share a number of unusual proteins (Axelrod and Weissbach, 1962; Somers and 
Klein, 1984 and Van Veen, 1986a), some of which (rhodopsin kinase (Somers and Klein, 1984) 
and S-antigen (Van Veen, 1986a) are involved transmembrane signalling (Stryer, 1986). In the 
rod outer segment, the GTP-binding protein orG protein, transducin, couples the photon receptor 
rhodopsin to a specific cGMP phosphodiesterase; light sensitive activation of this enzyme cascade 
results in a decrease in cGMP through activation of the cGMP-PDE (Bitensky et ai., 1984; 
Rosenthal and Schultz, 1987). The resulting decrease in cytosolic cGMP concentration causes a 
reduced cation channel activity, and hyperpolarization of the cell (i.e. "tum off") (Rosenthal and 
Schultz, 1987). 
Were there to be an inhibition of the activation of this cGMP-PDE, the cation channel activity 
would not be decreased, and activation of the VOC would contribute to a sustained elevation of 
Ca2+, and its dependent processes. In related work by Stem et ai., (1986), diltiazem has been 
shown to inhibit the "tum off" to light response, in rod photoreceptors. 
Although immunoreactive transducin does not appear to be present in the rat pineal gland (Van 
Veen et ai., 1986b), a related N protein controlling a specific cGMP phosphodiesterase could be 
present. 
This is however purely speculative and a full biochemical characterization would be required 
before any firm conclusions can be drawn, as to the type of inhibition taking place, and secondly, 
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the specific PDE which is being inhibited. For example, competitive inhibition if best analysed 
with Dixon plots, and Lineweaver-Beurk plots would also differentiate the types of inhibition 
(Dixon, 1953). 
What is apparent however, is i) that a CaM-sensitive PDE seems to be present in the pineal, and 
ii) that the CCBs were binding to CaM, and inhibiting the function thereof, especially when the 
pineal was being stimulated in vitro with NA in the presence of the CCBs, verapamil, diltiazem 
and nifedipine. This conclusion is reached from the data presented above which shows that 
specific CaM -antagonists are able to mimic the results found with the CCBs. 
6.4 COMMENTARY AND CONCLUSIONS ON THESE STUDIES 
The data of Theyer and Fairhurst, (1983) suggest that the dihydropyridine and CaM-antagonists 
(TFP and R24571) have a common binding site, to which they bind in a Ca2+ -dependent manner 
as described by Levin and Weiss (1979). The data also rule out non-specific membrane effects but 
show that the binding is competitive for the hydrophobic domains exposed on CaM, when it binds 
Ca2+. The dihydropyridines alter the 113Cd NMR spectrum of CaM (Brostrom, 1981) in an 
analogous manner to R 24571. Johnson and Wittenauer, (1983) made use of a dansylated CaM to 
characterise the interaction of hydrophobic ligands (including several dihydropyridines) with CaM 
and CaM -antagonists. More recent data suggest that the dihydropyridines may bind at the second 
binding site on CaM, while TFP binds to the carboxy-terminal domain (Orosz et aI., 1988; 
Inagaki and Hidaka, 1984). Johnson and Mills (1986) have shown that the two binding domains 
exert allosteric control over each other, but the exact relationship to target proteins has not been 
clarified. In some cases the antagonists bind to CaM, and prevent further binding, while in others 
a non-active adduct binds to PDE e.g. a TFP-CaM (Newton et at., 1985). 
6.4.1 Ca2+ -dependent interaction with a CaM-sensitive PDE in the pineal 
gland 
Results presented herein support a possible mechanism of action for the CCBs, verapamil 
diltiazem and nifedipine, which involves Ca2+-dependent interaction with CaM and consequent 
inhibition of Ca2+ -dependent enzymes e.g. cAMP-PDE. Such inhibitory effects would favour the 
present fmdings, and have been demonstrated with the dihydropyridine derivative, felodipine. 
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6.4.2 Differences in functional in vitro activity 
To date several attempts have been made to sort out and to classify the various compounds 
exhibiting Ca2+ -entry-blockade activity by means of their structural properties, their binding 
characteristics in general (and more specifically to CaM) and their pharmacology. 
Thus while the compounds as a group share several common properties such as antagonising Ca2+ 
entry, there exist certain distinct fundamental in vitro differences between them, e.g. data 
probably not relating to channel function suggest that all these agents bind to a greater or lesser 
. degree to CaM. The studies of Johnson and Mills, (1983) provided the first evidence that CaM 
was indeed an allosteric protein with regard to its drug protein binding sites. With regard to 
allosteric interaction, one of the best studied discrepancies is that verapamil-like agents inhibit the 
nifedipine analogue nitrendipine in several tissues whereas diltiazem facilitates its binding at these 
sites (Johnson, 1984). 
A further question on their mechanism of action is being raised by the presense of G proteins. 
With their role in receptor-mediated regulation of enzymes, G proteins may act as transducers 
between cell surface receptors and the VOC, mediating not only hormonal stimulation but also 
inhibition of ion channel activity (Rosenthal and Schultz, 1987). G proteins are not only involved 
in the hormonal modulation of Ca2+ channel activity, but apparently also modify the effects of 
Ca2+ channel ligands such as D600, nifedipine, and diltiazem on Ca2+ currents (Scott and 
Dolphin, 1987). 
These findings raise the question of whether CCBs interact exclusively with the channel protein 
or, if in addition, they interact with G proteins or other components that participate in the 
modulation of voltage dependent Ca2+ channels (Rosenthal et ai., 1988). 
Other non-channel in vitro differences are reported. Verapamil and diltiazem but not nifedipine 
have the ability to interfere with CaM activation of the Ca2+ -pump and ATPase. The failure of 
nifedipine to do this is in agreement with the studies of Lamers et al., (1985) who found the same 
discrepancy when working with soluble dog brain CaM-activated-PDE. 
The differences observed with diltiazem relative to results using verapamil and nifedipine in the 
present study, could possibly point to a difference in the respective ability of the CCBs to inhibit 
Ca2+ entry. This however is purely speculative, and should be regarded with care in view of the 
large intra-species variations seen in pineal work. For instance Meyer et al., (1986) have shown 
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that two classes of CCB administered in vivo to baboons, produced different effects on circulating 
plasma aMT levels. Nifedipine reduced aMT levels in the plasma, while verapamil did not. On 
the other hand, Morton et al., (1989) shows data where verapamil prevents a decrease in aMT (in 
rats forced to swim), while nifedipine is less effective. 
Thus explanations for the selectivity and/or functional differences of the pharmacological action of 
these drugs may also include: (a) differences in the functional dependence of certain organs or 
blood vessels on the extracellular calcium, (b) a possibility that modulation of the Ca2 + channel 
may modify specific binding and consequently sensitivity to Ca2+ channel inhibitors, (c) the fact 
that different vascular beds are dominated to a different extent by the sympathetic nervous system, 
and (d) differences in the relative importance of ac, ar and -y-adrenoreceptors (Neild and Ze1cer, 
1982) for a given system (Janis and Scriabine, 1983). 
It would however appear that in this system yet another functional in vitro difference between this 
heterogenous group of compounds is apparent, as typified by the difference which diltiazem 
(following ISO stimulation) exhibited for most of these studies. This leaves one firm conclusion 
to be made; caution should be exercised in the interpretation of experiments in biological systems 
when these drugs are used. 
6.4.3 Therapeutic relevance 
Considering the concentrations used in all these studies in an attempt to bring about inhibition, it 
would be hard to reconcile these results with any theraputic relevance. No clinically employed 
drug is presently known to exert its principal pharmacologically desired effects by binding to 
CaM, in spite of much research and even newer more specific agents (Van Belle, 1984; Agre 
et al., 1984). The micromolar concentrations used herein are in general higher than typical dose 
ranges for verapamil or diltiazem (0.01 to 10JLM) and nifedipine (0.001 to 1JLM) (Kim and Raess, 
1988). However, it is known that some of these drugs may reach concentrations in membranes 
that are ten to twenty times higher than their extracellular levels (Pang and Sperelakis, 1983; 
Keefe and Kates, 1982). Also, all the studies recorded herein are with in vitro studies, which 
could well be vastly different from the in vivo situation. 
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CHAPTER 7 
CHAPTER RESULTS AND SUMMARIES 
7.1 Chapter 1 
Systematic anatomical and physiological studies have led to the idea of the pineal gland as a 
neuroendocrine transducer converting neural and environmental information into a hormonal 
response, namely the secretion of melatonin. In the literature, the calcium signal has emerged as 
. an important component of intracellular regulation. In the pineal gland, the prominent 
calcification seen in the gland with increasing age was thought to slow pineal function, but more 
recently, ea2+ have been found to playa crucial role in the adrenergic regulation of the gland, 
acting via a1- adrenoceptors. 
NA released into the pineal perivascular space from sympathetic nerve terminals at night. 
increases melatonin synthesis by increasing the activity of NAT. An essential step in the 
adrenergic induction of NAT activity is an increase in intracellular cAMP. NA also elevates 
pinealocyte cGMP. Adrenergic regulation of these cyclic nucleotides involves both a 1- and {3-
adrenoceptors. {3 - Adrenoceptor stimulation is an absolute requirement, a 1-adrenoceptor 
activation amplifies the f3-adrenergically stimulated cAMP and cGMP responses. 
The amplification mechanism appears to involve a positive effect of a Ca2+ -/phospholipid-
dependent protein kinase (Protein kinase-C). Activation of the pinealocyte a1-adrenoreceptor 
rapidly translocates this enzyme by increasing [Ca2+]j; a correspondingly rapid increase in 
diacylglycerol (DG) generation appears to be totally dependent on extracellular Ca2+. 
Protein kinase-C (PK-C) activation appears to enhance cAMP and cGMP synthesis at a step 
beyond {3-adrenoceptor activation, perhaps involving adenylyl and guanylyl cyclase. In the case 
of cGMP, the increase in [Ca2+]j also appears to be important for activation of processes 
independent of PK-C; these processes may involve activation of phospholipase-A2 and the 
arachidonic acid cascade and are required for full potentiation of {3-adrenergic stimulation. 
As a Ca2+ influx into the pinealocyte appears to playa major role in the regulation of the pineal 
gland, this study attempted to examine this influx. 
In order to do so it was proposed to make use of the pineal gland's well-characterised metabolic 
activity and pathways, as a gauge of that gland's activity, and to use the Ca2+ antagonistic 
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activity of three heterogenous members of the CCB family to probe this phenomenon. 
7.2 Chapter 2 
Organ culture provides an interesting and useful way to study and monitor both the metabolic 
activity. and the effects of drugs thereon, in the pineal gland. 
By way of a validation of the culture system, the effect of isoprenaline stimulation on [14C]-
serotonin metabolism was monitored over a 24 h period, thus showing the progressive formation 
of the indole metabolites. This was the first study to show a full 24 h profile of isoprenaline 
stimulated [14C]-serotonin metabolism in organ cultures of rat pineal glands. 
The results confirmed that organ culture was both a valid and valuable technique with which to 
study the variation in pineal indole production, when pineal glands are subjected to various 
pharmacological manipulations. They further showed that 16 h profiles would appear to be 
optimal for determining the behaviour of isolated pineal glands in the presence of various drugs. 
These findings were published, and received much interest (Banoo et ai., 1987; Daya et ai., 
1989). 
To study the effect of the Ca2+ influx reported to concur with combined al- and ,I3-adrenoceptor 
stimulation in the pineal gland, two adrenergic agonists, ISO and NA, were selected for their 
respective ,13- and a 1 /,13 - adrenoceptor stimulating properties. It was speciously hypothesised that 
the use this drug paradigm would allow the Ca2+ influx occuring with NA stimulation to be 
compared with that of ISO stimulation in the pineal glands (where this influx should not be seen). 
An initial pilot study confirmed that NA[10JLM] produced the same effects as the al adrenergic 
agonist phenylepbrine[lOJLM] when used in combination with ISO[IOJLM]. 
7.2.1 Results 
The results of this study are summarised below in Figure 7.1. 
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Figure 7.1: The effect of organic calcium channel blockers [II} on the production 
of N-acetylated products (NaP), i. e., [sum of [14Cj-N-acetyiserotonin 
and [14Cj-aMTJ in the presence of either ISO or NA[lOpM}, compared 
to control glands with vehicle [E }, in the presence of either ISO or 
NA[10pM}. Each bar represents the mean ± SD,' n=4 pineal glands; 
* ** *** p < : 0.05, 0.01 and 0.025 (Students-t test). 
Following NA stimulation of glands incubated in the presence of verapamil, diltiazem and 
nifedipine a paradoxical increase in stimulation was found. A decrease in NaP production would 
be expected were the CCBs blocking the Ca2+ influx. 
After ISO stimulation verapamil and nifedipine showed the same enhancement, while diltiazem 
did not. In all the organ culture studies, the levels of aRT were found to be increased. These 
findings were published (Brown et al., 1989a). 
7.2.2 Discussion 
It thus seemed that the CCBs were in some manner causing an increase in NAT, the enzyme 
responsible for the formation of aRT. This made it pertinent to examine the effects of these CCBs 
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on the level of NAT in isolation. This would clarify if N AT levels are indeed raised, as suggested 
by the high levels of aRT observed. 
7.3 Chapter 3 
Leading on from the results of Chapter 2, the levels of NAT, the rate-limiting enzyme in the 
metabolic pathway to aMT synthesis, were investigated to see if they would corroborate those 
findings. 
Three initial investigations were undertaken to confirm relationships reported in the literature. 
7.3.1 Results 
A dose-response study showed significant stimulation of NAT to be evident only at concentrations 
of [3J.tM] and [lOJ.tM]. NA showed less stimulation of NAT than ISO had done, providing some 
evidence of intrinsic activity - and, or affinity differences between the two agonists. This dose 
range was similar to that used in the literature. 
The effects of either {3- or al- receptor blockade on ISO and NA stimulation of NAT was 
examined. 
The increase in NAT produced by either ISO or NA was totally abolished in the presence of 
propranolol, a {3-adrenoceptor blocker, confirming that NAT is dependent on {3-adrenoceptor 
stimulation. Prazosin, on the other hand, had no apparent effect on ISO stimulation of NAT. It 
did produce a significant reduction in NA stimulation of NAT activity which was less acute than 
that found with propranolol. This confirmed that NA was active on NAT via both its {3- and al-
receptors. 
The next investigation examined the role of Ca2+ in the adrenergic receptor control of NAT, by 
using several experimental manipUlations designed to vary the Ca2+ concentration. 
EGTA was used as a selective chelating agent, while the calcium ionophore A23187 was used to 
mimic the Ca2+ influx that occurs with the aI-receptor stimulation following ISO stimulation. 
Glands stimulated with ISO showed an increase in NAT. The addition of Ca2+ to the culture 
medium of glands already stimulated with ISO did not bring about any significant change in the 
level of NAT, but the removal ofCa2+ from the culture medium (using EGTA), totally abolished 
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NAT activity. Addition of Ca2+ to this medium restored NAT activity. A23187 was unable to 
stimulate NAT by itself, but when added to the vessel containing ISO [lILM ] , it was able to 
potentiate NAT activity to a level similar to that seen with [lOILM] ISO, showing that an influx of 
Ca2+ coupled to /3-receptor stimulation could produce a synergistic effect and the potentiation 
previously reported. 
Results with NA were much the same, except that the A23187 produced an even greater 
potentiation than that seen in the equivalent ISO study. 
The results in general confirmed that NAT activity was sensitive to manipulations of Ca2+ levels. 
Continuing the original investigation, levels of NAT activity in the pineal glands stimulated with 
either ISO or NA in the presence of the CCBs were determined. 
The following trend emerged: all glands stimulated with NA in the presence of anyone of the 
CCBs showed an increase in NAT activity. Glands stimulated with ISO showed no significant 
differences in NAT activity in the presence of verapamil and nifedipine, but did show an 
inhibition of NAT activity in the presence of diltiazem. 
7.3.2 Discussion 
Looking at the metabolic pathway simplistically represented as: 
t cAMP- t NAT - t aHT - t aMT 
the next logical point of investigation was cAMP. If cAMP levels remained high, correspondingly 
higher levels of NAT, leading to increased acetylation of HT and ultimately to higher 
concentrations of aMT, could be expected. 
7.4 Chapter 4 
The effect of the the three CCBs on rat pineal cAMP levels, was determined to ascertain if the 
latter were indeed raised, as suggested by the high levels of NAT found in Chapter 3. 
The pineal glands were split into two halves to enable the determination of the effect of the CCB 
on pineal cAMP levels in the same gland, by using one half as a control (agonist in the presence 
of vehicle) while the other half was stimulated with agonist in the presence of CCB. Initial 
-182-
studies showed that provided sufficient care was taken when splitting the glands, this approach 
was valid and the cAMP assay chosen was suitable. 
7.4.1 Results 
The finding for the cAMP groups are consonant with the previous NAT organ culture studies. 
The presence of nifedipine and verapamil did not alter the ISO induced increase in cAMP. 
Diltiazem, however, inhibited the effect of ISO on cAMP, showing a statistically significant 
decrease in cAMP levels. 
In those pineal glands stimulated with NA, all three CCBs were found to potentiate the effect of 
NA on cAMP formation. 
7.4.2 Discussion 
In Chapter 3 it was suggested that that the CCBs might in some way influence cAMP levels and 
interfere with the metabolic cascade: 
t cAMP~ t NAT ~ t aRT ~ t aMT 
Intracellular levels of cAMP reflect a balance between adenylyl cyclase and cAMP-PDE activities. 
Although Ct2 - receptors are known to be present on the pineal, and have a negative effect on 
adenylyl cyclase, the nature of the data collected argued against an effect at that level. This left the 
role of cAMP-PDE (the counterpoise) in the control of cAMP levels open to question. 
It is well known that adrenergic agonists will elevate cAMP, and that the same effect may be 
brought about by an inhibition of cAMP-PDE. A few recent reports had suggested that the 
organic calcium channel blockers might well be able to inhibit cAMP-PDE by binding to CaM, a 
protein itself requiring activation by Ca2+ before it can activate cAMP-PDE. 
7.5 Chapter 5 
Chapter 5 therefore made use of a TLC cAMP-PDE assay, coupled to the same drug paradigm, to 
determine whether cAMP-PDE levels were indeed being influenced. 
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7.5.1 Results 
A decrease, although not highly significant (p < 0.10), was observed in those glands stimulated 
with NA in the presence of diltiazem. In contrast, those glands stimulated with ISO in the 
presence of diltiazem showed a significant increase in cAMP-PDE levels, consistent with the 
decreased cAMP level found above. 
Glands stimulated with ISO were not significantly different from those stimulated with ISO in the 
presence of verapamil or nifedipine. However, those glands stimulated with NA in the presence 
of either verapamil or nifedipine also showed a decrease in cAMP-PDE, which could explain the 
raised cAMP levels observed in the previous chapter. 
The results from the cAMP and cAMP-PDE studies on the CCB's are combined in Figure 7.2 and 
clearly show the complementary increases in cAMP, where decreases in cAMP-PDE activity 
occur. These results have been published (Brown et ai., 1989b). 
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7.5.2 Discussion 
The pattern emerging thus showed that the CCBs could be influencing cAMP via an inhibition of 
cAMP-PDE. The possible mechanism for this inhibition, and its role in the pineal gland 
metabolic cascade is shown in the diagrammatic representation in Figure 7.3. Simplistically the 
effects of cAMP-PDE inhibition are: 
AcAMP ... t NAT ... t aHT ... +aMT 
ePDE~ 
5' -AMP 
The findings of Chapters 2 through 5, show a distinct trend of PDE inhibition in the presence of 
the CCBs. The latter group of drugs are reported to inhibit the CaM-activated form of PDE. Thus 
although not by design, the data collected from this study had a rather important consequence: 
they demonstrate the possible presence of a CaM-sensitive PDE within the pineal gland, which 
corresponds to the PDE I form of PDE's, disputing the assumption that the low-Km PDE is the 
dominant enzyme in the pineal. 
7.6 Chapter 6 
As the CCBs are not specific inhibitors of CaM, but inhibit it because of their structural (spatial) 
arrangement, it was decided to investigate this interesting concept further, by using CaM-
inhibitors which were far more specific in their mode of action. It was hoped that the judicious 
use of more specific tools to manipulate the CCS would allow the results found thus far to be 
mimicked. If this could be done, it would add considerable support to those findings. 
Experiments were aimed at two main objectives. Firstly experiments were performed at the organ 
culture level to see whether the earlier work involving Ca2+ manipulations remained valid at this 
level, and secondly to determine whether the results with the CCBs could be mimicked by the 
more specific CaM-inhibitor R 24571 and the CaM-sensitive PDE inhibitor, M&B 22948. 
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7.6.1 Results 
Results obtained in both ISO - and NA stimulated glands in the presence of the various drug 
manipulations, closely resembled those of the earlier studies, showing that it was in fact possible 
to mimic those findings, i.e. following NA stimulation in the presence ofR 24571, a peak in NaP 
production was evidenced similar to that seen in the presence of the CCBs following NA 
stimulation, while the peak did not occur following ISO stimulation. 
They clearly highlighted the critical nature of Ca2+ levels in the control of the CCS, and 
supported the earlier hypothesis that a CaM-mediated effect (the inhibition of CaM-sensitive PDE) 
could be responsible for the results found. 
The final investigation examined the role of calcium and the CCS more specifically at enzyme 
level, i.e. NAT and PDE activity were determined within the same gland, using experimental 
manipulations which varied not only the concentration of Ca2+ within the culture vessels, but also 
the CCS's activation of the CaM-sensitive PDE. 
As expected, cAMP-PDE rose in unison with NA, in both ISO - and NA stimulated glands. 
EGTA abolished the stimulation of both NAT and cAMP-PDE, showing their Ca2+ dependence. 
7.6.2 Discussion 
R 24571 by itself produced no effect, either on NAT or cAMP-PDE. In the presence of NA, a 
potentiation with R 24571 was seen which was greater than that with either ISO[10JLM] or 
NA[10JLM] alone. Of even greater interest was the fact that cAMP-PDE had not risen in a parallel 
manner, as would have been expected following normal adrenergic activation. This suggests that 
some form of PDE inhibition was probably occuring, and adding support to the hypothesis that a 
CaM -dependent mechanism is involved. Inhibition thereof (by binding to the CaM) prevented the 
activation of cAMP-PDE, thereby allowing cAMP levels and therefore NAT levels to rise, 
leading to the potentiation seen following NA stimulation in the presence of the CCBs. 
Supporting this, the CaM-sensitive PDE inhibitor (M&B 22948) brought about a rise in NAT 
activity. The PDE activity for this group, although greater than that observed with R 24571, 
remained considerably less than that found when a reference competitive PDE inhibitor 
(aminophylline) was used in pilot studies. 
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This fmding implied that some mechanism other than pure competitive inhibition was active, and 
although purely speculative, it could be that the M&B 22948 was inhibiting the cGMP-PDE 
component of PDE I, and in doing so, making less cAMP-PDE available (partial inhibition). A 
full biochemical characterization would however be required before any firm conclusions could be 
drawn. 
However, the trend is clearly seen, and parallels that seen in Figure 7.2, where increased cAMP 
levels accompany the decreased cAMP-PDE levels found in those glands stimulated with NA in 
the presence of verapamil and nifedipine. 
7.6.3 Summary 
The data thus collected tentatively suggested that a CaM-sensitive PDE would appear to be present 
in the pineal, and that when the pineal was stimulated in vitro with NA in the presence of 
verapamil, diltiazem and nifedipine, these drugs were possibly binding to - and inhibiting the 
function thereof. This conclusion was reached from the fact that the specific CaM -antagonist - R 
22571-, and the CaM-sensitive PDE inhibitor -M&B 22948- were both able to mimic the 
results found with the CCBs. 
CHAPTER 8 
CONCLUSION 
"A tenet of biochemical pharmacology is that the pharmacological effects of 
drugs are ultimately explainable by discrete biochemical actions. The caveat, of 
course, is that a particular biochemical action, no matter how well documented, 
may not necessarily be the cause of the pharmacological effect. In fact, rarely is 
the biochemical mechanism underlying the pharmacological effect of a drug 
known with certainty" . 
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The results of the current study are a perfect example of this view expressed by Weiss et al.. 
(1982). 
In the rat pineal gland, (j-adrenoceptor stimulation increases cAMP by activating adenylyl cyclase. 
Cyclic-AMP regulates the production of the pineal hormone melatonin, from serotonin, via the 
enzyme NAT. al-adrenoceptor activation, which alone is without effect, has been shown to 
enhance (j-adrenoceptor stimulation of cAMP. This enhancement has been linked to an increase in 
the entry of Ca2+ into the pinealocyte. The organic calcium channel blockers have been used in 
many studies as probes for calcium-mediated processes. The influence of three CCBs viz 
verapamil, diltiazem and nifedipine, on this calcium-mediated event was investigated. 
Instead of a decrease in melatonin production (which would be expected were the Ca2+ influx 
coupled to combined a/(j- adrenergic stimulation to be inhibited by the CCBs) a paradoxical 
increase was found. 
This study then focused on a mechanistic approach adopted to elucidate the possible mechanism 
responsible for the paradoxical increase in melatonin production which is seen following 
incubation of pineal glands when stimulated with the al/(j-adrenergic agonist NA, in the 
presence of the three CCBs. 
Interpretation of the data collected, leaves the following conclusions. 
1) The concentrations used to bring about any inhibition, coupled with the in vitro techniques used 
in this study, make it hard to reconcile these results with any therapeutic relevance. 
2) The widespread use of the organic calcium channel blockers as probes for calcium-mediated 
processes, is not sound practice, as they do not appear to be as specific as one would have liked. 
In fact, this lack of specificity complicated the present study by producing a paradoxical increase, 
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where a decrease was expected on pharmacological grounds. 
3) The results presented herein support a possible secondary mechanism of action for the CCBs, 
verapamil, diltiazem and nifedipine. This involves Ca2+ -dependent interaction with CaM and 
consequent inhibition of Ca2+-dependent enzymes e.g. cAMP-POE. Such inhibitory effects 
would favour the present findings, which suggest i) the possibility that a CaM-sensitive PDE is 
present in the pineal gland and ii) that the inhibition of this enzyme was in fact responsible for 
the paradoxical increase observed. 
4) Considering the possibility that the paradoxical increase observed is as a result of POE 
inhibition, although this study can not give a clear answer as to which precise POE it is, it does 
add tentative support to the findings of other authors as to the possible existence of an Ns-like 
GTP-binding regulatory protein which controls a specific CaM activated cGMP-POE, similar to 
that involved in the retina, and which in turn has control over ion channel activation. 
5) Further, this study raises the possibility of yet another functional in vitro difference between 
this heterogenous group of compounds exhibiting Ca2+ - entry-blockade activity, as typified by 
the difference which diltiazem exhibited (following ISO stimulation), relative to verapamil and 
nifedipine. 
6) Finally, this study shows that the interpretation of experiments in biological systems can be 
extremely difficult when these three drugs are used, and therefore cautions that care should be 
exercised if they are to be used. 
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